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ABSTRACT 
Mobilisation of injured tendons results in improved tendon healing and reduced 
adhesions. The precise mechanism for the effect on adhesions is unknown. This 
thesis presents the development of a series of techniques to examine the hypotheses: 
that mobilisation exerts its favourable effects by modifying local strain responses to 
applied stress by altering cell attachment to the extracellular matrix; that selectively 
blocking cell-matrix attachment can mimic these effects. 
 
Attachment of tendon-synovial complex cells and mobilised and immobilised 
adhesion cells to collagen and fibronectin was examined in vitro. Attachment of 
intrinsic cells and mobilised adhesion cells was higher than that of extrinsic cells and 
immobilised adhesion cells. These data suggest that mobilisation favours intrinsic 
cell attachment to the matrix and their contribution to healing.  
 
An in vivo model system was developed in the injured flexor tendon-synovial 
complex, enabling quantitative hierarchical mechanical assessment of mobilised and 
immobilised adhesions. Three-fold higher local strain values and increased 
heterogeneity of local strain values were seen in mobilised adhesions. Mobilisation 
may result in localised mechanical failure due to altered local strain patterns. 
 
A novel biomaterial was investigated in vitro and in vivo. Reduction in restrictive 
adhesion parameters was observed, with an associated decrease in adhesion 
cellularity without compromising tendon cellularity. Inhibition of fibroblast 
attachment resulted in a mimicking of the effects of mobilisation.  
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AIMS AND HYPOTHESES 
Mobilisation of injured tendons results in improved tendon healing and reduced 
adhesion formation. The precise mechanism for this is unknown. The work presented 
in this thesis tests the hypotheses in the healing flexor-tendon synovial complex: that 
mobilisation results in increased intrinsic cell attachment and reduced extrinsic cell 
attachment in adhesions; that mobilisation has a favourable effect on the local strain 
responses of adhesions to applied stress, which reduces the restrictive nature of 
adhesions; and that selectively blocking cell-matrix attachment mimics the effects of 
mobilisation by reducing adhesion formation without compromising tendon 
cellularity. 
 
These hypotheses were tested through the following aims: 
 To investigate the properties of a novel biomaterial in vitro (Chapter 3).  
 To test the biomaterial to determine its efficacy in reducing restrictive adhesion 
and its effects of tendon and adhesion cellularity, using a flexor tendon-synovial 
complex injury model in vivo (Chapter 4). 
 To develop a suitable model for analysing the effect of mobilisation on tendon 
adhesion tissue organisation, to quantify local strain responses produced in 
adhesions to applied strain and to relate these micromechanical findings to gross 
restrictive parameters (Chapter 5). 
 To determine if there is a difference in cell attachment between the cells of 
different origins from within the digital tendon-synovial complex to collagen and 
fibronectin in vitro. To determine if mobilisation has an effect on attachment of 
cells contributing to tendon adhesion formation (Chapter 6). 
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NOMENCLATURE AND TENDON HISTOLOGY 
Tendons are connective tissue structures, which are made up of a large number of 
collagen fibres, predominantly type I, but also types III and IV. Within the tendon 
core, collagen fibrils are orientated in a longitudinal fashion to form fibres, which are 
encased by a loose connective tissue to form fascicles.  
 
The various cells within the tendon-synovial complex have been termed fibroblasts, 
tenocytes (tendon embedded fibroblasts) or fibrocytes (Manske, Gelberman et al. 
1985). In this thesis, the term fibroblast will be used throughout. Fibroblasts are, in 
fact, found in all parts of the tendon, at different levels and may represent different 
sub-populations (Banes, Donlon et al. 1988). Each group may have a modified role 
in cell attachment, migration and ECM production in response to wounding 
(Riederer-Henderson, Gauger et al. 1983; Khan, Occleston et al. 1998; Ragoowansi, 
Khan et al. 2003; Klass, Rolfe et al. 2009; Wong, Lui et al. 2009).  
 
Tendons may be either intrasynovial or extrasynovial. The former, in whole or part, 
have a synovial sheath, whilst the latter do not. The synovial sheath is a synovial 
lined fibro-osseous tunnel through which the tendon passes freely. The functional 
unit of the intrasynovial long flexor tendons in zone 2 is composite, having the main 
tendon core, an outer tendon surface and a tendon synovial sheath. The whole 
composite unit is referred to in this thesis as the tendon-synovial complex. In order 
to simplify and reduce confusion, in this thesis the fibroblasts of different origins 
within the healing tendon are termed tendon core, tendon surface, and synovial 
sheath fibroblasts. 
30 
 
CHAPTER 1 
GENERAL INTRODUCTION 
1.1 INTRODUCTION: THE CLINICAL PROBLEM 
1.1.1 Nomenclature and Tendon Histology 
1.2 HISTORY OF TENDON HEALING AND ADHESION 
FORMATION 
1.2.1 Extrinsic Model of Tendon Healing 
1.2.2 Intrinsic Model of Tendon Healing 
1.2.3 Modern Concepts in Tendon Healing 
1.2.4 The Effects of Mobilisation on Tendon Healing and 
Adhesion Formation 
1.3 FLEXOR TENDON ANATOMY AND FUNCTION 
1.3.1 Flexor Digitorum Superficialis 
1.3.2 Flexor Digitorum Profundus 
1.3.3 Flexor Tendon Synovial Sheath 
1.4 ANIMAL MODELS IN THE STUDY OF TENDON 
HEALING 
1.4.1 In Vitro Tendon Healing Models 
1.4.2 In Vivo Tendon Healing Models 
1.4.3 Rabbit Tendon Healing Model 
1.4.4 Types of Tendon Injury  
31 
 
1.5 THE EXTRACELLULAR MATRIX IN TENDON 
HEALING 
1.5.1 Phases of Tendon Healing 
1.5.2 Cell Interaction with the Extracellular Matrix 
1.5.3 Fibronectin 
1.5.4 Collagen 
1.5.5 An Extracellular Matrix Gradient 
1.5.6 Integrins 
1.5.7 Mechanotransduction 
1.6 ASSESSMENT OF TENDON HEALING AND 
ADHESIONS 
1.6.1 Clinical Assessments 
1.6.2 Histological Assessments 
1.6.3 Biomechanical Assessments 
1.7 METHODS OF ADHESION REDUCTION 
1.7.1 Mechanical Barriers 
1.7.2 Biochemical Agents 
1.8 BIOMATERIALS AND TISSUE ENGINEERING 
 
 
 
 
32 
 
1.1 INTRODUCTION: THE CLINICAL PROBLEM 
After injury or surgery default mechanism are to repair wounds. In the adult the 
resultant repair is identified by the formation of scar tissue characterised by 
extracellular matrix (ECM) being deposited in an excessive and disorganised way 
(Whitby and Ferguson 1991). However, scarring is unnecessary for tissue repair as 
identified in fetal wound healing (Rowlatt 1979; Larson, Longaker et al. 2010), and 
following hepatic or gingival injury (Schor, Ellis et al. 1996; Michalopoulos 2007).  
 
The initial fibrinous connection  of two or more injured tissue surfaces ultimately 
leads to collagen deposition and fibrotic adhesion formation (Thompson and 
Whawell 1995). Post surgical adhesions occur in up to 93% of patients undergoing 
abdominal operations and 97% of gynaecological pelvic procedures (Liakakos, 
Thomakos et al. 2001). Adhesions can be associated with debilitating pain, infertility 
and bowel obstruction, which has a mortality of up to 15% (Jeekel 1997; Menzies, 
Parker et al. 2001). In tendons, adhesions are most frequent in the digital flexor 
tendon synovial sheath (Potenza 1962; Potenza 1963; Matthews and Richards 1976; 
Phillips, McGrouther et al. 1985). Peritendinous adhesions impede the functionality 
of the normally separate tissue interfaces, restricting tendon movement.  
 
Interventions aim to improve outcomes by restoring tendon glide whilst minimising 
the risk of tendon rupture by not impeding tendon healing. These include the use of 
suture techniques (Savage and Risitano 1989; Lee 1990; Messina 1992) and 
controlled motion regimes such as the Belfast regimen (Small, Brennen et al. 1989). 
Small and colleagues described early active mobilisation following flexor tendon 
repair in zone 2. In this regime the two passive movements of flexion and extension 
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were followed by two corresponding active movements of the digit. The range of 
motion was increased over 6 weeks, at which time the splint was removed. In the 
prospective study in 114 patients with 138 zone 2 flexor tendon injuries the results of 
early active mobilisation commenced within 48 hours of surgery was assessed using 
the grading system recommended by the American Society for Surgery of the Hand. 
The authors found that the active range of motion recovered was graded excellent or 
good in 77% of digits, fair in 14% and poor in 9%. Dehiscence of the repair occurred 
in 11 digits (9.4%) and in these an immediate re-repair followed by a similar 
programme of early active mobilisation resulted in an excellent or good outcome in 
seven digits. The authors proposed that, in contrast to immobilisation or passive 
mobilisation, early active mobilisation could safely achieve a greater range of gliding 
with reduced adhesions.  
 
During healing there is a loss in tensile strength of repaired tissue. However, the 
application of early postoperative motion stress in tendons mitigates this loss (Aoki, 
Kubota et al. 1997). When injured flexor tendons are immobilised, adhesions are 
formed within the synovial sheath between the tendon and synovial sheath surfaces 
(Wong, Lui et al. 2009) (Figure 1.1). A tendon repair is required that can withstand 
early active motion. The resistance to active digital flexion has been shown to 
increase rapidly over the first 5 days after surgery (Xie, Cao et al. 2008), supporting 
the need for early mobilisation. However, early active mobilisation protocols 
produce optimal results in only 69% (Peck, Bucher et al. 1998) to 89% of cases 
(Kitsis, Wade et al. 1998). In addition, lack of patient compliance continues to 
impede success (Silfverskiold, May et al. 1993). Persistent reduced excursion due to 
adherent repairs may require flexor tenolysis. This is effective in only 67% of  
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Figure 1.1  The hypothetical spatial distribution of Fn in the healing tendon-
synovial complex during the early stages of healing. The influx of synovial sheath 
fibroblasts (red arrows) and tendon surface fibroblasts (black arrows) to the early 
adhesion matrix is shown. There is minimal contribution from tendon core cells 
during early healing. The synovial sheath cells produce greater quantities of Fn than 
tendon surface cells. Tendon surface cells produce greater quantities of collagen than 
synovial sheath cells. There is therefore an extracellular matrix gradient within the 
adhesion from a Fn matrix closer to the synovial sheath to a collagen matrix closer to 
the tendon.    
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cases (Lister, Kleinert et al. 1977; Strickland 2000). Tenolysis acts as a further 
stimulus to adhesion formation (Strickland 1985; Menzies and Ellis 1990; Holmdahl 
1999). One study has suggested waiting 6 months to a year before considering 
tenolysis (May and Silfverskiold 1993). In summary, the entire process of tendon 
repair, rehabilitation and subsequent intervention can require over a year to 
complete. Consequently, adhesions are a common, debilitating and costly surgical 
problem. There is, therefore, a significant and unmet need for a safe, successful and 
cost effective anti-adhesion therapy.  
 
Adhesion formation and tendon healing have  been described as a “double-edged 
sword” (Lin, Cardenas et al. 2004). That is, while adhesions may contribute to 
tendon healing, excessive scarring can restrict tendon gliding: Deficient or impaired 
repair may lead to premature rupture at the injury site. With regard to the cellular and 
ECM response, a combination of many factors must be simultaneously balanced in 
order to achieve a functionally healed tendon (Lin, Cardenas et al. 2004). Current 
research into tendon healing aims to manipulate the interplay between the biological 
and mechanical factors affecting healing, which may further improve outcomes 
(James, Kesturu et al. 2008).  
 
Mobilisation augments tendon strength by favouring intrinsic tendon healing 
(Gelberman, Amiel et al. 1981; Gelberman, Nunley et al. 1991; Gelberman, 
Steinberg et al. 1991; Kubota, Manske et al. 1996), and decreasing adhesion 
formation (Takai, Woo et al. 1991; Khanna, Gougoulias et al. 2009). The exact 
mechanism for how mobilisation affects adhesion formation is not known. This 
thesis investigates the effect of mobilisation on adhesion formation in terms of how 
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it influences cell behaviour and consequently modifies the biomechanical properties 
of adhesions. The study explores strategies that reduce formation of adhesions 
without impairing healing at the tendon surface. 
 
1.2 HISTORY OF TENDON HEALING AND ADHESION 
FORMATION 
Two mechanisms of tendon healing have been proposed: the extrinsic model and the 
intrinsic model. 
 
1.2.1 Extrinsic Model of Tendon Healing 
In the extrinsic model of tendon healing, it was thought that the tendon had no 
internal ability to heal on its own (Skoog and Persson 1954; Potenza 1962; Potenza 
1963; Peacock 1965). Potenza showed that cells of granulation tissue proliferated 
from synovial sheath cells and invaded the laceration site (Potenza 1962; Potenza 
1963; Potenza 1964). He demonstrated in vivo that mechanically separating the 
laceration site from the surrounding synovial sheath only delayed the invasion of 
peripheral fibroblasts into the wound site, as they circumvented the barrier. Potenza 
regarded the fibrous adhesions between the tendon and the surrounding tissues as an 
integral part of the healing process and essential for vascular and nutritional support 
of the healing tendon. As a result of this, adhesions were thought to be inevitable. 
Potenza deduced from his observations that granulation tissue formed in proportion 
to the amount of tissue injury with resultant new collagen formation.  Granulation 
tissue is made of inflammatory cells, fibroblasts, neo capillaries, cytokines and 
chemokines. Potenza recognised that tendon collagen fibres must mature and 
increase in size and those collagen fibres in adhesions must become loosely arranged 
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and selectively absorbed to restore tendon glide. The mechanisms of how this would 
be achieved are not understood. 
 
1.2.2 Intrinsic Model of Tendon Healing 
The extrinsic concept was later refuted by authors who put forward an alternative 
intrinsic theory of tendon healing (Matthews and Richards 1974; Furlow 1976; 
Lundborg 1976; Matthews and Richards 1976; Lundborg and Rank 1978; Manske, 
Gelberman et al. 1984; Manske and Lesker 1984; Lundborg, Rank et al. 1985; 
Manske, Lesker et al. 1985; Mass and Tuel 1991). In this theory tendon healing was 
the result of fibroblasts intrinsic to the tendon itself, namely those from the tendon 
core and tendon surface, invading the healing site. Intrinsic tendon healing was 
thought to be associated with lack of adhesion formation.  
 
Matthews and Richards produced lacerations in isolated rabbit flexor tendon 
segments while maintaining integrity of the flexor synovial sheath environment 
(Matthews and Richards 1974; Matthews and Richards 1975; Matthews and 
Richards 1976). They observed healing of lacerations in the absence of peripheral 
adhesions. Lundborg studied rabbit flexor tendon segments kept isolated in the knee 
joint cavity as a "tissue culture in situ" model (Lundborg and Rank 1978). Healing 
was observed, and no adhesions were formed. These studies supported the concept 
that tendon healing is an intrinsic process and thus that adhesions are a non-essential 
response at the site of injury.   
 
Potenza and Herte demonstrated that acellular canine profundus tendons placed in 
knee joints also healed, proposing that extrinsic synovial cells must have seeded onto 
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the nonviable tendon (Potenza and Herte 1982). Lundborg later refuted this 
explanation after modifying the experiments in a way that prevented cell seeding. 
(Lundborg, Rank et al. 1985). This was achieved by isolating rabbit tendons in 
silicone tubes sealed with GORE-TEX and placing these subcutaneously in the back 
of the rabbits. Tendons healed by 6 weeks. 
 
Becker and colleagues prepared explants from chicken tendons, and found that these 
produced collagen synthesising fibroblasts (Becker, Graham et al. 1981). Manske 
and Lesker maintained rabbit, dog, chicken and monkey flexor tendon explants in 
culture for 6 weeks (Manske and Lesker 1984). These workers found that the cells 
proliferated and migrated from both the tendon surface and tendon core, and could 
synthesise collagen. They provided both biochemical and histological evidence of 
the capacity for intrinsic tendon healing. Gelberman and colleagues demonstrated 
evidence of healing in the same species (Gelberman, Manske et al. 1984). They used 
lacerated tendon segments maintained in culture, showing that the tendon surface 
layer of cells initiated the repair process by proliferating and migrating into the 
laceration site.  
 
1.2.3 Modern Concepts in Tendon Healing 
The biology of tendon healing has been dominated by the extrinsic and intrinsic 
models. There has been much debate in the literature, and much experimental 
evidence to prove or disprove each healing mechanism. Previous studies have 
shown, using vital tracker dye techniques, that cells from both tendon surface (Jones, 
Mudera et al. 2003) and the surrounding synovial sheath (Harrison, Mudera et al. 
2003) have been observed directly to migrate into the zone of flexor tendon injury. 
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These studies have provided direct evidence of both extrinsic and intrinsic cellular 
contributions to tendon healing. Strickland has proposed that the relative 
contributions of each will depend on factors that relate to both the nature of the 
injury and the repair (Strickland 2005).  
 
The differences between extrinsic and intrinsic mechanisms extend beyond the site 
of origin of the healing cells. The extrinsic mechanism appears to be active earlier in 
the healing sequence, whereas the intrinsic mechanism is often delayed (Khan, 
Occleston et al. 1998; Khan, Kakar et al. 2000). Khan and colleagues have shown in 
vivo, using monoclonal antibody location of different inflammatory markers, that the 
synovial sheath reacts with a greater proliferative and inflammatory response 
compared to the tendon core and tendon surface (Khan, Edwards et al. 1996). Kakar 
and colleagues demonstrated, using a rabbit model, that the tendon surface and 
synovial sheath became hypercellular at one week post injury, with decrease in the 
cellularity  and apoptosis of cells of the tendon core (Kakar, Khan et al. 1998). The 
occurred even though the investigators avoided any direct injury to the synovial 
sheath. They found that by twelve weeks after injury, however, the tendon core itself 
also started to show hypercellularity. 
 
Other studies suggest that extrinsic synovial sheath fibroblasts may contribute more 
actively to adhesion formation than intrinsic cells in a number of ways. Synovial 
sheath fibroblasts have a higher proliferative level relative to tendon core fibroblasts 
(Khan, Occleston et al. 1998). Synovial sheath fibroblasts are significantly larger in 
terms of their area and perimeter, and have numerous extensions and lamellopodia, 
indicating a migratory phenotype (Ragoowansi, Khan et al. 2003). They have an 
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increased capacity to degrade the ECM as reflected by matrix metalloproteinase 
(MMP)-2 and MMP-9 production, facilitating the process of migration (Ragoowansi, 
Khan et al. 2003). Khan and colleagues also showed greater MMP production by 
synovial sheath fibroblasts than tendon core cells (Khan, Occleston et al. 1998), 
although neither of these studies specifically assessed MMP activity. Ragoowansi 
and colleagues found that synovial sheath fibroblasts were more aggressive 
contractors of a collagen lattice when compared to tendon core cells. This indicates 
that synovial sheath fibroblasts have the cytoskeletal infrastructure to actively 
participate in fibrous tissue contraction (Ragoowansi, Khan et al. 2003).  
 
Other studies have shown that predominance of the extrinsic mechanism of healing 
is associated with increased collagen content at the injury site as well as reduction in 
the level of collagen organisation and material properties of the reparative tendon 
tissue (Matthews and Richards 1976; Nyska, Porat et al. 1987). Wong and colleagues 
have also shown that greatest activity following tendon injury occurs in tissues 
surrounding the tendons such as the subcutaneous tissues (Wong, Lui et al. 2009). 
For these reasons, it is believed that the extrinsic mechanism of healing leads to 
increased peritendinous adhesions.  
 
Modulating the healing process to enhance the intrinsic pathway (and augment end-
to-end tendon healing) while suppressing the extrinsic pathway (and diminishing 
adhesions from forming between the tendon and the surrounding tissues) could lead 
to improvement in treatment of tendon injuries. While investigations into the biology 
of tendon healing have shed light on the mechanisms by which tendon tissue heals, 
there has been relatively little progress toward biological enhancement of the healing 
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process after injury and repair. Novel strategic approaches are required to reduce 
adhesion formation by selectively favouring intrinsic healing over extrinsic healing 
in the tendon-synovial complex. 
 
The difference in cell attachment between extrinsic and intrinsic fibroblasts to the 
ECM has not been previously studied. Fibroblasts must attach to the ECM to gain 
traction for migration, but they also have to detach from the ECM to translocate 
(Lauffenburger and Horwitz 1996; Palecek, Loftus et al. 1997). Optimum migration 
rates occur at intermediate attachment conditions as cells need to form stable 
attachments for traction by the leading cell edge whilst allowing attachments at the 
trailing end to be broken during locomotion (Ahmed, Underwood et al. 2000; 
Munevar, Wang et al. 2001). Cell migration speed is the result of cell integrin 
expression levels, substratum ligand levels and integrin-ligand binding affinity 
(Palecek, Loftus et al. 1997). It would follow that cells that express maximal 
migration speed have modified integrin-ligand interactions, and a lower binding 
affinity. Tendon surface and tendon core cells have a less migratory phenotype than 
synovial sheath cells (Ragoowansi, Khan et al. 2003). This would suggest that they 
have a higher affinity for attachment than the synovial sheath cells. This has been 
confirmed in vitro (Riederer-Henderson, Gauger et al. 1983). However, these authors 
did not assess attachment of cells to ECM components.  
 
As fibroblast attachment is a prerequisite for migration, the attachment of intrinsic 
and extrinsic tendon cells to collagen type-I and fibronectin (Fn) was tested in this 
thesis. This was investigated to determine if there was a difference, which could be 
used as a selective strategy in modifying adhesion formation during tendon healing. 
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As a well recognised modulator of adhesion formation, the effect of mobilisation on 
attachment of cells present within healing adhesions was also tested. This thesis also 
investigated the effects of preventing cell attachment on adhesion formation using a 
novel anti-adhesive biomaterial. Due to greater adhesion forming characteristics of 
synovial sheath cells, these were used when testing the anti-adhesive properties of a 
novel biomaterial in vitro.  
 
1.2.4 The Effects of Mobilisation on Tendon Healing and 
Adhesion Formation 
Interrelated biochemical, structural and mechanical changes are seen in tendons as a 
result of increased or decreased applied loads (Lin, Cardenas et al. 2004). Tendons 
that are immobilised exhibit decreased mechanical properties, and increased 
adhesion formation (Gelberman, Vande Berg et al. 1983; Murrell, Lilly et al. 1994; 
Palmes, Spiegel et al. 2002). Mobilisation after tendon repair results in improved 
tensile properties at the repair site, enhanced gliding function, decreased adhesions 
and therefore improved clinical outcome (Woo, Gelberman et al. 1981; Gelberman, 
Vande Berg et al. 1983; Gelberman, Manske et al. 1986; Hitchcock, Light et al. 
1987; Feehan and Beauchene 1990).  
 
Gelberman and colleagues demonstrated that application of early passive motion 
stress to repaired canine tendons led to a more rapid recovery of tensile strength, 
fewer adhesions, improved excursion and better tendon nutrition compared with 
immobilised tendons (Gelberman, Manske et al. 1986). These authors concluded that 
healing is enhanced by stimulating maturation of the tendon wound simultaneously 
with remodelling of the tendon adhesion. Aoki and colleagues found that active (in 
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contrast to passive) mobilisation applied stress to sutured tendons, enhanced strength 
of repair and the biological response (Aoki et al, 1997). Kitis and colleagues have 
demonstrated that controlled active mobilisation results in improved outcomes 
relative to controlled passive movement (Kitis, Buker et al. 2009). It has been shown 
that combined effects of both motion and tension on the healing response in injured 
chicken flexor tendons resulted in significantly greater tendon repair strength and 
cellular activity when compared to either motion or tension applied alone (Kubota, 
Manske et al. 1996). Previous authors have proposed that controlled motion may 
augment tendon strength by favouring intrinsic repair (Gelberman, Amiel et al. 1981; 
Gelberman, Nunley et al. 1991; Gelberman, Steinberg et al. 1991; Kubota, Manske 
et al. 1996). Mobilisation may result in increased cellular activity, DNA content, 
weight, vascularisation, collagen and glycosaminoglycan content in tendons, 
whereas immobilisation may cause increased collagen degradation and reduction in 
collagen crosslinking (Birdsell, Tustanoff et al. 1966; Munro, Lindsay et al. 1970; 
Gelberman, Amiel et al. 1981; Amiel, Woo et al. 1982; Gelberman, Woo et al. 1982; 
Woo, Gomez et al. 1982; Vailas, Pedrini et al. 1985; Gelberman, Manske et al. 1986; 
Hannafin, Arnoczky et al. 1995; Kubota, Manske et al. 1996; Yasuda and Hayashi 
1999; Sharma and Maffulli 2006).  
 
However, the precise mechanism by which postoperative mobilisation enhances 
tendon excursion compared to immobilisation remains unclear (Strickland and 
Glogovac 1980; Woo, Gelberman et al. 1981; Hitchcock, Light et al. 1987; Halikis, 
Manske et al. 1997). What is established is that cells within tissues react to 
mechanical stimuli with molecular responses that aim to maintain the overall 
integrity of the tissue (Huang, Kamm et al. 2004). Indeed, fibroblasts are known to 
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increase collagen synthesis and structural stiffness of collagen gels under cyclic 
strain in vitro (Berry, Shelton et al. 2003). Juncosa-Melvin and colleagues have 
shown that applying a tensile stimulus to stem cell seeded constructs in a rabbit 
tendon healing model resulted in increased collagen type-I and collagen type-III 
gene expression, as well as an increase in linear stiffness and elastic modulus, 
relative to nonstimulated constructs (Juncosa-Melvin, Matlin et al. 2007). Slack and 
colleagues have also demonstrated that when a mechanical load is applied to cells in 
vitro, protein production and cell division increases (Slack, Flint et al. 1984). This is 
in accord with in vivo observations by Aoki and colleagues who found that active  
mobilisation applied stress to the sutured tendon and enhanced strength of the repair 
(Aoki, Kubota et al. 1997). The question remains, however, why fibroblasts 
subjected to tensile forces, and the associated collagen formation, do not produce 
stronger adhesions when the tendons themselves demonstrate improved tensile 
strength? Spalazzi and colleagues have shown that compression of tendon grafts 
upregulates transforming growth factor-β3 (TGF- β3), which may be associated with 
anti-scarring effects in some tissues (Spalazzi, Vyner et al. 2008). Fong and 
colleagues have demonstrated using microarray analysis in rat flexor tendon cultures 
that shear stress induced an anti-fibrotic expression pattern with decreased 
transcription of collagen type-I, collagen type-III and TGF- β2, with increased 
expression of MMPs and decreased expression of tissue inhibitors of 
metalloproteinase (TIMP) (Fong, Trindade et al. 2005). However, these studies did 
not assess the micromechanical effects of these changes on local adhesion tissue 
strain. Clearly, a more sophisticated model is required to predict the behaviour of 
adhesions in relation to mobilisation. 
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The effect of tendon mobilisation on cell attachment in the healing tendon-synovial 
complex has not been extensively investigated. The effect of mobilisation on 
determining local adhesion tissue strains and their relation to gross adhesion 
mechanics has not previously been determined. These lines of investigation form the 
basis for this thesis. 
 
1.3 FLEXOR TENDON ANATOMY AND FUNCTION  
1.3.1 Flexor Digitorum Superficialis 
In humans, the flexor digitorum superficialis (FDS) tendons diverge in the palm and 
bifurcate. This allows transmission of the deeper profundus tendon, which becomes 
more superficial at a site corresponding to the level of the A2 pulley. At the point of 
bifurcation the central fibres continue into 2 equal slips, which insert into the anterior 
surface of the middle phalanx (Grays 1989).  
 
1.3.2 Flexor Digitorum Profundus 
The flexor digitorum profundus (FDP) is a deep flexor muscle in the forearm. It 
divides into 4 tendons, which gain entry into the palm via the carpal tunnel deep to 
the flexor retinaculum. The tendon to each finger remains deep to the flexor 
digitorum superficialis as it enters the mouth of the first annular (A1) pulley. As the 
FDS tendon bifurcates at the distal end of this pulley, the profundus tendon becomes 
superficial to it. It then courses distally within the synovial sheath and inserts into the 
base of the distal phalanx in each finger (Grays 1989).  
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1.3.3 Flexor Tendon Synovial Sheath 
The flexor tendon synovial sheath is a fibro-osseous tunnel which encases the long 
flexors to the fingers and thumb. The synovial sheath produces an almost frictionless 
surface for tendon gliding and hence digital movement. The synovial lining also 
produces synovial type fluid, which is important in tendon nutrition, and thus healing 
(Lundborg, Holm et al. 1980). The synovial sheath has a number of specialised 
thickenings, or pulleys, the number of which varies between the fingers and the 
thumb. These have an important functional role preventing flexor tendons from 
bowstringing away from the normal close proximity of the phalanges during digital 
flexion (Strauch and de Moura 1985). This arrangement adds to the biomechanical 
efficiency of the tendons, ensuring maximal digital movement relative to tendon 
excursion.   
 
The fingers have 5 annular pulleys which arch transversely over the tendons. The 
narrow A1, A3, and A5 pulleys all lie over joints, the metacarpophalangeal, proximal 
interphalangeal, and distal interphalangeal joints respectively. The functionally more 
important and broader A2 and A4 pulleys lie over the base of the proximal and 
middle phalanx respectively. There are 3 cruciate pulleys whose fibres run 
diagonally across the tendon and perpendicular to each other.  
 
For the purpose of description, tendon injuries of the hand are divided up into zones. 
With respect to the deep and superficial flexors of the fingers, the anatomical 
location of the tendon insult can be ascribed to one of 5 zones. The most commonly 
affected zone with the poorest outcome of repair is zone 2. 
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1.4 ANIMAL MODELS IN THE STUDY OF TENDON 
HEALING 
A number of different animal models have been employed in the study of tendons, 
including, mouse (Wong, Lui et al. 2009; Katzel, Wolenski et al. 2010), rat 
(Iwuagwu and McGrouther 1998; Ishiyama, Moro et al. 2010), chicken (Chen, Zhou 
et al. 2009; Bhavsar, Shettko et al. 2010; Ishiyama, Moro et al. 2010; Yilmaz, Avci 
et al. 2010), rabbit (Khan, Edwards et al. 1996; Abrahamsson 1997; Chang, Most et 
al. 1998; Kakar, Khan et al. 1998; Berglund, Reno et al. 2006; Healy, Mulhall et al. 
2007; Branford, Mudera et al. 2008; Liu, Skardal et al. 2008; de Wit, de Putter et al. 
2009; Klass, Rolfe et al. 2009; Branford, Brown et al. 2010; Dogramaci, Kalac et al. 
2010; Henn, Kuo et al. 2010; Ozboluk, Ozkan et al. 2010; Tan, Nourbakhsh et al. 
2010), dog (Gelberman, Boyer et al. 1999; Zhao, Zobitz et al. 2009; Thomopoulos, 
Kim et al. 2010; Zhao, Sun et al. 2010), pig (Hausmann, Vekszler et al. 2009), sheep 
(Haddad, Peltz et al. 2010), cow (Samiric, Ilic et al. 2004; Hausmann, Vekszler et al. 
2009), horse (Lin, Moolenaar et al. 2006; Schnabel, Lynch et al. 2009), and monkey 
(Manske, Lesker et al. 1985; Russell and Manske 1990). Comparisons between 
species have also been conducted (Gelberman, Manske et al. 1984; Hausmann, 
Vekszler et al. 2009). 
 
1.4.1  In Vitro Tendon Healing Models  
In vitro tendon cell culture has been widely adopted in order to examine a range of 
different processes thought to be involved in tendon healing. Techniques for 
acquisition of tendon cells for culture include explanting, enzymatic digestion and 
tissue dicing. By far the most popular method of obtaining cells in culture is the 
explant method (Klass, Rolfe et al. 2009; Branford, Brown et al. 2010). A segment 
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of tendon is dissected and then incubated in sterile culture media. Cell monolayers 
can be obtained within 2 to 5 weeks. 
 
When using in vivo animal models of tendon healing, a multitude of biological 
processes directly or indirectly affects the repair, some of which the researcher has 
no control over. Investigators must try to standardise these variables. In contrast, in 
vitro models enable assessment of only isolated changes in the culture environment. 
 
Whilst tendons from different species undergo similar steps to effect repair in 
culture, they do so at different rates. Gelberman and colleagues compared rabbit, 
chicken, dog and monkey tendons sustained in culture for 3 months (Gelberman, 
Manske et al. 1984). A characteristic sequence of repair, including tendon surface 
thickening, cell differentiation, cell migration, and phagocytosis was demonstrated. 
Rabbit tendons showed nearly complete closure of the repair site by 12 weeks. A 
lesser response was seen in chicken, followed by dog and monkey. This repair in 
culture in absence of extrinsic cell input has also been demonstrated in human 
tendon culture (Mass and Tuel 1989; Mass and Tuel 1990). Whilst repair seen in 
culture has many parallels with its in vivo counterpart, it appears to progress in a 
slower and less regulated fashion (Abrahamsson, Lundborg et al. 1991). 
 
1.4.2  In Vivo Tendon Healing Models  
In order for improvements in the outcome of tendon repair to be made in humans, 
research relies on essential animal work. These models allow hypotheses of disease 
pathogenesis and its treatment to be rigorously tested. Important criteria should be 
adhered to when choosing a model, so that comparisons can be drawn with the 
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human condition under investigation. The size of animal should be large enough to 
allow adequate and reproducible tissue manipulation. The animal must be available 
and affordable, giving sufficient numbers to allow statistical comparison. Finally, the 
tissue must be amenable to measurement in a controlled reproducible fashion 
(Carpenter, Thomopoulos et al. 1999).  
 
1.4.3 Rabbit Tendon Healing Model 
The rabbit has been used extensively in vitro and in vivo to examine flexor tendon 
healing and peritendinous adhesion formation (Khan, Edwards et al. 1996; 
Abrahamsson 1997; Chang, Most et al. 1998; Kakar, Khan et al. 1998; Berglund, 
Reno et al. 2006; Healy, Mulhall et al. 2007; Branford, Mudera et al. 2008; Liu, 
Skardal et al. 2008; de Wit, de Putter et al. 2009; Klass, Rolfe et al. 2009; Branford, 
Brown et al. 2010; Dogramaci, Kalac et al. 2010; Henn, Kuo et al. 2010; Ozboluk, 
Ozkan et al. 2010; Tan, Nourbakhsh et al. 2010). The rabbit was used in this thesis to 
investigate both in vitro and in vivo tendon healing. Rabbit is relevant to man in 
terms of cellular behaviour during healing and structural anatomy. Deep flexor 
tendons of the forepaw have gained popularity due to their accessibility and ease of 
use (Ngo, Pham et al. 2001; Henn, Kuo et al. 2010; Tan, Nourbakhsh et al. 2010). 
The hind deep flexors have also been used (Malaviya, Butler et al. 1998; Churei, 
Yoshizu et al. 1999). In this thesis the grooming forepaw was chosen over the hind 
paw as it is functionally more akin to human hand tendons. 
 
1.4.4 Types of Tendon Injury  
In previous experiments the nature of the tendon injury has varied greatly for 
studying tendon healing and repair. It has ranged from complete transection and 
50 
 
repair (Chang, Thunder et al. 2000; Ngo, Pham et al. 2001; Chen, Cao et al. 2008; 
Tan, Nourbakhsh et al. 2010), partial transection (Zhao, Moran et al. 2007; 
Dogramaci, Kalac et al. 2010), crush injury, avulsion injury or partial tenotomy 
window (Matthew, Moore et al. 1987; Iwuagwu and McGrouther 1998; Kakar, Khan 
et al. 1998; Akali, Khan et al. 1999; Khan, Kakar et al. 2000; Jones, Burnett et al. 
2002; Harrison, Mudera et al. 2003). In this thesis partial tenotomy window was 
used. This has been used in several rabbit models (Kakar, Khan et al. 1998; Akali, 
Khan et al. 1999; Khan, Kakar et al. 2000; Jones, Burnett et al. 2002). This injury 
avoids the need for suture repair, thereby minimising the number of injury variables 
and allows for immediate postoperative mobilisation (Kubota, Manske et al. 1996; 
Chan, Fu et al. 1998).   
 
Previous tendon immobilisation methods have used internal and external fixators, 
splints, casts and frames (Carlstedt, Madsen et al. 1986; Enwemeka, Spielholz et al. 
1988; Murrell, Lilly et al. 1994; Palmes, Spiegel et al. 2002; Tan, Nourbakhsh et al. 
2010). In this thesis, where immobilisation was required, a proximal division of the 
FDP tendon was used as in a previous flexor tendon adhesion model (Jones, Burnett 
et al. 2002). This avoided the need for a splint, for the purpose of animal welfare. 
 
In this thesis a rabbit model was developed using the digital tendon-synovial 
complex in which the mechanical restriction was in one axis only. This facilitates 
assessment, enabling the restrictive nature of an adhesion to be defined in 
biomechanical terms.   
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1.5 THE EXTRACELLULAR MATRIX IN TENDON 
HEALING 
1.5.1 Phases of Tendon Healing 
Following tendon injury the process of tendon healing and adhesion formation can 
be divided into phases, distinguishable by specific peaks in a cascade of cellular and 
biochemical events. These phases overlap and their duration can vary greatly 
(Gomez 1995).  
 
Almost immediately after tendon injury there is a phase of haemostasis and 
inflammation (Wong, Lui et al. 2009). During this phase there is an increase in Fn, 
which along with glycosaminoglycan, water and collagen type-III stabilise the newly 
formed ECM (Grinnell 1984).  
 
A causative relation has been reported between Fn secretion and fibroblast 
chemotaxis and attachment to the ECM in the days after injury and repair 
(Gelberman, Steinberg et al. 1991). Well-hydrated provisional ECM supports 
cellular migration from tissue margins (Lorenz 2003).  
 
The proliferative/fibroblastic phase occurs approximately from 3 days until 2 weeks. 
During this time, there is disorganised ECM of granulation tissue at the injury site. 
This is the precursor of adhesion tissue. This phase is characterised by fibroplasia, 
fibroblast migration and proliferation and ECM formation. Histologically, the 
predominant cell type here is the fibroblast (Stadelmann, Digenis et al. 1998). 
Fibroblasts proliferate and migrate (Yamada 1996; Greiling and Clark 1997). This is 
a phase of active ECM synthesis by the cells (Jozsa 1997). During  this time there is 
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a sequential appearance of Fn and collagen (Kurkinen, Vaheri et al. 1980), with 
collagen type-I, collagen type-III and Fn being  widespread throughout  the ECM 
(Abrahamsson 1991). 
 
The process of maturation, organisation and remodelling can last many months, 
fibroblasts depositing an increasingly mature, mechanically functional collagen 
matrix (Stadelmann, Digenis et al. 1998). There is optimisation of collagen synthesis 
and gradual conversion of collagen type-III to collagen type-I (Gomez 1995). During 
this time there is reduced ECM synthesis by the fibroblasts, collagen fibre 
reorientation and crosslinking. 
 
1.5.2 Cell Interaction with the Extracellular Matrix 
Fibrous proteins of the tendon ECM constitute two subclasses: the structural 
collagens and elastin and the adhesive Fn and laminin that support the attachment 
and migration of cells (Abrahamsson 1991). The interaction of cells, ECM and 
growth factors affects adhesion, morphology, viability, gene expression and growth 
of cells (Hynes 2009; Schultz and Wysocki 2009). Subcomponents of ECM 
molecules can bind to cell surface receptors and affect cellular activities (Schultz and 
Wysocki 2009). 
 
Human fibroblasts have differential properties when attaching to ECM proteins. In a 
study by Shimo-Oka and colleagues production of a Fn fragment following 
trypsinisation inhibited fibroblasts from attaching to and spreading on Fn (Shimo-
Oka, Hasegawa et al. 1988). However, the Fn fragment did not cause inhibition of 
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attachment to collagen, vitronectin or laminin. This is the result of fibroblasts having 
different binding sites for different proteins.  
 
The binding site for collagen in Fn is distinct from that interacting with cell surfaces, 
as cell attachment promoting activity is found with collagen-nonbinding fragments 
of Fn (Ruoslahti, Hayman et al. 1980). Therefore, strategies that prevent cell 
attachment to Fn based on non-collagen binding fragments of the Fn molecule may 
preserve cell to collagen binding. This may be a potential therapeutic mechanism to 
achieve a differential effect in cell binding. In this way, tendon healing may be 
preserved while adhesion formation is prevented. Attachment of cells to the ECM is 
investigated in this thesis. Intrinsic and extrinsic tendon fibroblasts and the cells 
found in healing tendon adhesions from immobilised and mobilised digits were 
investigated for differences in their attachment to collagen and Fn.  
 
The relationship between changes in cell morphology and tissue strain is thought to 
occur through binding of cells to ECM proteins (Ingber 1991; Banes, Tsuzaki et al. 
1995; Rosales, O'Brien et al. 1995). Therefore, in this thesis the effect of 
mobilisation on adhesion derived cell attachment, cell morphology and local tissue 
strain were examined.   
 
1.5.3 Fibronectin 
Fn (from fibra, fibre and nectere, connect) is an important component of the early 
healing process (Grinnell 1984; Gelberman, Steinberg et al. 1991). Fn is, in its main 
functional form, a high molecular weight glycoprotein multimer which interacts with 
numerous ECM components and cell surfaces (Ruoslahti, Hayman et al. 1982) 
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(Figure 1.2). Fn has been found to bind to collagen, sulphated proteoglycans, 
hyaluronic acid, fibrin, fibrinogen, heparin, thrombin, plasmin and factor XIIIa 
(Hynes and Yamada 1982; Castellani, Siri et al. 1986). In vitro Fn is found 
associated with fibroblast membranes, cell culture surface and the culture medium 
(Sekiguchi, Siri et al. 1985). 
 
Fn plays a major role in cell adhesion, promoting attachment and migration of 
fibroblasts on the ECM (Schwarzbauer 1991). Fn also acts as an intermediary 
scaffold for deposition of collagen by fibroblasts (Grinnell 1984). It is central to 
most aspects of cell phenotype behaviour during early tendon healing. In summary, 
Fn binding affects cell morphology, division and spreading, cytoskeletal 
organisation, migration, differentiation and haemostasis (Hynes and Yamada 1982). 
 
Consequently, fibroblast to Fn adhesion is central to migration, collagen deposition 
and therefore fibrotic adhesion formation. Strategies that prevent fibroblast to Fn 
attachment without compromising fibroblast to collagen binding may prevent 
adhesion formation without compromising tendon cellularity. This concept is 
explored in this thesis through the in vitro and in vivo testing of a novel derivative 
Fn-fragment based biomaterial (DFn).  
 
1.5.3.1 Structure of Fibronectin 
Fn exists in two main forms, as an insoluble fibrillar dimer in the ECM, and as a 
soluble dimer in plasma, amniotic and synovial fluids (Akiyama, Hasegawa et al. 
1985). These are known as cellular Fn and plasma Fn, respectively (Hayashi and 
Yamada 1981). Plasma Fn is secreted by hepatocytes. Cellular Fn is secreted by  
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Figure 1.2   A diagrammatic representation of the structure of a single strand of 
cellular fibronectin (Fn). Sites of major proteolytic digestion are shown (red arrows, 
above Fn molecule). Interaction sites for Fn with other molecules are shown (purple 
lines, below molecule). Sites for integrin binding are also shown (in green, below 
molecule). S = Disulphide bond. 
 
 
 
 
 
 
 
 
 
 
56 
 
fibroblasts and many other cell types and is incorporated into a fibrillar matrix on the 
cell surface (Hynes 1990). 
 
The Fn molecule consists of 2 nearly identical subunits, each of between 220 and 
250 kDa molecular weight, joined at the C-terminus (Johansson, Svineng et al. 
1997). The 2 subunits are covalently linked by a pair of disulphide bonds, and may 
exist as a homodimer of 2 identical subunits or a heterodimer of 2 similar but non-
identical subunits (Hynes 1990). The subunits of Fn are flexible, and can exist in a 
compact globular form or extend into an elongated, fibrous form (Ejim, Blunn et al. 
1993; Phillips, King et al. 2004).  
 
Each Fn monomer is made up of homologous modules of 40-90 amino acids, 
classified as type I, II, or III repeats or modules (Miyamoto, Katz et al. 1998). Each 
Fn subunit contains 12 type I repeats, located near the N and C termini, 2 type II 
repeats at the N terminus, and 15-17 type III repeats encoded in the Fn gene 
(Hohenester and Engel 2002). Types I and II repeats contain 2 intrachain disulphide 
bonds while type III repeats do not have disulphide bridges. Each type I repeat is 
made of β-sheets surrounding a hydrophobic core. Type II repeats consists of 2 anti-
parallel β-sheets, linked by disulphide bonds and perpendicular in relation to each 
other (Constantine, Brew et al. 1992). The type III repeats are composed of 7 β-
strands arranged in 2 anti-parallel β-sheets, enclosing a hydrophobic core (Copie, 
Tomita et al. 1998).  
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1.5.3.2 Fibronectin Binding Domains  
Some of the early work with plasma Fn molecule identified the Fn binding domains 
using affinity chromatography and molecular mass on Fn proteolytic digests, as Fn is 
sensitive to proteases. Collagen, heparin, fibrin, gelatin and cell binding domains 
were identified this way (Hayashi and Yamada 1983; Zardi, Carnemolla et al. 1985). 
Relative positions of the corresponding domains in intact Fn are now well 
characterised (Hynes 1990).  
 
Fn mediates attachment of different cell types to the rest of the ECM via several cell-
binding sites distributed in the type III repeating modules. The major cell-binding 
site located in the central region of the tenth type III repeat, bearing the amino acid 
sequence arg-gly-asp-ser (RGDS), and its synergistic sequence in the III9 module 
pro-his-ser-arg-asn (PHSRN), are recognised by cell adhesion receptor integrin α5β1 
(Aota, Nomizu et al. 1994). Blocking of either site with monoclonal antibodies leads 
to a greater than 90% reduction in cell spreading of baby hamster kidney (BHK) 
cells (Nagai, Yamakawa et al. 1991).  
 
The heparin binding domain (Hep 2), consisting of 12-14 type III repeats has 6 major 
cell adhesive sites that mediate RGDS-independent, heparin dependent cell adhesion. 
Heparin is abundant on cell surfaces and in the ECM. The IIICS region is recognised 
by the integrin receptor α4β1 (Mould, Komoriya et al. 1991). Recently, it has been 
suggested that alternative splicing of the IIICS domain may influence signalling 
between cell surface heparan proteoglycans and Hep 2 binding domain of Fn 
(Santas, Peterson et al. 2002). In this way, Fn can mediate with cell surface adhesive 
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sites and hence has the ability to regulate cellular processes like growth, spreading, 
migration, and differentiation. 
 
1.5.3.3 Fibronectin Fragments Inhibit Cell Attachment 
Attachment of cells to Fn is inhibited by some fragments of Fn. These include a 
soluble GRGDSC fragment (Streeter and Rees 1987), 2 synthetic RGD containing 
peptides (Yamada and Kennedy, 1984), and a 10-residue peptide including the RGD 
sequence (Sethi et al., 2002). This inhibition is competitive, non-cytotoxic and 
reversible (Yamada and Kennedy 1984). Although there is negligible binding of Fn 
to cells in suspension (Carter, Rauvala et al. 1981), high concentrations of plasma Fn 
almost completely inhibit fibroblastic cell adhesion to a Fn substrate (Yamada and 
Kennedy 1984; Yamada, Akiyama et al. 1985). RGD peptides have been shown to 
prevent focal adhesion formation (Wang, Collighan et al. 2010), which is required 
for cell attachment. Fn-derived fragments, possessing anti-adhesive properties, may 
provide a therapeutic strategy to reduce cell attachment. This may modify 
subsequent deposition of adhesion tissue in vivo. A novel biomaterial with potential 
anti-adhesive properties is tested in this thesis in vitro and in vivo. 
 
1.5.3.4 Fibronectin Matrix Assembly 
Fn matrix assembly is a cell-mediated step-wise process that converts soluble Fn into 
an organised matrix of Fn fibrils presenting binding sites to orchestrate assembly of 
several other extracellular proteins (Hynes 2009). Subjecting the Fn molecule to 
tensile forces through mechanical shearing and at a moving plastic-liquid interface 
results in Fn self-assembly (Ejim, Blunn et al. 1993; Brown, Blunn et al. 1994). Fn 
fibril formation is the result of Fn interacting with cell surface integrins, which 
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initiate a process involving conformational activation of Fn outside and organisation 
of the actin cytoskeleton inside. Apart from supporting the cell adhesion process, cell 
surface receptors, and notably the α5β1 receptor, are also involved in assembly of 
inactive soluble Fn dimers into insoluble Fn fibrils to further support the cell 
adhesion process (Huveneers, Truong et al. 2008). 
 
Firstly, Fn accumulates at focal adhesions where integrins bind to the RGD site. This 
induces conformational change of Fn, exposing a site near its N-terminus that binds 
to 51 integrins on the cell surface (Johansson, Svineng et al. 1997). This process 
is saturable and reversible (Magnusson and Mosher 1998), and is required for Fn 
fibrillogenesis (Wierzbicka-Patynowski and Schwarzbauer 2003). Over-expression 
of 51 results in a large increase in Fn assembly, whereas 1 knockout cells are 
unable to assemble a Fn matrix (Zhang, Sakai et al. 1999). Fn molecules lacking the 
70 kDa N-terminal fragment containing the 51 binding site do not assemble into 
fibrils (Magnusson and Mosher 1998; Wierzbicka-Patynowski and Schwarzbauer 
2003). 
 
Initial 51-Fn binding occurs at focal adhesions. As a dimeric ligand, Fn induces 
51 integrin aggregation which results in increase in the local external 
concentration of Fn and internal co-localisation and phosphorylation of focal 
adhesion kinase (FAK) (Wierzbicka-Patynowski and Schwarzbauer 2003). Activated 
FAK recruits Src and these kinases mediate early assembly (Wierzbicka-Patynowski 
and Schwarzbauer 2003). The 51 integrin, still bound to Fn, then translocates 
from the focal adhesion to fibrillar adhesions. Acto-myosin generated tension is 
translocated to Fn, via the 51 integrin, stretching the globular protein into a linear 
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conformation that promotes fibrillogenesis by exposing 4 cryptic self-association 
sites (Pankov, Cukierman et al. 2000).  
 
Initially Fn fibrils are short and only extend from cell to neighbouring cell or nearby 
substrate. As more Fn accumulates the fibrils become more stable and are thought to 
be gradually converted into high molecular weight, disulphide-stabilised multimers 
(Wierzbicka-Patynowski and Schwarzbauer 2003).  
 
Fn in solution exists as a compact folded dimer, incapable of undergoing fibril 
assembly. Extension of the Fn molecule occurs in solution by changes in pH, ionic 
strength, or mechanical shear (Phillips, King et al. 2004). It is clear that forces 
generated by mobile cells may be important in Fn fibril shear aggregation and 
assembly, in a manner analogous to Fn shear aggregation used at the gross level to 
prepare scaffolds (Ejim, Blunn et al. 1993; Phillips, King et al. 2004).  
 
1.5.4 Collagen 
The word „collagen‟ is derived from the Greek word for „glue‟. This super family of 
ECM proteins comprises 15-35% of all proteins in the human body.  
 
1.5.4.1 Collagen Synthesis 
Collagen is constitutively synthesised by fibroblasts and other connective tissue cells 
(Parsons, Kessler et al. 1999). Individual polypeptide chains are generated at free 
ribosomes as precursor prepropeptides called pro- chains. These pro- chains 
undergo processing in the endoplasmic reticulum and Golgi apparatus (Canty and 
Kadler 2005). Proline and lysine residues are hydroxylated to hydroxyproline and 
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hydroxylysine and a proportion of the hydroxylysine residues are glycosylated. This 
is followed by the assembly of 3 pro- chains to form a procollagen triple helix. This 
is initiated by folding and disulphide bond formation within the C-terminal 
extensions (Canty and Kadler 2005). The protein is then shuttled directly and 
continuously from the trans-Golgi network to the cell membrane in coated vesicles 
and secreted into the ECM (Ross 1975). Cleavage of the amino and carboxy-terminal 
extensions by peptidases reduces solubility of the molecule and leads to the 
spontaneous formation of collagen fibres (Mayne and Brewton 1993).  
 
Despite the ability of collagens to spontaneously form fibrils in vitro collagen 
fibrillogenesis is tightly controlled by cells in vivo (Stopak, Wessells et al. 1985). 
Fibrillogenesis may also be affected by the small leucine-rich proteoglycan decorin, 
which is prevalent in collagenous tissues, interacts with Fn and affects TGF-β1 
activity (Douglas, Heinemann et al. 2006) The final diameter of fibrils varies 
between tissues depending on their function. Large fibrils, around 500 nm, can be 
found in mature tendon, which are subjected to tensile strain (Jokinen, Dadu et al. 
2004). Collagen fibrillogenesis has been shown to require a Fn matrix, collagen-Fn 
binding and be influenced by the collagen binding integrins 21 and 111 
(Velling, Risteli et al. 2002; Canty and Kadler 2005).  
 
1.5.4.2 Fibronectin and Collagen Binding 
The effect of Fn on collagen type-I has been widely studied (Yamada and Okigaki 
1983; Gildner, Lerner et al. 2004). Fn only contains one binding site for all 
collagens. Denatured collagen I binds this site more effectively than native collagen 
type-I; and collagen type-III binds more effectively than collagens I and II  (Hynes 
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1990). Presence of Fn has been reported to increase the attachment of epithelial cells 
to collagen type-I coated tissue culture plastic (Johansson, Svineng et al. 1997), and 
to decrease the rate of migration of neonatal and foetal fibroblasts on collagen I 
coated glass (Park, Park et al. 2001); presumably by increased adhesion. However, 
Burrill and colleagues found that whilst pre-adsorbed Fn increased attachment of 
rabbit intestinal epithelial cells to collagen I, soluble Fn in the medium did not 
(Burrill, Bernardini et al. 1981). 
 
1.5.3 An Extracellular Matrix Gradient 
1.5.5.1 A Spatial Extracellular Matrix Gradient 
1.5.5.1.1 Tendon Surface Cells Produce More Collagen Than Synovial Sheath 
Cells 
Tendon cells have been shown to produce three times as much collagen in vitro than 
synovial sheath cells (Riederer-Henderson, Gauger et al. 1983). During the first 2 
weeks in in vitro tendon culture, tendon surface cells have been shown to proliferate, 
migrate and encapsulate the tendon (Mass and Tuel 1989). In contrast, tendon core 
cells have been shown to produce collagen after 2 weeks in culture (Gelberman, 
Manske et al. 1984; Manske, Gelberman et al. 1984). Russell and Manske confirmed 
that tendon surface cells have a role in collagen production in culture at an earlier 
time-point than tendon core fibroblasts (Russell and Manske 1990). Gelberman and 
colleagues later confirmed that tendon surface cells contribute the greatest quantity 
of native tendon collagen to the repair site during early intervals after tendon suture 
(Gelberman, Amiel et al. 1992). These authors used an in situ hybridisation 
technique to analyse production of pro-alpha (I) collagen messenger RNA in 
repaired intrasynovial flexor tendons. This was to determine the precise mechanism 
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by which tendon healing occurs at the cellular level treated with early controlled 
passive mobilisation. They showed that increasing levels of collagen activity were 
detected through 10 days, decreasing at 17 days. Genetic expression of procollagen 
mRNA was localised specifically to the tendon surface cells overlying the repair site 
and to cells in the gap between the tendon stumps. No detectable expression was 
noted in the tendon core fibroblasts.  
 
1.5.5.1.2 Synovial Sheath Cells Produce More Fibronectin than Tendon Cells 
Banes and colleagues have shown qualitatively with immunological staining that 
synovial sheath cells, rather than tendon derived cells preferentially secrete Fn both 
in vitro and in vivo (Banes, Link et al. 1988). Brigman and colleagues later 
confirmed using an enzyme-linked immunosorbent assay that synovial sheath 
fibroblasts in culture produce higher levels of Fn than cells derived from the tendon 
core (Brigman, Hu et al. 1994). Primary cell cultures from these tissues and their 
secretions were also assayed for Fn levels using the polymerase chain reaction and 
northern blot analysis. Levels of Fn in tendon surface were almost 4-fold higher than 
in the tendon core, and levels in the outer sheath were 21-fold greater than in the 
inner portion of sheath. These in vitro experiments suggested that this preponderance 
of Fn associated with the synovial sheath was not the product of plasma deposition 
but of local cell synthesis. In addition, the synovial cells secreted significantly 
greater amounts of Fn than remained cell associated, whereas there was no 
difference in secreted and cell-associated Fn levels from the tendon core fibroblasts. 
The steady-state levels of Fn mRNA were almost 2-fold greater with the synovial 
cells than with the tendon cells by RT-PCR. This was supported by a proportionately 
greater level of Fn mRNA quantitated by northern blot.  This study showed that the 
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majority of Fn found in the tendon complex is produced and exists within the 
synovial sheath layer. It could be argued that there is an anatomical or spatial 
distribution of Fn within the healing tendon-synovial complex with higher Fn levels 
closer to the synovial layer (Figure 1.1). Recently, it has been found that TGF-β1 
upregulates Fn production in tendon core, tendon surface and synovial sheath 
fibroblasts and may explain why the growth factor it is associated with tendon 
adhesion formation (Klass, Rolfe et al. 2009). 
 
1.5.5.2 A Temporal Extracellular Matrix Gradient  
Following tendon injury granulation tissue is initially largely Fn based and becomes 
more collagenous over time. During the fibroblastic phase of tendon healing there is 
a sequential appearance of Fn and collagen (Kurkinen, Vaheri et al. 1980). There is 
also sequential utilisation of Fn then collagen receptors for cell to ECM attachment 
during healing (Sethi, Yannas et al. 2002). Mature tendon is a highly collagenous 
structure, akin to an „end-product‟ of the healing process. It follows from these 
observations that there is both a temporal gradient (as healing progresses) and spatial 
gradient (from the synovial sheath to the tendon) from a Fn-based matrix to a 
collagen-based matrix. Previous authors have identified spatial and temporal-specific 
aspects to the healing process in a rabbit flexor tendon injury model (Berglund, Reno 
et al. 2006). They demonstrated a shift in collagen expression over time in the tendon 
and the sheath. Wong and colleagues demonstrated that the peak in collagen type-I 
production was later for tendon than in peritendinous tissues (Wong, Lui et al. 2009). 
These concepts suggest that a differential effect on tendon healing may be possible 
using an approach based on the selective prevention of cell attachment.  A reduction 
in adhesion formation may be achieved by preventing peritendinous cell attachment 
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to Fn, while maintaining cellularity at the collagenous tendon surface. This forms the 
basis of the in vitro and in vivo testing of the novel biomaterial in this thesis.  
 
1.5.6 Integrins 
Integrins are a super family of heterodimeric transmembrane protein cell surface 
receptors. Integrins are important in cell-cell adhesion and cell-ECM adhesion, 
migration, division, differentiation, wound healing, morphogenesis, orientation, 
immune recognition, development and programmed cell death in vertebrate 
organisms (Katz and Yamada 1997; Damsky and Ilic 2002; Rosso, Giordano et al. 
2004). 
 
Integrins provide a physical and biochemical bridge that links the ECM to the 
intracellular environment both physically to the actin cytoskeleton and biochemically 
to signaling pathways controlling metabolism and gene expression (Schwartz 2001) 
(Figure 1.3). In this way integrins mediate signal transduction and mechanical force 
through the plasma membrane in both directions (Liu, Calderwood et al. 2000). 
Integrin-mediated responses include the aggregation of receptors, activation of signal 
transduction, cytoskeletal rearrangements and co-regulation of growth factor 
activities (Rosso, Giordano et al. 2004).  
 
1.5.6.1 Structure of Integrins 
Different combinations of  and  subunits give rise to receptors with different 
ligand specificities, including receptors for Fn, vitronectin, collagen and laminin. 
Both  and  subunits are subject to alternative splicing and post-translational 
modifications   (Arnaout,   Goodman et al.   2002).    Both    subunits    are    type  I  
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Figure 1.3 A diagrammatic representation of the common pathway linking 
growth factor signalling and local mechanical forces through the integrin receptor 
via the cytoskeleton and intracellular signal transduction to the cell nucleus. Growth 
factors released by fibroblasts in response to local mechanical stimuli modulate 
signaling events that lead to gene expression and protein synthesis. Integrin-growth 
factor cross-talk may be due to proximity of growth factor receptors and ligand-
integrin interactions in focal adhesion complexes, or modulation of growth factor 
receptor activity by adaptor protein recruitment or receptor internalisation. The 
binding, or prevention of binding, of fibronectin (Fn) to integrins may be a target 
that has wide ranging effects on modifying the nature of adhesions. Int = integrin. 
GF = Growth Factor. GFR = Growth Factor Receptor, AP = Adaptor Proteins. 
 
67 
 
transmembrane proteins expressed on the cell surface membrane (Calderwood, 
Shattil et al. 2000) (Figure 1.4). There are several  subunits (1 to 11, IIb, D, 
E, L, M, V and X) and  subunits (1 to 8) identified forming a number of 
different integrins (Humphries, Byron et al. 2006). The  and  subunits each 
contain a large, N-terminal extracellular domain, a single C-terminal transmembrane 
domain and a cytoplasmic domain that in most cases consists of 20-70 amino acid 
residues (Calderwood, Shattil et al. 2000). 
 
Integrins are able to bind multiple ligands (Katz and Yamada 1997). For instance, 
V3 integrin binds to vitronectin, Fn, fibrinogen, von Willenbrand factor, 
thrombospondin and osteopontin. Further, several integrins may bind to one ligand. 
Fn is an example of this, as it currently binds to 10 integrins. This does not 
necessarily result in redundancy as the intracellular signals generated depend on the 
specific combination of ligand and integrin. 
 
1.5.6.2 Integrins for Collagen Binding 
Collagen is recognised by 5 members of the integrin family: 11, 21, 31, 
101 and 111 (Xu, Gurusiddappa et al. 2000; Tulla, Pentikainen et al. 2001). 
Expression of these integrins is cell type dependent (Nykvist, Tu et al. 2000).  
 
1.5.6.3 Integrins for Fibronectin Binding 
Fn is recognised by 10 members of the integrin family: 31, 41, IIb3, V3, 
V1, V5, V6, 51, 81 and 47 (Pankov and Yamada 2002). 51 was 
the first integrin found to bind to Fn, it is also the only integrin to bind solely to Fn 
and as such, it is often referred to as „the Fn integrin‟. Integrin 51 is involved in  
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Figure 1.4 A diagrammatic representation of a transmembrane integrin receptor. 
A representative α5β1 receptor is shown attached to the RGD central cell binding 
site of fibronectin. The cytoplasmic adaptor proteins and associated protein tyrosine 
kinases are also shown. With this arrangement forces may be transmitted across the 
plasma membrane in both directions. Integrin-ligand binding results in the activation 
of intracellular proteins via the action of the protein kinases. Tal = Talin; Pax = 
Paxillin; Vin = Vinculin; FAK = Focal Adhesion Kinase. 
 
 
69 
 
adhesion, binding to Fn fibrils, slowing of cell migration and is crucial for assembly 
of a Fn matrix (Zamir, Katz et al. 2000; Wierzbicka-Patynowski and Schwarzbauer 
2003). Most Fn integrins recognise the RGD sequence on the 10
th
 type III repeat, 
however, there are several other binding sites for integrins.  
 
1.5.6.4  Integrin Activation 
Integrin activation is a complex process involving several factors that affect the 
avidity of integrin-ligand binding. Integrin avidity is under tight spatial and temporal 
control (Calderwood, Shattil et al. 2000). Occupancy by a ligand is one of the main 
events in integrin activation (LaFlamme, Akiyama et al. 1992). Ligand occupancy 
alone results in integrin localisation to pre-existing contacts but not FAK 
phosphorylation (Yamada, Pankov et al. 2003). Formation of cell-cell contacts 
reduces migration, cell-surface protrusion and actin cytoskeletal dynamics (Braga 
2000). Integrin clustering, or aggregation, is another event important in integrin 
function (LaFlamme, Akiyama et al. 1992). Integrins are dispersed at the cell surface 
but become aggregated at cell-ECM adhesion sites during binding (Singer, Scott et 
al. 1988).  
 
1.5.6.5 Cell-Extracellular Matrix Attachments 
Binding of integrins with their ECM ligands results in the formation of large, stable, 
cytoplasmic, multi-protein assemblies composed of both cytoskeletal and signalling 
molecules (Katz and Yamada 1997; Danen and Yamada 2001). Formation of these 
cell-substrate adhesions requires integrin-ligand binding, integrin clustering, tyrosine 
phosphorylation events and actin cytoskeleton integrity (Danen and Yamada 2001). 
Composition and activity of these assemblies is regulated by the nature of the 
70 
 
integrin-ligand interaction, and intracellular regulators including protein tyrosine 
kinases (PTKs) and phosphatases and guanine triphosphate (GTP)ases (Katz and 
Yamada 1997). 
 
Four types of cell-ECM attachment have currently been described; these are known 
as focal complexes, focal adhesions, fibrillar adhesions and mosaic adhesions.  
 
1.5.6.5.1 Focal Complexes 
The term „point contact‟ refers to the short-lived adhesions formed at the leading 
edges of lamellopodia (Riveline, Zamir et al. 2001; Zaidel-Bar, Ballestrem et al. 
2003). These can mature into focal complexes (Galbraith, Yamada et al. 2002). 
Time-dependent analysis of these adhesions revealed that they are formed by V3 
integrins which become tyrosine phosphorylated. Focal complexes are precursors of 
focal adhesions (Galbraith, Yamada et al. 2002). Maturation from focal complex to 
focal adhesion requires both tensile force and intracellular signalling (Zamir, Katz et 
al. 2000; Riveline, Zamir et al. 2001; Galbraith, Yamada et al. 2002). This force can 
be generated from either inside or outside the cell (Galbraith, Yamada et al. 2002).  
 
1.5.6.5.2 Focal Adhesions 
One common pathway for force transmission is via focal adhesions. Focal adhesions, 
also known as focal contacts, are mature, elongated, attachments (Riveline, Zamir et 
al. 2001). The number, size and distribution of these vary between cell types (Braga 
2000). Focal adhesions are promoted by the stiffness of the underlying ECM. They 
are the major link connecting the ECM to the actin cytoskeleton through integrin 
receptors (Geiger, Spatz et al. 2009). Focal adhesion are generally associated with 
71 
 
the end of actin stress fibres (Zamir, Katz et al. 1999; Riveline, Zamir et al. 2001), 
where they act as anchoring sites and are therefore under isometric tension (Pankov, 
Cukierman et al. 2000). Time dependent analysis of focal adhesions with GFP-
paxillin revealed that they are highly dynamic (Zamir, Katz et al. 2000).  
 
1.5.6.5.3 Fibrillar Adhesions 
Fibrillar adhesions are also known as ECM contacts or adhesion plaques (Zamir, 
Katz et al. 1999). They are elongated or beaded in structure and are located more 
centrally than focal adhesions (Katz, Zamir et al. 2000). Tensin, 5 and 1 also co-
localise with the thin actin fibrils that associate with fibrillar adhesions (Katz, Zamir 
et al. 2000). Fibrillar adhesions are observed on the exterior surface of the plasma 
membrane (Katz, Zamir et al. 2000).  
 
Fibrillar adhesions emerge from the ends of focal adhesions and are transported 
towards the cell centre in an actomyosin dependent manner (Zamir, Katz et al. 2000). 
Formation of fibrillar adhesions involves mobilisation and reorganisation of 
extracellular Fn and this ECM mobilisation is responsible for the segregation of 
focal adhesions and fibrillar adhesions (Katz, Zamir et al. 2000). If Fn is prevented 
from moving, for example by covalent attachment to a surface, fibrillar adhesions do 
not form. Instead, large focal adhesions containing integrins V3 and 51, and 
tensin, vinculin, paxillin and phosphorylated tyrosine residues form. Cells plated on 
covalently attached Fn show little Fn fibrillogenesis (Katz, Zamir et al. 2000; Zamir, 
Katz et al. 2000). 
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Analysis of fibrillar adhesions with GFP-tensin revealed that they are highly 
dynamic (Zamir, Katz et al. 2000) and are motile under tensile stress (Pankov, 
Cukierman et al. 2000). 
 
1.5.6.5.4 Mosaic Adhesions 
Between mature focal adhesions and newly formed fibrillar adhesions Zamir and 
colleagues observed „mosaic‟ adhesions (Zamir, Katz et al. 1999). These contain a 
combination of classical focal adhesion proteins and fibrillar adhesion proteins 
organised in a polarised manner (Zamir, Katz et al. 2000).  
 
1.5.6.6 Focal Adhesion Kinase  
FAK was first identified in 1991 as a non-receptor tyrosine kinase activated by 
integrin mediated adhesion (Guan, Trevithick et al. 1991). Integrin aggregation 
results in localisation of FAK at sites of adhesion, but FAK phosphorylation relies 
on an intact actin cytoskeleton (Gemba, Valbracht et al. 2002). The response is 
modulated by growth factors via the actin cytoskeleton (Guan 1997). 
 
FAK phosphorylation precedes cell spreading and stable adhesions, and FAK null 
cells spread more slowly on ECM proteins, have enhanced focal adhesions and 
impaired migration. As such, FAK is thought to play a role in focal adhesion 
assembly (Guan 1997; Parsons 2003; Wozniak, Modzelewska et al. 2004). 
Interestingly, studies of focal adhesions of cells in 3-dimensional matrices show 
differences from those on 2-dimensional matrices including poor phosphorylation of 
FAK. FAK may, therefore, not be as important in vivo as in vitro (Yamada, Pankov 
et al. 2003; Wozniak, Modzelewska et al. 2004). The major downstream effect 
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controlled by FAK is cell migration, but it is also important in the control of cell 
adhesion, survival, and growth, actin polymerisation and protein degradation.  
 
1.5.6.7 Signalling Via the Actin Cytoskeleton 
Integrin mediated attachment to ECM proteins initiates reorganisation of the actin 
cytoskeleton, which results in changes in cell shape and increased tension, 
influencing cellular behaviour and gene expression. Cell spreading has been found to 
be important in many responses to cell adhesion. Rapid cell spreading on ECM 
proteins occurs within the first 4 to 6 hours. However, F-actin is required for cell 
spreading over the next 48 hours (Mooney, Langer et al. 1995). Cell attachment to 
laminin, Fn, collagen I or collagen IV results in a 20-fold increase in F-actin mass 
within 30 minutes, before any significant changes in cell shape, and does not require 
protein synthesis (Mooney, Langer et al. 1995). Disruption of the actin cytoskeleton 
results in loss of attachment and spreading and inactivation of several signalling 
pathways (Assoian 1997). 
 
Integrins action via the cytoskeleton is mediated by actin binding proteins. These 
bind primarily with  subunit cytoplasmic tails and modulate actin cytoskeletal 
dynamics. Actin binding proteins include -actinin, talin, filamin, tensin, vinculin 
and paxillin (Parsons 2003). Talin, -actinin and filamin localise to focal adhesions 
and are associated with focal complex formation and force-dependent adhesion 
strengthening (Wozniak, Modzelewska et al. 2004). Talin is a key player in integrin 
activation, acting as an intracellular ligand: interaction of talin with integrin 
cytoplasmic tails causes conformational changes within the extracellular domains, 
which increase binding affinities for ECM ligands at the cell surface (Calderwood 
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2004; Shattil, Kim et al. 2010). -actinin and filamin are also localised along stress 
fibres, and in the case of filamin, along cortical actin fibres. Their recruitment to 1-
integrin containing focal adhesions is stimulated by mechanical stress and leads to F-
actin recruitment (Liu, Calderwood et al. 2000). 
 
There are three types of cytoskeleton within cells: microtubules, intermediate 
filaments and microfilaments (Qin, Buehler et al. 2010). Microfilaments, chiefly 
actin filaments, have several essential roles in the normal function of eukaryotic 
organisms. These include cell locomotion, cell spreading and cell division as well as 
membrane dynamics (Chen, Bernstein et al. 2000). Actin filaments act in a number 
of different subcellular structures including focal adhesions, dorsal arcs, stress fibres 
and dendritic structures (Tseng, An et al. 2002). In vivo, actin is generally located in 
a complex and highly dynamic network just below the plasma membrane known as 
the membrane cortex, and there is an intracellular web and a perinuclear web. This 
allows the network to control cell surface movements and respond to cell-surface 
receptor-binding and mechanical deformation.  
 
The actin cytoskeleton-integrin linkage is dynamic and responds to tensile forces. 
This was demonstrated by „trap-retrap-retrap‟ experiments using ligand coated beads 
and a laser trap (Felsenfeld, Schwartzberg et al. 1999). A ligand-coated bead was 
placed on the upper surface of a cell and allowed to attach. The bead was then 
moved by the cell in an actin cytoskeleton dependent manner. If the bead was then 
held by the laser trap, the force exerted by the cell increased to pull the bead from the 
trap. Retrapping the bead the following time required a proportional increase in laser 
power. 
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1.5.7 Mechanotransduction 
There has been much focus on the process of mechanotransduction in tendons 
(Screen, Shelton et al. 2005; Yamamoto, Kogawa et al. 2005; Wang 2006; Maeda, 
Shelton et al. 2009). Mechanotransduction is the process of converting physical 
forces into biochemical signals and integrating these signals into cellular responses 
(Arnoczky, Lavagnino et al. 2002; Huang, Kamm et al. 2004). Cells dynamically 
adapt to force by modifying their behaviour and modifying their microenvironment 
(Regent, Planus et al. 2010). Mechanotransduction provides a framework for 
understanding how tissues “perceive” and are modified by mechanical forces. It has 
a central position in understanding the manipulation of healing tissues.  
 
1.5.7.1 Integrins and Mechanotransduction 
Integrins have been shown to be involved in the process of mechanotransduction 
(Salter, Robb et al. 1997). This has been investigated in diseased cartilage, where the 
signalling pathway via the 51 integrin in response to mechanical stimulation may 
be of importance in the production of phenotypic changes (Millward-Sadler, Wright 
et al. 2000; Millward-Sadler, Wright et al. 2000). These authors showed tyrosine 
phosphorylation of 3 major proteins (including FAK) within 1 minute of onset of 
mechanical stimulation. This was inhibited by RGD containing oligopeptides (and 
gadolinium, which is known to block the stretch-activated ion channels) in human 
articular chondrocytes. As Fn has only a moderate affinity for its integrins, changes 
in Fn (or integrin concentration) could shift the binding equilibria and therefore the 
number or organisation of Fn-integrin complexes, within minutes. This may be 
important in regulation of Fn activity (Brigman, Hu et al. 1994), making Fn binding 
a potential anti-adhesion therapeutic target (Branford, Mudera et al. 2008; Branford, 
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Brown et al. 2010). The 51 integrin is considered to be of major importance in the 
formation of Fn fibrils and for ECM deposition and remodelling in 
mechanotransduction (Regent, Planus et al. 2010). 
 
1.5.7.2 Tissue Load is Transmitted Intracellularly 
Mechanotransduction in response to tissue load is likely to be mediated through the 
deformation of the ECM, which in turn results in in situ cell deformation (Banes, 
Tsuzaki et al. 1995; Sung, Whittemore et al. 1996). Integrins provide the connection 
for the transmission of load between the ECM and the actin cytoskeleton via the 
focal adhesions (Geiger, Spatz et al. 2009). As such, integrins are a primary pathway 
for intracellular force transmission and, therefore, are initiating sensors for local 
ECM mechanical forces as mechanoreceptors (Regent, Planus et al. 2010). Fn 
binding integrins have mechanotransduction related properties and can be involved 
in “perception” of force by cells (Wang, Butler et al. 1993). Lutz and colleagues 
have demonstrated that pericellular Fn, secreted by normal fibroblasts, is a necessary 
component of the strain-sensing machinery and is integral to mechanotransduction 
(Lutz, Sakai et al. 2010). The relationship between cell morphology and tissue strain 
is thought to be mediated through cell interactions with ECM proteins such as Fn 
(Banes, Tsuzaki et al. 1995; Sung, Whittemore et al. 1996).  Thus the common 
connection or nexus between tissue load following mobilisation and the physical 
nature of the resultant adhesions may be Fn-fibroblast integrin attachment (Figure 
1.3). In this thesis a novel DFn with potential anti-adhesive effects was therefore 
investigated in vitro and in vivo for its effects on modifying cell attachment and 
consequently adhesion formation. 
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1.5.7.3 Mechanotransduction and Tendon Adhesion Formation 
Local tissue strains are the result of cellular processes resulting from applied forces. 
However, it is not clear from the literature how local tissue strains in adhesions are 
related to gross tissue strain and how local tissue strains are affected by mobilisation 
and, therefore, tissue load. Mechanotransduction principles are consequently very 
relevant to investigating tendon adhesion formation.  
  
The importance of load (stress) in the homeostasis of connective tissues has been 
well documented (Woo, Gomez et al. 1982; Hannafin, Arnoczky et al. 1995; Yasuda 
and Hayashi 1999). Several studies have shown that stress deprivation in ligaments 
and tendons results in significant alterations in their structural and functional 
properties (Woo, Gomez et al. 1982; Hannafin, Arnoczky et al. 1995; Yasuda and 
Hayashi 1999). Application of dynamic strains influences the structural integrity of 
both healthy and healing soft tissues (Tipton, Vailas et al. 1986). Tendons are known 
to be highly responsive to mechanical loading (Asundi and Rempel 2008). These 
effects are believed to be mediated by changes in metabolism of cells in response to 
the changing mechanical environment (Amiel, Akeson et al. 1983). Cells are, 
therefore, both the detectors and effectors of adaptation of tissues to their mechanical 
environment, as occurs during physiological change or disease. Tendon fibroblasts 
detect mechanical stimuli in vivo and it is through mechanotransduction pathways 
that they initiate ECM remodelling (McNeilly, Banes et al. 1996; Lee and Bader 
1997; Akhouayri, Lafage-Proust et al. 1999; Bouten, Knight et al. 2001; Screen, Lee 
et al. 2003; Chiquet, Gelman et al. 2009). This is also likely to be the case for tendon 
adhesions. Cells within tissues react to mechanical stimuli with molecular responses 
and ECM production that aim to protect the overall integrity of the tissue (Lee and 
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Bader 1997; Akhouayri, Lafage-Proust et al. 1999; Bouten, Knight et al. 2001; 
Huang, Kamm et al. 2004). Cyclical strain applied to cultured tendon cells can 
enhance cell proliferation and ECM production (Riboh, Chong et al. 2008). It would 
follow that applying load to fibroblasts may result in greater collagen deposition and 
the strengthening of adhesions. However, from a review of the literature this does 
not appear to be the case (Woo, Gelberman et al. 1981; Gelberman, Vande Berg et 
al. 1983; Gelberman, Manske et al. 1986; Hitchcock, Light et al. 1987; Feehan and 
Beauchene 1990). It is therefore not clear why the tensile strength of tendons is 
improved by mobilisation yet mobilised adhesions are more likely to fail.  
 
ECM turnover in tendons is influenced by mechanical activity. Collagen synthesis 
and MMP production increase with mechanical loading, and growth factor release is 
enhanced following exercise (Kjaer 2004; Asundi and Rempel 2008). Cells involved 
in the tendon repair process and adhesion formation are responsible for maintaining 
the balance between synthesis and breakdown of ECM components in response to 
injury and mechanical stress (Abrahamsson 1991). It is possible that mobilisation 
has a differential effect on this balance either at the tendon surface or in the 
surrounding synovial sheath. This may account for the strengthening of tendon repair 
and reduced adhesions that are seen following mobilisation. Fong and colleagues 
have shown, using rat tendon cultures using microarray analysis, that mechanical 
shear stress induced an anti-fibrotic expression pattern (Fong, Trindade et al. 2005). 
There was decreased transcription of collagen type-I and collagen type-III. Shear 
stress induced an overall decrease in TGF-β signalling pathway molecules with 
down-regulation of TGF-β2, TGF-β3, TβRI, and TβRII expression, although TGF-
β1 was differentially up-regulated by shear stress. Sheared tendon cells increased 
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expression of MMPs and decreased expression of tissue inhibitors of 
metalloproteinase (TIMP), an expression pattern consistent with an anti-fibrotic 
increase in ECM degradation. However, these authors also found up-regulation of 
genes implicated in tendon healing, specifically, vascular endothelial growth factor-
A. However, they did not examine local strain responses to mechanical shear stress. 
 
Central to probing mechanotransduction, is the development of techniques used to 
apply controlled mechanical stresses to non-fixed cells and tissues. Local strains 
have been shown to be significantly less in tendons relative to applied strains 
(Screen, Lee et al. 2003). While the stress strain behaviour of tendons has been well 
documented (Woo, Gomez et al. 1982; Banes, Horesovsky et al. 1999; Arnoczky, 
Lavagnino et al. 2002), little information exists regarding in situ strains which may 
take place on a cellular level in response to tensile load in tendon adhesions. It is 
clear from a review of the literature that much of the work on tendon adhesions has 
been secondary to that of the investigation of tendons themselves. While the 
underlying mechanotransduction mechanisms are also likely to operate for 
adhesions, the literature does not inform us directly how an adhesion responds to 
applied strain. Any biomechanical assessment of injured tendon function that does 
not also specifically assess adhesions is incomplete as these are so critical to tendon 
glide. Few studies have focussed on changes in the properties of adhesions 
themselves following mobilisation. Masuda and colleagues have previously 
demonstrated that changes in two digital flexor tendon adhesion tissue models may 
be due to alterations in ECM collagen crosslinking (Masuda, Ishii et al. 2002). 
However, that study did not assess effects of mobilisation and did not assess 
adhesions biomechanically. Akeson and colleagues found that collagen in 
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periarticular connective tissue surrounding immobilised rabbit knee joints was 
increasingly crosslinked as a result of lack of physical stress and immobilisation 
(Akeson, Amiel et al. 1977). However, they did not specifically assess tendon 
adhesions.  
 
It is the local strains experienced by cells that are important in the process of 
mechanotransduction, as those are strains exerted at the level of the ECM. It is 
therefore important to describe what the local mechanical environment is like for 
cells. In this thesis an in vivo model system was developed in the injured flexor 
tendon-synovial complex. The techniques employed have investigated how adhesion 
tissues are organised at a local level, and how they respond to forces experienced 
during mobilisation, by modifying the ECM. In this way local strain responses 
produced in adhesions to applied strain were quantified. These micromechanical 
findings were also related to gross restrictive parameters. 
 
1.6 ASSESSMENT OF TENDON HEALING AND 
ADHESIONS 
1.6.1 Clinical Assessments 
Although a number of clinical outcome measurements for flexor tendon surgery 
exist, there is no universal agreement as to what constitutes an ideal evaluation 
system. The widely accepted and simple Boyes‟ method measures the distance from 
the fingertip pulp to the distal palmar crease during maximal active finger flexion 
(Boyes 1950; Boyes 1955). Several other evaluation methods exist including the 
Louisville system (Lister, Kleinert et al. 1977), the American Society for Surgery of 
the Hand method (Hand 1976), and the Buck-Gramcko system (Buck-Gramcko, 
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Dietrich et al. 1976). However, although useful clinically, these methods do not 
allow for specific assessment of severity and quality of adhesions.  
 
1.6.2 Histological Assessments 
Much of the data in the literature investigating adhesion formation is based on 
histological assessment, some using quantifiable methods (Akali, Khan et al. 1999). 
Cell proliferation in response to injury as measured by cell counts has been shown to 
be greater within the synovial sheath and tendon surface than within the tendon core 
in a rabbit model (Kakar, Khan et al. 1998). This reaction has variously been 
described as “thickening” (Gelberman, Manske et al. 1984; Manske, Gelberman et 
al. 1984) or “capping” (Manske and Lesker 1984). 
 
1.6.3 Biomechanical Assessments 
1.6.3.1 Gross Mechanical Testing 
Gross mechanical testing of tendon has been performed, under a variety of testing 
conditions (Woo, Gomez et al. 1982; Butler, Grood et al. 1984). These studies are 
required to define functional parameters of restriction following adhesion formation 
so that anti-adhesive treatments may be compared.  
 
However, few studies have incorporated both biomechanical and histopathological 
assessments of adhesions in a quantitative way (Isik, Ozturk et al. 1999; Strick, Filan 
et al. 2004; Thomopoulos, Kim et al. 2010). Tang and colleagues described a 
biomechanical and histological method of assessing tendons (Tang, Shi et al. 1996). 
However, mechanical evaluation used in that study assessed whole tendon-adhesion-
synovial complex and not adhesions specifically. The authors‟ adhesion assessment, 
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although measuring extent, was not dynamic and did not assess quality of the 
adhesions. Furthermore, these descriptions tell us little about adaptations and 
mechanical response of adhesions to applied load.  
 
1.6.3.2 Micromechanical Testing 
Screen and colleagues have quantified local strain fields in tendons by monitoring 
relative movement and deformation of fibroblast nuclei, where local strains were 
found to be significantly less than gross applied strain, and to be non-homogenous 
(Screen, Lee et al. 2003). Structural heterogeneity within tissues may alter their 
response to load and lead to mechanical failure (Zioupos, Gresle et al. 2008). It is 
also likely that adhesions are non-uniform and therefore to predict their behaviour it 
is necessary to assess their organisation and response to mechanical strain. The 
nature of a strain field associated with a tensile system is important in determining 
ultimate cell response in vivo (Shelton, Bader et al. 2003). In order to be able to 
examine tissue cellular responses and to apply representative physiological strains to 
cells in in vitro experiments it is therefore necessary to first determine local strains 
experienced by those cells (Screen, Lee et al. 2003). In this thesis a method for 
determining the stress strain behaviour of adhesions was developed. This has 
permitted examination of both local strains in response to tensile load and dynamic 
local changes in adhesion tissue morphology as a result of mobilisation. A dynamic 
local mechanical assessment of changes in the adhesion following application of 
strain may provide greater understanding of local tissue arrangement, forces and 
strains involved over the „snapshot‟ assessment afforded by histology. This is 
necessary to begin to understand how externally applied forces to an adhesion may 
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be linked to the process of mechanotransduction and the modulation of the nature of 
the ECM.  
 
1.7 METHODS OF ADHESION REDUCTION 
In addition to using different suture techniques and rehabilitation regimes, various 
strategies to modify adhesion formation in flexor tendon healing have previously 
been investigated experimentally, which may be categorised as either physical 
barriers or biochemical agents.  
 
1.7.1 Mechanical Barriers 
Barriers are interposed between tendon and the surrounding synovial sheath in order 
to physically block adhesion formation. Examples of physical barriers are cellophane 
sheeting (Potenza 1963), silicone film (Eskeland, Eskeland et al. 1977; Stark, Boyes 
et al. 1977), hydroxyapatite and alumina sheaths (Siddiqi, Hamada et al. 1995), 
polytetrafluoroethylene membranes (Hanff and Hagberg 1998), ADCON-T/N (a 
carbohydrate polymer) (Mentzel, Hoss et al. 2000; Golash, Kay et al. 2003),  lubricin 
(Zhao, Sun et al. 2010), Seprafilm (carboxymethylcellulose) (Yilmaz, Avci et al. 
2010) and a phospholipid polymer hydrogel (Ishiyama, Moro et al. 2010), alginate 
(Namba, Shimada et al. 2007) and FocalSeal-L (hydrogel sealant) (Ferguson and 
Rinker 2006). 
 
Potenza observed that mechanically excluding the site of injury from the surrounding 
synovial sheath did not prevent invasion by the peripheral fibroblasts as they 
bypassed the barrier (Potenza 1963). Golash and colleagues conducted a prospective 
randomized clinical trial to study the effects of ADCON-T/N after flexor tendon 
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repair.  ADCON-T/N had no significant effect on total active finger motion, and a 
higher rupture rate was noted in the treatment group. Zhao and colleagues 
demonstrated decreased adhesions in dogs following treatment with lubricin, but at 
the expense of a significant increase in tendon rupture rates (Zhao, Sun et al. 2010). 
In addition, barrier materials have variably caused infection, material fragmentation, 
impaired healing (and tendon rupture), or have had little effect. Many of these 
materials are not biodegradable and may therefore stimulate fibrosis. As a result 
none are used routinely following tendon repair (Strickland 2000).  
 
1.7.2 Biochemical Agents 
Biochemical agents are used to modify or suppress the cellular or inflammatory 
response. Examples of these are cis-hydroxyproline (Lane, Bora et al. 1975), 
antihistamines (Lindsay and Walker 1961), steroid preparations (Carstam, 1953), 
beta-aminoproprionitrile (Peacock and Madden 1969; Speer, Feldman et al. 1985),  
ibuprofen (Kulick, Brazlow et al. 1984; Tan, Nourbakhsh et al. 2010), hyaluronate 
(sodium hyaluronate or hyaluronic acid) (Amiel, Ishizue et al. 1989; Hagberg and 
Gerdin 1992; Salti, Tuel et al. 1993), fibrin sealant (Frykman, Jacobsson et al. 1993; 
Jones, Burnett et al. 2002), neutralising antibody to TGF-β1 (Chang, Thunder et al. 
2000; Xia, Yang et al. 2009), mannose-6-phosphate (Bates, Morrow et al. 2006), and 
5-fluorouracil (Khan, Occleston et al. 1997; Akali, Khan et al. 1999; Khan, Kakar et 
al. 2000; Zhao, Zobitz et al. 2009).  
 
Carstam examined the role of parenteral cortisone in reduction of post-surgical 
adhesions in the extensor hallucis longus tendon of 341 rabbits (Carstam, 1953). He 
suggested that if started several days prior to surgery and continued postoperatively, 
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cortisone therapy resulted in suppression of adhesion formation, as measured by 
tensiometer pulls. This was in contrast to those rabbits that commenced parenteral 
steroid therapy 3 weeks after repair. Groups who did not receive treatment or received 
local application of cortisone at the time of repair did not result in appreciable effect 
on subsequent adhesion formation. In spite of these findings pre-and postoperative 
parenteral steroid courses have not become standard procedure due to associated 
increased rupture and infection rates (Douglas et al., 1967).  
 
Peacock and Madden later examined the role of beta-aminoproprionitrile, a 
lathyrogenic compound and showed it to be successful in treating peritendinous 
adhesions (Peacock and Madden 1969). However, the compound produced significant 
side effects such as hepatotoxicity, fever and dermatitis after 20 days of 
administration. 
 
Kulick and colleagues injected ibuprofen at the time of tendon repair with over 50% 
reduction in adhesion formation (Kulick, Brazlow et al. 1984). A further study by the 
same group showed significant benefits of oral ibuprofen in reduction of tendon 
adhesion formation in a primate model (Kulick, Smith et al. 1986). Tan and colleagues 
also demonstrated reduction in adhesion formation following ibuprofen administration 
in an in vivo rabbit model (Tan, Nourbakhsh et al. 2010). 
 
Hagberg and Gerdin showed that efficacy of sodium-hyaluronate is affected by both 
concentration and molecular weight of the sodium-hyaluronate preparation used 
(Hagberg and Gerdin 1992).  
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Khan and colleagues, using a rabbit flexor tendon model, assessed the effect of a 
single intraoperative application of 5-fluorouracil (5FU) to the tendon synovial 
sheath in repair of a partial tendon laceration was assessed. At one week there was a 
significant reduction in synovial sheath reaction/thickening, cell counts and 
proportional length of adhesions in treated tendons (Khan, Occleston et al. 1997). 
However, Zhao and colleagues found that 5FU had only a transient effect in an in 
vivo canine model where injured FDP tendons were mobilised (Zhao, Zobitz et al. 
2009). 
 
Bates and colleagues investigated the effect of mannose-6-phosphate, a natural 
inhibitor of TGF- (as it prevents activation of latent TGF-β) in vitro and in vivo in a 
rabbit model and found that it reduced TGF- upregulated collagen production, and 
significantly improved range of motion of the operatively treated digits. The effect 
on breaking strength of the tendon repair was inconclusive (Bates, Morrow et al. 
2006). 
 
Other agents have been investigated including neutralising antibody to TGF-1 
(Chang, Thunder et al. 2000; Xia, Yang et al. 2009), and fibrin sealant (Frykman, 
Jacobsson et al. 1993), with varying results. Other techniques, such as thermal 
preconditioning, have also been tested (Healy, Mulhall et al. 2007) in a rabbit model. 
Some of these compounds and methods have demonstrated favourable effects in 
vivo, but none have found their way into widespread clinical usage (Strickland 
2000).  
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1.8 BIOMATERIALS AND TISSUE ENGINEERING 
A biomaterial is “a material intended to interface with biological systems to evaluate, 
treat, augment or replace any tissue, organ or function of the body” (Williams, Black 
et al. 1992). Biomaterials play crucial roles in reconstructive surgery, tissue 
engineering and regenerative medicine (Maskarinec and Tirrell 2005). These 
materials include a wide range of polymers. They may be natural (derived from 
natural sources such as the modified polysaccharides cellulose, chitin, and dextran, 
or modified proteins such as fibrin, Fn, gelatin and collagen) or synthetic (for 
example polylactide, polyglycolide, and polydioxanone). Although protein based 
polymer biomaterials may have weaker mechanical properties than their synthetic 
counterparts, they offer other significant advantages. They have an ability to guide 
cell and tissue behaviour during healing as a function of complex interplay that 
exists between their mechanical and bioactive properties (Maskarinec and Tirrell 
2005; Brown and Phillips 2007). They may also have the capacity to be remodelled 
and degraded by cells and integrated into tissues. The key is what is happening at the 
cell-material interface. Advances in biomimetic polymeric biomaterials, which send 
receptor mediated signals to cells, have resulted in cell type specific influences. 
 
Tissue engineering has been defined as "the application of engineering principles to 
create devices for the study, restoration, modification, and assembly of functional 
tissues from native or synthetic sources" (Williams, Black et al. 1992). The challenge 
of tissue engineering is to control cell behaviour through rational design of 
biomaterials, incorporating the biomechanical principles and methods of engineering 
design. An ideal polymer biomaterial would have adequate mechanical properties to 
match the application. It would be biodegradable reducing its likelihood to stimulate 
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further inflammation and adhesion formation. It would also be fully metabolised 
once it degrades. It would be sterilisable and easily processed into a final end 
product with an acceptable shelf-life. A good example of a protein based biomaterial 
is Fn. During healing, Fn is required for attachment of fibroblasts to fibrin and is 
important in migration of fibroblasts. There is subsequent formation of a Fn scaffold 
by these fibroblasts, upon which collagen is deposited (Ruoslahti, Hayman et al. 
1982; Grinnell 1984; Gelberman, Steinberg et al. 1991; Stadelmann, Digenis et al. 
1998). Preventing fibroblast attachment to Fn is therefore a potential strategy to 
reduce adhesion formation.  
 
Production of Fn mats and cables for tissue engineering has been described (Ejim, 
Blunn et al. 1993; Brown, Blunn et al. 1994; Underwood, Afoke et al. 2001; Phillips, 
King et al. 2004). These constructs guide attachment and migration of cells in vitro. 
These have also been tested in vivo in nerve and tendon healing (Whitworth, Brown 
et al. 1995; Wojciak-Stothard, Denyer et al. 1997; Ahmed and Brown 1999; Zavahir, 
McGrouther et al. 2001; Harding, Afoke et al. 2002; Priestley, Ramer et al. 2002; 
King, Henseler et al. 2003). However, certain fragments of the Fn molecule are anti-
adhesive, inhibiting attachment of fibroblasts to Fn (Yamada and Kennedy 1984; 
Fukai, Takahashi et al. 1996; Ruoslahti 1996; Fukai, Hasebe et al. 1997; Watanabe, 
Takahashi et al. 2000). During production of shear aggregated Fn based biomaterials 
with adhesive properties in this laboratory, withdrawal of a washing step resulted in 
a derivative of Fn (DFn) with inhibitory properties (Djerkovic, Phillips et al. 2005). 
This thesis explores the anti-adhesion properties of this novel material (DFn) 
investigating its in vitro effects on cell attachment (Branford, Brown et al. 2010) and 
its adhesion modifying effects in vivo (Branford, Mudera et al. 2008). 
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2.1 MATERIALS AND METHODS  
Unless otherwise stated all tissue culture materials were supplied by Gibco (Gibco, 
Paisley, UK) and Sigma (Sigma-Aldrich, Gillingham, UK), tissue culture plastics by 
Greiner (Greiner, Stonehouse, UK), and all chemicals used in this study were 
AnalaR grade, where available, and supplied by Sigma (Sigma-Aldrich, Gillingham, 
UK) and BDH (BDH Chemicals, Poole, UK). The source material for the derivative 
fibronectin biomaterial (DFn) and fibronectin control biomaterial (Fn control) was 
frozen cryoprecipitate (Bio Products Laboratory, Elstree, UK), derived from pooled 
human plasma from donors from the United States. Details of other suppliers of 
chemicals or compounds used are noted as and when appropriate within the text. 
 
Primary fibroblast cell strains were obtained from New Zealand White (NZW) rabbit 
forepaws. All cell culture work was carried out in sterile class II laminar airflow 
hoods, (Laminar HB2448, Heraeus Instruments) and cells maintained in a Galaxy S 
incubator (Wolf Laboratories) at 37C, humidified with a CO2 concentration of 5%. 
All in vivo work was performed on NZW rabbit forepaws. All animal care and 
procedures complied with the UK Home Office “Guide for the Care and the Use of 
Laboratory Animals” 1996, under licence of the Department of Health. 
 
2.2 IN VITRO METHODS 
2.2.1 Primary Rabbit Tissue Culture 
Routine tissue culture was performed in Normal Growth Media with 10% Fetal Calf 
Serum (FCS; referred to as 10% NGM in the text) and was made up as follows: 
Dulbecco's Modified Eagle‟s Medium (DMEM), 10% FCS, Penicillin-Streptomycin 
(100 units mL
-1
 and 100 μg mL-1, respectively) and 2 mM L-Glutamine. Culture 
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media was stored at 4C, used within 4 weeks and warmed in a 37C water bath 
prior to use. 
 
2.2.1.1 Preparation of Explant Cultures 
Tendon core, tendon surface, synovial sheath, mobilised adhesion and immobilised 
adhesion cell strains were obtained using explant culture (Burt and McGrouther 
1992) as follows.  
 
NZW rabbit forepaws were removed following Schedule 1 Termination. Paws were 
wrapped in gauze moistened with phosphate buffered saline (PBS) and stored at 4°C 
prior to analysis, which was always within 48 hours of harvest. After shaving the 
paws, the epidermis and fatty tissue were removed using sterile forceps and a sterile 
scalpel. The digital flexor tendon-synovial complexes in unoperated samples, 
comprising tendon and synovial sheath, and peritendinous adhesions in operated 
samples (harvested at 2 weeks post injury), were removed en bloc under loupe 
magnification. The macroscopic appearance of the operated specimens was recorded.  
 
The individual components of the tendon-synovial complex were carefully dissected 
out using a dissecting microscope, separating the flexor digitorum profundus (FDP) 
tendon from its enveloping sheath. The tendon was stripped of its surface using a 
scalpel, thus separating tendon surface from tendon core.  
 
Each of the tissue types were thoroughly washed in sterile saline, then divided into 
2-5 mm
3 
pieces. All explants were then placed separately, according to their source 
of origin, into 25 cm
2
 adherent tissue culture flasks with 5 mL of 10% NGM. The 
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tissue pieces were removed once fibroblasts were seen in culture. The flasks were 
incubated at 37C for approximately 3 weeks; refreshing the media twice per week 
until approximately 80% of the surface area was covered with fibroblasts (80% 
confluence).  
 
Cells were passaged as follows. The flasks were washed twice briefly with warmed 
versene. 1 mL of a 1:10 solution of trypsin: versene (final enzyme concentration of 
0.25%) was added to the flasks, which were incubated at 37C, until the cells had 
detached. The trypsin solution was neutralised with the addition of 4 mL 10% NGM. 
The cell suspensions were pelleted by centrifugation for 5 minutes at 1000 g and re-
suspended in fresh 10% NGM, and sub-cultured on a split ratio of 1:3. 
 
Media was refreshed twice weekly and cells were further sub-cultured routinely in a 
split-ratio of 1:3, by trypsinisation (as described above) on confluency. Only cells of 
passages 1-6 were used for experimentation. 
 
2.2.1.2 Cryogenic Storage 
Exponentially growing cells were trypsinised, pelleted by centrifugation (1000 g, 5 
minutes) and re-suspended in „freezing medium‟ (9 mL FCS and 1 mL Dimethyl 
Sulphoxide (DMSO; Sigma-Aldrich, Gillingham, UK)). Typically a confluent 75 
cm
2
 adherent tissue culture flask was re-suspended in 3 mL of freezing medium, 
which was then aliquoted into cryovials (1 mL per cryovial). Insulated cryovials 
were slowly frozen by placing insulated into a -80C freezer for 24 hours before 
being transferred to liquid nitrogen for long-term storage. 
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Cells were retrieved from cryogenic storage by rapidly thawing the cryovials in a 
water bath at 37C. The cell suspension was immediately transferred to a 15 mL 
labelled centrifuge tube. To this 9 mL of 10% NGM was added slowly, gently 
agitating the solution. The cells were then centrifuged (5 minutes at 1000 g), re-
suspended in 10 mL of fresh 10% NGM, transferred to 75 cm
2
 adherent tissue 
culture flasks and cultured as described in section 2.2.1.  
 
2.2.1.3 Fixation of Tissues or Cells on Biomaterials 
In order to fix either tissues or cells on the biomaterials to enable maintenance of 
morphology, 10% neutral buffered formalin (Appendix I) was used unless otherwise 
stated.  
 
Samples were processed using an enclosed automatic processing system (VIP 2000F/ 
300E) programmed with the following processing schedule: 10% neutral buffered 
formalin for 2 hours at 40C, 70% industrial methylated spirit (IMS) for 1 hour at 
40C, 90% IMS for 1 hour at 40C, absolute IMS for 3 hours at 40C, xylene 
(Merck, Poole, UK) for 4 hours at 40C, paraffin wax for 3 hours at 60C.  Tissues 
were embedded in paraffin wax utilising the Tissue-Tek III. Blocks were cut using a 
microtome and sections were cut to 5 to 8 m as appropriate. 
 
2.2.2 Preparation of Derivative Fibronectin Biomaterial and 
Fibronectin Control 
Two types of Fn biomaterials were prepared for testing – the novel DFn and an 
adherent positive control (Fn control) as previously reported (Ejim, Blunn et al. 
1993; Underwood, Afoke et al. 2001; Phillips, King et al. 2004). The initial stages of 
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production of these mats were identical, and based on the wet extrusion method 
previously described (Underwood, Afoke et al. 2001) which is detailed as follows.  
 
2.2.2.1 Cryoprecipitate Source Material 
The source material for the DFn and Fn control mats was frozen cryoprecipitate 
(Figure 2.1). Briefly, the frozen cryoprecipitate was thawed overnight at 4ºC, hand 
shredded into small pieces, and dissolved in 20% Tris buffer at 37ºC (0.05 mol L
-1
 
Tris (hydroxymethyl) aminomethane (Sigma-Aldrich, Gillingham, UK), 0.15 mol L
-1
 
NaCl, pH 7.4 in deionised water).  
 
2.2.2.2 Method for Heat Depletion of Fibrinogen 
The cryoprecipitate in Tris buffer solution was heated to between 52ºC and 56ºC in a 
microwave on a low setting to precipitate the fibrinogen in the process of heat 
depletion (Tsukada, Ying et al. 1995). The temperature was not allowed to exceed 
56ºC to avoid protein denaturation. The preparation was allowed to cool slightly at 
room temperature. The fibrinogen was filtered out using a sieve with a 2 mm pore 
size (Figure 2.2). The remaining solution was centrifuged at 3200 g in a swing-out 
rotor at 4ºC for 10 minutes to remove the remaining fibrinogen.  
 
2.2.2.3 Method for Polyethylene Glycol Precipitation of Fibronectin 
Fn was precipitated from this solution at room temperature by adding 30% 
Polyethylene Glycol 3500 (Sigma-Aldrich, Gillingham, UK) (Homandberg 1987; 
Harding, Underwood et al. 2000; Underwood, Afoke et al. 2001; Phillips, King et al. 
2004). The preparation was mixed gently and left for 30 minutes at 4ºC. The 
contents were mixed again gently then centrifuged at 3200 g for 10 minutes 
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producing Fn pellets (Figure 2.3), which were kept and the supernatant was 
discarded. 
 
2.2.2.4 Shear Aggregation of Biomaterial 
The Fn pellets were then dissolved in urea (4 mol L
-1
) as 1 mL urea per 1 g of pellet, 
producing a Fn solution after 2 hours on a roller mixer at 37°C. Urea transforms Fn 
from its compact conformation to its extended form (Homandberg 1987), facilitating 
its aggregation (Underwood, Afoke et al. 2001). The Fn was extruded using a 5 mL 
syringe on to a rotating rod at 10 revolutions per minute, forming thin-walled tubes 
by the process of shear aggregation (Phillips, King et al. 2004; Figure 2.4, Figure 
2.5, Figure 2.6). The diameter of the tube was determined by the diameter of the rod 
on to which the biomaterial was applied. For the production of mats for in vitro 
testing 1 cm rods were used. For the production of biomaterials for in vivo testing 3 
mm rods were used. 
 
The biomaterial tubes were air dried, being divided into samples or mats of the 
required dimensions with a scalpel blade at 6 hours (before becoming brittle as a 
result of drying) for a total of 24 hours. The biomaterials were lyophilised in a high 
vacuum freeze dryer (Edwards, Sussex, UK) at –50°C, 80 mbar vacuum pressure. 
Before use the mats were sterilised using a total dose of 28.6 kGray of γ irradiation. 
These were stored in sealed sterile tubes until use. 30 g of cold precipitate yielded 3 
g of Fn, which was sufficient to produce 100 Fn mats weighing approximately 30 mg 
and measuring 1 cm x 1cm.  
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Figure 2.1 The cryoprecipitate raw material. 
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Figure 2.2  The process of heat depletion resulted in the precipitation of 
fibrinogen, removing it from the biomaterial preparation.  
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Figure 2.3  Fn pellets were produced following polyethylene glycol precipitation 
and centrifugation of the preparation. 
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Figure 2.4  Shear aggregation of biomaterial onto a rotating rod. 
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Figure 2.5  Air dried biomaterial tube prior to being cut into mats. 
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Figure 2.6  Air dried biomaterial tube end-on showing thin wall. 
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2.2.2.5 Preparation of Derivative Fibronectin Biomaterial and Fibronectin 
Control 
The production of DFn and Fn control mats differed by the latter subsequently 
undergoing a number of washing stages. The washing stages for the Fn control mats 
consisted firstly of elution for 24 hours in 0.1 mol L
-1
 PBS at 4ºC, followed by 
washing once in PBS at 4ºC and then again in distilled water at room temperature. At 
each stage the elution was discarded.  
 
Prior to any cell seeding both DFn and Fn control mats were briefly rehydrated for 
30 minutes in 0.1 mol L
-1
 PBS at 4ºC. Where materials were used to coat glass cover 
slips these were applied directly and air dried in a sterile hood. The materials were 
stuck to the mats without difficulty.  
 
2.2.3 Protein Analysis of Derivative Fibronectin Biomaterial and 
Fibronectin Control 
To determine the protein content of the DFn and Fn control biomaterials a Titan Gel 
Immunoelectrophoresis kit (Helena Laboratories, Beaumont, USA) and a Radial 
Immunodiffusion Partigen® Plate (Dade Behring, Marburg, Germany) were used as 
follows.  
 
2.2.3.1 Immunoelectrophoresis Analysis of Biomaterial Composition 
The protein content of the solutions from the various stages of purification was 
analysed semi-quantitatively using a Titan Gel Immunoelectrophoresis (IEP) kit 
(Helena Laboratories, Beaumont, USA) as follows.  
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Immunoelectrophoresis combines two techniques, electrophoresis and 
immunodiffusion. In this two part procedure protein solutions (at 2 μL per well) 
were first separated according to charge by electrophoresis on an agarose plate. The 
cryoprecipitate raw material dissolved in Tris 1:2 solution, the fibrinogen-depleted 
solution prior to the precipitation of Fn and the discarded supernatant after Fn 
precipitation were tested for their protein content.  
 
Whole human serum (WHS) was used as a control. 2 drops of albumin marker was 
added to this. 100 mL of Electra® B1 Buffer (Helena Laboratories, Beaumont, USA) 
was poured into each outer section of the chamber, with the supplied sponge wick 
being placed in each buffer-lined compartment. 2 μL samples were applied to the 
plates, taking care not to damage the wells during sample application. The plates 
were immediately placed in the electrophoresis chamber, agarose side down, with 
the wells toward the cathode (negative terminal). The cover was placed on the 
electrophoresis chamber and allowed to equilibrate with the buffer for 60 seconds 
before applying the current. The plates were electrophoresed at 100 V for 45 
minutes. Migration distance was verified by observing the position of the albumin 
marker. 
 
The plates were removed from the chamber and placed on a flat surface, agarose side 
up. Then 25 μL of each of the antisera to human Fn, human fibrinogen, and WHS 
were applied to the troughs in the plate.  The plates were incubated at room 
temperature and allowed to diffuse for 24 hours. The plates were then placed in 
0.85% saline for 6 hours, changing the saline every hour, to remove unbound 
protein. Plates were pressed-dry using blotters, and then dried at 60ºC for 5 minutes. 
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The dry plate was placed in the IEP stain (Helena Laboratories, Beaumont, USA) for 
4 minutes. The plate was then destained by washing in destain solution twice for a 
total of 60 seconds. The plates were again dried at 60ºC for 5 minutes. 
 
Precipitin arcs formed where a favourable antigen to antibody ration existed, 
indicating that the protein complementary to the antiserum used was present in the 
test sample. The size and location of the arc were indications of the amount of total 
protein in the test sample, making this a semi-quantitative technique. Thick 
precipitin arcs closer to the antiserum trough indicated higher protein concentrations 
relative to control. 
    
2.2.3.2 Immunodiffusion Analysis of Biomaterial Composition 
The protein content of the solutions from the various stages of purification was 
analysed quantitatively utilising a radial immunodiffusion Partigen® plate as 
follows.  
 
The Partigen® plate was left to stand at room temperature for 5 minutes prior to use 
to allow any condensed water to evaporate. Fn standards were used undiluted (283 
mg L
-1
), as 25% (70.75 mg L
-1
) and as 50% (141.5 mg L
-1
) dilutions. Samples of 
cryoprecipitate raw material dissolved in Tris 1:2 solution, the fibrinogen-depleted 
solution prior to the precipitation of Fn, and the discarded supernatant following 
precipitation of the Fn were tested for their protein content. To bring the 
concentration of the samples to within the measuring range of the Partigen® plate 
the samples were used undiluted and in a 1:10 dilution in PBS and were applied at 20 
μL per well. Plates were allowed to stand at room temperature for 3 days.  
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The gel contained a monospecific antiserum to human plasma Fn. The Fn formed 
immune complexes with the specific antibodies in the agarose gel of the Partigen® 
plates. These complexes became visible as precipitin rings (radial immunodiffusion). 
The diameter of the precipitin ring was directly proportional to the concentration of 
the relevant protein in the sample. The diameter of the precipitin rings was 
measured. This method has an accuracy of 0.1 mm to 0.2 mm with the plates viewed 
against a dark background with side illumination. The precipitin ring diameters of 
the standard dilutions were squared and the values were plotted against their 
concentrations. The line of best fit was used to calculate the concentrations of the 
samples tested based on their squared precipitin ring diameters, with the relevant 
factor for diluted solutions being taken into account. 
 
2.2.3.3 Determination of Degradability of the Derivative Fibronectin 
Biomaterial and Fibronectin Control 
The biodegradability of the DFn and Fn control was tested using colorimetric 
detection and quantitation of total protein in solution over 21 days as follows.  
 
DFn and Fn control samples were placed in sterile Eppendorf Tubes (Fisher 
Scientific, Leicestershire, UK) containing 3 mL of one of the following: 10% NGM; 
PBS; or PBS containing the protease inhibitor Aprotinin (300 iu mL
-1
). Aprotinin 
was included to test for proteases present in DFn. Experiments were performed in 
triplicate for both DFn and Fn control, which were maintained in solution at 37°C for 
21 days. Protein loss from the biomaterials in solution was evaluated by taking 10 µl 
samples at regular intervals over 21 days. These were immediately frozen at -20ºC 
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for later simultaneous testing using a Bicinchoninic Acid (BCA) Protein Assay 
Reagent Kit (Pierce Biotechnology, Illinois, USA).  
 
The colorimetric detection of protein uses the biuret reaction: this is the reduction of 
Cu
2+
 to Cu
1+
 by protein in an alkaline medium. The cuprous cation (Cu
1+
) is detected 
using a reagent containing BCA (Smith, Krohn et al. 1985). The chelation of 2 
molecules of BCA with 1 cuprous ion forms a purple reaction product. This water-
soluble complex exhibits a strong absorbance at 562 nm that is nearly linear with 
increasing protein concentrations over a broad working range (20 to 2000 μg mL-1).  
 
The protein concentration of the samples were determined and reported with 
reference to known bovine serum albumin (BSA) dilutions (from 0 to 2000 μg mL-1) 
which were assayed alongside the test samples by comparing their absorbance at 562 
nm. The same diluents were used to prepare the protein standards as the test samples.  
 
The 10 µl samples taken at regular intervals over 21 days and standards were placed 
into 96-well plates. 200 µl of the BCA working reagent was added to each well. 
Plates were mixed on a plate shaker for 30 seconds. The plates were then covered 
and incubated at 37ºC for 30 minutes. Plates were then allowed to cool to room 
temperature and the absorbance measured at 562 nm. The mean absorbance of the 
blank standard (0 μg mL-1) replicates was subtracted from all the other individual 
standard and test samples. 
 
In order to generate a standard curve the average blank corrected 562 nm 
measurement for each BSA standard was plotted against its concentration in           
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μg mL-1. The protein concentration of each test sample was determined using the 
standard curve. The absorbances of samples containing 10% NGM were corrected 
for the protein present in the FCS using biomaterial free samples in 10% NGM. 
 
2.2.4 Measurement of Cell Attachment to Derivative 
Fibronectin Biomaterial and Fibronectin Control 
Both DFn and Fn biomaterials were tested for their effects on synovial sheath 
fibroblast attachment in the following manner. 
 
Samples (1 cm by 1 cm) of the DFn and Fn control mats were prepared as described 
in section 2.2.2, and then dried on glass cover slips. Experiments were performed in 
triplicate and repeated for 5 different fibroblast strains, representing 15 samples per 
group. Biomaterials were rehydrated prior to the addition of fibroblasts (1 x 10
5
 in 1 
mL 10% NGM) in 6-well plates. 15 plain (non treated) glass cover slips were also 
seeded with fibroblasts. All samples were incubated for 6 hours at 37°C.  
 
2.2.4.1 Immunostaining Protocol for α-Smooth Muscle Actin with 
Propidium Iodide Counter-Stain for Cells Attached to Biomaterials 
The medium was aspirated carefully and replaced with 2 mL of 10% formal saline 
(Appendix I). The samples were left overnight to fix at room temperature. The 
following day the cover slips were then carefully washed three times with PBS for 
15 minutes. Just prior to staining, the PBS was replaced with 2 mL of ice cold Analar 
Grade Methanol (to permeabilise the cell membranes) for 1 hour at -20C. The cover 
slips were then washed three times with PBS for a further 1 hour in total on a 
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Luckham R100 Rotatest Shaker orbital shaker (Luckham Ltd., Burgess Hill, United 
Kingdom).  
 
Cover slips were stained with an immunofluorescent α-smooth muscle actin (α-
SMA) stain to detect the presence of stress fibres, which are expressed by cells that 
have undergone activation as myofibroblasts (Harris, Stopak et al. 1981; Darby, 
Skalli et al. 1990), and with the fluorescent nuclear stain Propidium Iodide as a 
nuclear counter-stain as follows. 
 
Cover slips were incubated with 500 μL per well of dilute primary mouse Anti-α-
SMA Antibody (1:1000 dilution of primary antibody in PBS; Sigma-Aldrich, 
Gillingham, UK) overnight at room temperature. Separate DFn and Fn coated cover 
slips used as negative controls were incubated in the same way but with 1 mL of 
PBS alone. The cover slips were then washed in their wells three times with PBS for 
30 minutes in total before adding 2 mL of the secondary antibody, rabbit anti-mouse 
Fluorescein Isothiocyanate (as 1:400 dilution in PBS; Sigma-Aldrich, Gillingham, 
UK), with Propidium Iodide (25 g mL-1; Sigma-Aldrich, Gillingham, UK) as a 
nuclear counter-stain. Cover slips were left for 1 hour in a dark box to prevent photo-
bleaching of the fluorescence. 
 
Cover slips were washed three times in PBS for 30 minutes in total, in the dark at 
room temperature.  Cover slips were then carefully placed on a slide with 2 drops of 
Vectashield Vector H-1000 Anti-Fade Mounting Medium (Vector Laboratories, 
Peterborough, UK) and covered with a further cover slip. These were then 
immediately viewed with a Zeiss Axioskop Optical Microscope (Carl Zeiss, Jena, 
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Germany) under an ultraviolet lamp and 5 random x40 high power microscopy fields 
per sample were captured as digital micrographs. Myofibroblasts, which were 
positive for -SMA demonstrated intracellular stress fibers that fluoresced bright 
green.  Negative cells showed red nuclear staining only. The number of cell nuclei 
per microscopy field and the number of myofibroblasts were recorded for test (n=5) 
and control (n=5) groups, and mean values calculated.   
 
2.2.5 Assessment of Synovial Sheath Fibroblast Migration into 
Derivative Fibronectin Biomaterial and Fibronectin 
Control 
The barrier properties of the DFn and Fn control were tested in vitro as follows. 
 
DFn and Fn control samples were prepared and rehydrated as described in section 
2.2.2. Fibroblasts (1 x 10
5
 in 1 mL of 10% NGM) were added to the uppermost 
surface of the biomaterials and were allowed to attach for 24 hours at 37°C. 
Experiments were performed in triplicate and repeated for 3 separate synovial sheath 
fibroblast cell strains (n=3). Biomaterials were washed in PBS to remove unattached 
cells, and then fixed in formalin. During this process the orientation of the 
biomaterials was maintained, so that the surface that had been in contact with 
fibroblasts was known throughout. After paraffin embedding, 8 μm sections were cut 
perpendicular to the seeded surface of the biomaterials using a microtome. The 
sections were then placed on glass slides, deparaffinised, and then stained with 
Haematoxylin and Eosin (H and E). The slides were then examined using light 
microscopy (Nikon Eclipse T5100, Nikon, Tokyo, Japan) for fibroblasts attached to, 
or having migrated beneath, the surface of the biomaterials.    
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2.2.5.1 Haematoxylin and Eosin Staining of Seeded Biomaterials 
The sections were first deparaffinised as follows. The slides were pre-warmed in an 
incubator, and then immersed in two consecutive xylene baths (Merck, Poole, UK) 
for 5 minutes to remove wax.   This was followed by immersion in absolute alcohol, 
90% alcohol and 70% alcohol for 5 minutes each to remove the xylene. The slides 
were rehydrated in distilled water for 5 minutes. 
 
The slides were then placed into a 1% solution of Harris Haematoxylin (BDH 
Chemicals, Poole, UK) and Eosin (BDH Chemicals, Poole, UK) and incubated at 
room temperature for approximately 15 minutes on a rotary shaker. The slides were 
washed thoroughly three times with distilled water (dH2O) before being examined by 
light microscopy. 
 
2.2.6 Determination of Synovial Sheath Fibroblast Viability on 
Derivative Fibronectin Biomaterial  
Synovial sheath fibroblasts were stained with Trypan Blue to determine viability as 
follows. 
 
Fibroblasts (1 x 10
5
 in 1 mL of 10% NGM) were plated into each of the wells of a 6-
well culture plate and allowed to attach for 24 hours at 37°C. The culture plates were 
washed with 10% NGM to remove unattached cells. DFn was added to the wells of 
the culture plate, held apposed to the base of the plate by a metal ring and incubated 
at 37°C for 24 hours (Figure 2.7). The rings were then lifted out from the plates, any 
remaining biomaterial carefully removed and the solution aspirated. 2 mL of Trypan  
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Figure 2.7 Metal ring used to hold DFn apposed to plated cells. 
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Blue (0.4%)  (Sigma-Aldrich, Gillingham, UK) was diluted 1:1 in 10% NGM and 
added to each well to determine cell viability. 
 
2.2.7 Time Lapse Observation of Cells on Derivative 
Fibronectin Biomaterial 
In order to examine the interaction between synovial sheath fibroblasts and the DFn 
biomaterial time lapse images were produced as follows. 
 
DFn was used to coat a glass cover slip as described in section 2.2.4. Fibroblasts (1 x 
10
5 
in 10% NGM) were loaded onto the biomaterial coated cover slip, which was 
maintained at 37°C on the stage of a Diaphot Inverted Stage Microscope (Nikon, 
Tokyo, Japan). Digital images of the edge of the biomaterial on the glass cover slip 
were taken over 24 hours.  
 
2.2.8 Determination of Cell Attachment and Examination of 
Morphology of Cells on Collagen Type-I and Fibronectin 
In order to assess the attachment and morphology of fibroblasts derived from the 
tendon-synovial complex and adhesions to collagen type-I and Fn cells were first 
seeded on protein coated plates and then stained with crystal violet. Absorbance was 
determined as a measure of cell attachment and cell morphology was quantified 
using ImageJ software (US National Institutes of Health, Bethseda, USA) as follows. 
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2.2.8.1 Adsorption of Collagen Type-I and Fibronectin 
Collagen type-I (First Link, Brierley Hill, United Kingdom) and Fn (Sigma-Aldrich, 
Poole, United Kingdom) were diluted in ice-cold PBS to obtain 0, 1, 2, 6, 12, 25 and 
50 μg mL-1 solutions. The solutions were then stored on ice, before adding 50 μL per 
well of either collagen type-I or Fn solution to appropriate wells of high-binding 
Nunc MaxiSorp 96-well ELISA plates (Nunc, Paisley, United Kingdom). Each well 
was reproduced in quadruplicate. The plates were then incubated in a 37C tissue 
culture incubator for 1 hour. The wells were aspirated and gently washed with PBS 
to remove unattached protein.  
 
2.2.8.2 Cell Seeding on Collagen Type-I and Fibronectin 
Cells at passage three or four were washed with Versene for 5 minutes at 37ºC, then 
harvested using Accutase, then resuspended in DMEM with 0.01% BSA (to block 
non-specific cell adhesion to the 96-well plates). Cells were counted and centrifuged 
at 1000 g for 5 minutes. The supernatant was then removed and the cell pellet re-
suspended in 100 μL DMEM with 0.01% BSA, to give 1 x 105 cells mL-1. 
 
When the cells were ready for the assay the PBS was aspirated from the 96-well 
plates and then the cells were added and incubated for 1 hour at 37°C. 1 cell strain 
was tested per plate. Control wells contained PBS and DMEM with 0.01% BSA only 
without cells. The wells were washed twice using 100 μL PBS using a fine needle 
vacuum to aspirate. Cell attachment was measured by crystal violet staining. 
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2.2.8.3 Crystal Violet Cell Adhesion Assay 
The culture medium was carefully aspirated using a fine needle vacuum and each 
well was gently washed twice with 100 μL of PBS. Adherent cells were fixed and 
stained using 25 μL crystal violet solution (0.5% crystal violet, 5% formal saline, 
50% ethanol in dH2O, 0.85% sodium chloride) and incubated for 10 minutes at 
37°C. The crystal violet was aspirated using a fine needle. The wells were washed 
twice with 400 μL PBS, using a multichannel pipette to drip the solution onto the 
side wall whilst holding the plate at 45º to avoid dislodging attached cells. The wells 
were drained by inversion onto a paper towel.  
 
100 l of 33% acetic acid was then added per well to elute the dye from the cells 
(Figure 2.8). The optical density was then read using a microplate reader at 595 nm. 
Cell-free wells were used as intra-plate background control measurements, which 
were subtracted from all well measurements for that plate. Absorbance was 
calculated as the mean of the corrected quadruplicate well values for each 
concentration for each matrix protein for the tendon-synovial complex cell groups 
and for the adhesion cell groups.  
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Figure 2.8  Crystal violet cell adhesion assay. 
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2.2.8.4 Morphological Assessment of Cells Attached to Collagen Type-I and 
Fibronectin 
To quantify cell area, perimeter and circularity, and to determine the proportion of 
elongated cells for the tendon-synovial complex cell groups and for the adhesion cell 
groups, images were processed as follows. 
 
Digital images taken at random of the cells attached to either collagen type-I or Fn at 
25 μg mL-1 were captured using a x20 lens with a Zeiss Axioskop Inverted Optical 
Microscope (Carl Zeiss, Oberkochen, Germany). Cell area, perimeter and circularity 
were quantified using ImageJ software (Ng, Hinz et al. 2005; Papadopulos, Spinelli 
et al. 2007). All cells in each image (typically 10 to 100 cells) were evaluated. 
Particle counting was used to determine the number of elongated or circular cells. In 
order to quantify cell area, perimeter and circularity for the different cell groups each 
digital micrograph image was first converted into a binary image using the threshold 
function with fixed limits determined from sample images. These were then 
despeckled, the watershed function applied to delineate apposed cells as shown in 
Figure 2.9, and processed using established macros (Ng, Hinz et al. 2005).  
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Figure 2.9 Morphological assessment. (Above) Digital micrograph of tendon 
cells. Magnification x20. (Centre) Binary image in ImageJ. (Below) Outline image 
ready for data analysis.  
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2.3 IN VIVO METHODS 
2.3.1  Tendon Injury Model 
In order to create reproducible flexor tendon injuries while minimising the number of 
injury variables a partial tenotomy model was used as follows. 
 
Surgery was conducted on digits 2 and 4 in a single paw (the right forepaw) in NZW 
male rabbits (2.4 - 3.3 kg) aged between 10 and 11 weeks under general anaesthesia 
with a Zeiss operating microscope (Carl Zeiss, Jena, Germany) using microsurgical 
operating instruments. Anaesthesia was induced by Hypnorm® (fentanyl-fluanisone 
0.2 mL kg
-1
, im, Jansen Copenhagen, Denmark) and Diazepam (2 mL kg
-1
, iv, 
Phoenix Pharmaceuticals Ltd, Gloucester, United Kingdom). Oxygen was delivered 
by an anaesthetic mask flowing at 1 L per minute.  
 
The palmar skin was shaved with electric clippers, prepared with chlorhexidine in 
alcohol and then isolated with sterile drapes. Minimally traumatic tissue handling 
was employed throughout the procedure. Conveniently the „dew claw‟ identified the 
position of the apex of the incision, being just proximal to it (Figure 2.10). Care was 
made not to incise the dew claw to reduce irritation for the rabbit paw post 
operatively. A „V‟ shaped incision proximal to the A1 pulley and the 
metacarpophalangeal joints gave access to the flexor digitorum profundus (FDP) 
tendons of digits 2 and 4 (Figure 2.11) avoiding direct injury to the synovial sheath. 
Once the FDP tendons were exposed, great care was taken to prevent desiccation of 
the tissue with frequent irrigation using 0.9% normal saline. 
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The flexor digitorum superficialis tendon was then excised, limiting adhesions to 
those formed between the FDP tendon and the sheath. Once the FDP tendon was free 
from surrounding tissue, gentle traction was applied with the aid of a skin hook. This 
flexed the digit concerned delivering part of the intrasynovial region of the tendon 
into the palmar wound.  
 
A 1/3 thickness 5 mm long injury (Figure 2.12) was made (Jones, Burnett et al. 
2002) with a with a No.15 scalpel blade (Swann-Morton Limited, Sheffield, UK). 
Partial tenotomies have been used in several rabbit models (Kakar, Khan et al. 1998; 
Akali, Khan et al. 1999; Khan, Kakar et al. 2000). On extending the digits the injured 
tendon was returned to the neutral position within the sheath. This approach 
circumvents the need for suture repair, thereby minimising the number of injury 
variables and allowing for immediate postoperative tendon mobilisation (Kubota, 
Manske et al. 1996; Chan, Fu et al. 1998).   
 
Skin was closed using interrupted 4-0 nylon sutures. The wound was cleaned using 
gauze with iodine in alcohol and Cicatrin® (neomycin sulphate/ bacitracin zinc, 
GlaxoSmithKline, United Kingdom) antimicrobial powder applied. All animals 
received buprenorphine (0.025 mg kg
-1
, sc) as postoperative analgesia.  
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Figure 2.10 The dew claw was just proximal to the apex of the incision. Care was 
taken not to injure it. 
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Figure 2.11  The „V‟ shaped incision gave good access to the FDP tendons of 
digits 2 and 4. 
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Figure 2.12 Partial tenotomy injury in the intrasynovial portion of the FDP tendon 
in the rabbit prior to removal of the segment. 
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2.3.2 Investigation of the Effects of Derivative Fibronectin 
Biomaterial Treatment on Adhesions 
In this investigation, following creation of a partial tenotomy injury (section 2.3.1), 
rabbits were randomised to biomaterial treated or untreated injury groups. In the 
treatment group the DFn was introduced over a proximally placed temporary suture 
as a 10 mm long tube around the injured tendons in digits 2 and 4 of the right 
forepaw (Figures 2.13 and Figure 2.14). The injured untreated digits received 3 
minutes air exposure, as this time was required to insert the material around the 
treated tendons.  
 
In order to minimise the number of variables all injured FDP tendons were 
immobilised by proximal complete transection via the same incision (Jones, Burnett 
et al. 2002). After recovery, animals were allowed to move freely.  
 
The animals were euthanised at 14 days and the right and left paws were harvested. 
Digits 2 and 4 of the left forepaw were harvested as unoperated controls. Digits were 
randomised to mechanical (section 2.3.2.1) or histological (section 2.3.4.1) and 
immunohistochemical assessments (section 2.3.4.2; Figure 2.15). 
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Figure 2.13 Biomaterial tube insertion around the injured tendon using a 
temporary suture. 
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Figure 2.14 Diagram of biomaterial in situ around tendon injury.  
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Figure 2.15 Study design showing randomisation of animals having received a 
partial tendon injury to digits 2 and 4 of their right forepaw to biomaterial treated or 
untreated injury groups. Digits were harvested at 2 weeks, with subsequent 
randomisation of digit groups to either mechanical or histological and 
immunohistochemical scoring. 
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2.3.2.1 Mechanical Pullout Evaluation  
In order to assess the effects of DFn treatment on mean peak force required for 
tendon pullout and adhesion structural stiffness, digits were subjected to tensile 
testing as follows. 
 
Forepaws were maintained in saline soaked gauze and freshly assessed. The 
incisions were reopened with the assistance of a Zeiss operating microscope. The 
digital claw was held using a clamp and the free proximal end of the cut FDP tendon 
was identified, transfixed with a silk 2/0 suture and secured to a tensile testing 
machine (Zwick Roell Group, Ulm, Germany; Figure 2.16). Vertical shear reducing 
pullouts were carried out at constant speed (2.5 mm per minute) to determine the 
force required to draw the tendon from its sheath with the tendon transected at its 
insertion just before assessment. This method allowed the tendon to lie freely within 
the sheath, disconnected at either end so that a force applied proximally would 
measure solely the strength of any adhesion between the tendon and the sheath. The 
applied force was increased until adhesions failed (force returning to zero Newtons 
(N)).  
 
Untreated injured digits were used to determine adhesion strength. The treated 
injured digits were tested to investigate the material‟s effect on modifying adhesion 
strength. The restriction parameters were the mean peak force in N required for 
tendon pullout and the adhesion mean structural stiffness (determined in the linear 
portion of each force displacement curve, being the resistance of the adhesion to 
deflection by an applied force in N m
-1
).  
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Figure 2.16 Mechanical pullout assessment with the digital claw being held at one 
end and the FDP tendon of the same digit being held using a transfixion suture at the 
other.  
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To assess biomaterial degradation, it was recorded whether biomaterial was present 
macroscopically within the wound at the time of dissection of digits subjected to 
mechanical pullouts. 
 
2.3.3 Investigation of the Effects of Mobilisation on the 
Hierarchical Biomechanical Properties of Adhesions 
In order to describe how mobilisation affects adhesion tissue organisation, to 
examine local strains in adhesions and to relate local tissue responses to gross 
restrictive parameters a hierarchical approach was used as follows (Figure 2.17). 
Digits 2 and 4 of the right forepaw were operated on in each animal (as described in 
section 2.3.1) in order to reduce numbers, although paired comparisons were not 
made. 
 
2.3.3.1 Mobilisation Regime for Injured Digits 
In order to examine the effects of mobilisation on injured tendons, rabbits were 
randomised to mobilised or immobilised injury groups as follows.  
 
Tendons were immobilised by proximal complete transection via the same incision 
(Jones, Burnett et al. 2002). In those animals that were mobilised tendons were not 
transected, allowing normal digital excursion. After recovery, animals were allowed 
to move freely. The animals were euthanised at 14 days and the paws were 
harvested.  
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2.3.3.2 Sample Preparation 
Paws were wrapped in gauze moistened with PBS and stored at 4°C prior to analysis, 
which was always within 48 hours of harvest. The paw skin was excised and the 
tendon-adhesion-synovial complexes, comprising tendon, peritendinous adhesions 
and surrounding soft tissues, were removed en bloc from the phalanges of digits 2 
and 4 under x3.5 loupe magnification. The macroscopic appearance of the specimens 
was recorded.  Samples were kept moistened with PBS throughout subsequent 
testing. 
 
2.3.3.3 Determination of Gross Adhesion Mechanics  
Gross mechanical testing, as represented by structural stiffness and the peak load at 
failure, provides an assessment of the overall material properties of a tissue.  
 
Mobilised and immobilised samples were secured using a grip at each end separated 
by a fixed length of 15 mm, with the tendon being held at one end and the 
peritendinous tissues at the other (Figure 2.18). In this way, each sample was loaded 
in tension up to failure of the adhesion (connecting the fixed tendon and surrounding 
tissues) at a constant rate of 2.5 mm per minute, using the Bionix® 100 mechanical 
testing system (MTS Systems
 
Limited, Cirencester, United Kingdom). The linear 
proportion of the resulting load-extension data yielded structural stiffness and the 
peak load represented the load at failure for the adhesion in each sample (Figure 
2.18).  
 
 
131 
 
 
Figure 2.17 Study design showing randomisation of digits to either gross tensile 
testing or to micromechanical assessment. 
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Figure 2.18  Macromechanical testing of adhesions. (Left) Gross tensile testing 
system. (Right) Representative load-displacement curve for a test sample, showing 
load at failure and structural stiffness (S). 
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2.3.3.4 Micromechanical Assessment 
In order to examine local tissue organisation and strain responses in tendon 
adhesions a straining system was used to apply load, using the fluorescently labelled 
cell nuclei as dynamic local strain markers as follows. 
 
2.3.3.4.1 Straining System 
A custom designed tensile straining rig (Screen, Lee et al. 2003; Screen, Lee et al. 
2004; Screen 2004; Cheng 2007) was used to apply load to the adhesions with the 
specimen being held in an identical manner to that during the gross tensile testing in 
section 2.3.3.3. The rig was mounted on the stage of an inverted TCS SP2 confocal 
laser scanning microscope (Leica Microsystems GmbH, Wetzlar, Germany; Figure 
2.19). The design of the rig ensured that the specimen was located adjacent to the 
glass coverslip, enabling visualisation of cells within the tissue. The rig was driven 
by stepping linear actuators and controlled using LabVIEW™ (National Instruments 
UK Limited, Newbury, United Kingdom). A maximum displacement of 10% was 
applied at increments of 75 μm ± 15 μm, equivalent to a strain increment of 0.5% 
strain at a strain rate of 1.5% per minute
 
(Screen, Lee et al. 2003). The 2 motors on 
either side of the rig moved simultaneously, ensuring that the central region of the 
sample remained within the microscopic field of view during the application of strain 
to facilitate cell tracking. Specimens were bathed in PBS in a chamber maintained at 
37
o
C using heater pads. 
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Figure 2.19   Micromechanical testing of adhesions. (Above left) Micromechanical 
straining system with specimen held in tissue grips. (Below left) Custom designed rig 
on stage of inverted confocal laser microscope. (Above right) Digital confocal image 
of adhesion cell nuclei fluorescently labelled with ethidium homodimer-1: At 0% 
applied strain. (Below right) Digital confocal image at 10% applied strain. 
Magnification x10. 
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2.3.3.4.2 Confocal Microscopy 
Invasive imaging methods such as histology, and scanning electron microscopy, also 
lack real three-dimensional information and require long and harsh processing steps. 
Confocal microscopy has been an important advance in imaging, enabling the non-
destructive visualisation of optically non-transparent specimens to produce high 
resolution images of tissue structure using fluorescent probes (Stephens and Allan 
2003; Tan, Sendemir-Urkmez et al. 2004). The technique scans the specimen using a 
focused beam of light, collecting the fluorescence signal via a pinhole that rejects 
light from out of focus areas. In this way cell distribution and tissue architecture may 
be examined in real time or with time lapse imaging. It is therefore possible to make 
repeated observations within a single sample in response to mechanical stimuli (Tan, 
Sendemir-Urkmez et al. 2004). Local tissue mechanics may be reconstructed in three 
dimensions over time (Cukierman, Pankov et al. 2001; Voytik-Harbin, Rajwa et al. 
2001). Confocal microscopy has been used to detect alterations in cell shape, in 
response to loading and increasing local tissue strain in articular cartilage (Guilak 
1995; Guilak, Ratcliffe et al. 1995; Guilak, Tedrow et al. 2000), which may stimulate 
cell signalling events through calcium mediated pathways (Guilak 1994). 
 
In this thesis confocal microscopy was used in combination with image processing 
software to examine local tissue strains in mobilised and immobilised adhesions. 
This was in order to analyse the effect of mobilisation on tendon adhesion tissue 
organisation, to quantify the local strain responses produced in adhesions to applied 
strain and to relate these micromechanical findings to gross restrictive parameters. 
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2.3.3.4.3  Confocal Assessment 
Samples were incubated in 20 µM ethidium homodimer-1 (Invitrogen, Paisley, UK) 
in PBS for 1 hour at 37
o
C to label the cell nuclei fluorescently. The specimens were 
briefly rinsed in PBS, and then loaded into the straining rig as detailed in section 
2.3.3.4.1. The confocal laser scanning microscope was used to visualise the adhesion 
cell nuclei, with a Plan Apo x10 magnification objective lens (Nikon, Kingston-
Upon-Thames, United Kingdom) and the argon laser set at 10% power. The laser 
excitation wavelength was 488 nm and emission was detected above 586 nm.  
 
Strain was applied following the method detailed in section 2.3.3.4.1. A population 
of cells within the adhesion were imaged at each strain increment, using the cell 
nuclei to ensure maintenance of the same focal depth (Figure 2.19). The image 
immediately preceding the first detectable cell movement was defined as 0% strain. 
Orthogonal directions (x and y) were defined with the y axis being in the direction of 
the applied strain. Images were captured every 20 seconds. 
 
2.3.3.4.4 Image Analysis 
By tracking the cell nuclei throughout the entire strain range it was possible to 
determine local strain values, using the nuclei as local strain markers as follows.  
 
All of the digital confocal images for each sample were first centred on a reference 
nucleus using Adobe® Photoshop® CS4 (Adobe Systems Incorporated, San Jose, 
Calif.) with the assistance of the grid function. These images were then uploaded 
into the image analysis package Imaris® 6.1 (Bitplane AG, Zurich, Switzerland). 
The software was used to assign exact values of the x and y axis positions of the cell 
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nuclei in each of the images (Figure 2.20). The reference nucleus was assigned the 
position x = 0, y = 0 at all levels of strain. The tracking module of the software was 
then used to track the displacement of all the cell nuclei up to 10% applied strain 
(Figure 2.20). The resulting data were converted into a spreadsheet format for further 
processing. 
 
2.3.3.4.5 Data Analysis 
The distribution of the local strain across each sample was determined as follows. 
 
Local strain was defined as the change in dimension along the y axis resulting from 
the applied displacement. Using the Cartesian co-ordinate system the distance of 
each peripheral nucleus from the central reference nucleus was measured at each 
applied strain and subsequently converted to local strain values using the formula 
(Cheng 2007):               
 
Local strain (%) = (y2 - y1) x 100/  y1 
 
Where y1 and y2 are the distances between the position of the central reference 
nucleus and the peripheral nucleus in the y axis at 0% and 10% applied strain, 
respectively (Figure 2.21). By plotting the displacement of each peripheral nucleus, 
(y2 - y1), against y1, the slope represents the local strain for each adhesion sample.  
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Figure 2.20   Processed confocal images of adhesion cell nuclei. (Above) Cell 
nuclei identified by red spheres. (Centre) Tracks generated by nuclear displacement 
(blue at 0% strain: white at 10% strain). (Below) Geometric vector displacement over 
the range of applied strain shown as grey arrows.  
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Figure 2.21 Schematic of the measurements relevant to calculating local strain. y1 
is the distance between the position of the central reference nucleus (c) and the 
peripheral nucleus (p1) in the y axis at 0% applied strain and y2 the distance between 
the position of the central reference nucleus and the peripheral nucleus (p2) in the y 
axis at the higher increment of applied strain. The direction of the applied strain is 
shown by the arrows centred on c.  
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2.3.4  Histology and Immunohistochemical Scoring in Derivative 
Fibronectin Biomaterial Treated and Untreated Injured 
Tendons and Adhesions 
Tendon and adhesion cellularity and cell proliferation were assessed to clarify the 
material‟s mechanism of action as follows. 
 
2.3.4.1 Histological Scoring 
Digits were divided into halves in the sagittal plane, formalin fixed, decalcified in 
ethylenediamine tetraacetic acid (EDTA) for a total of 4 days and paraffin wax 
embedded. 3 longitudinal 5 μm sections were cut from 3 longitudinal equally spaced 
zones within each half. The high number of sections enabled both haematoxylin and 
eosin (H and E) and immunohistochemical staining to be carried out, and ensured 
that sufficient specimens contained tendon. 1 representative sample was taken from 
each half digit and stained with H and E using the technique described in section 
2.2.5.1.  
 
The presence of adhesions on microscopic examination as a characteristic densely 
cellular band connecting tendon to the surrounding tissues (Figure 2.22) was 
recorded. Digital micrographs were uploaded into Adobe® Photoshop® for analysis. 
Cell counts from 1 sample from each half were used to provide mean digital counts. 
Tissue cellularity was quantified using the grid function, with the grid being placed 
so that its sides were parallel with the tissue surface.  Cell counts were made in 10 
μm high rows from superficial to deep over a 200 x 200 μm grid (Figure 2.23). For 
tendon the grid was placed in the zone of injury.  
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Figure 2.22 Micrograph of an adhesion bridging interface between tendon and 
surrounding soft tissues. Magnification x10. 
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Figure 2.23 The cellularity of tendon and adhesion tissue was quantified using cell 
counts over a 200 x 200 µm grid. The grid was placed so that its sides were parallel 
with the tissue surface. Counts were made in 10 μm high rows from the surface into 
the tissue substance. For tendon the grid was placed in the zone of injury. 
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A representative tendon or adhesion was assessed from each sample. Slides were 
scored independently by 3 observers. A similar technique has previously been used 
to study the surface cell response to tendon injury (Akali, Khan et al. 1999; Jones, 
Mudera et al. 2003).  
 
2.3.4.2 Immunohistochemical Detection of Ki-67 Antigen 
The number of proliferating cells in the sections was assessed by 
immunohistochemical detection of Ki-67 antigen, detecting all active stages of the 
cell cycle but not the G0 „resting‟ stage (Scott, Hall et al. 1991), as follows. This was 
then quantified using the grid technique described in section 2.3.4.1 (Figure 2.23). 
Slides were scored independently by 3 observers. 
 
Firstly, slides were deparaffinised in xylene (Merck, Poole, UK) and then rehydrated 
in reducing percentages of ethanol, to distilled water as described in section 2.2.5.1. 
Endogenous peroxidases were then removed by soaking in a 3% fresh solution of 
hydrogen peroxide (Merck, Poole, UK; Appendix I) followed by a wash in the buffer 
PBS. The primary antibody was optimised for antigen retrieval by microwaving in 
sodium citrate buffer (Appendix I) for 10 minutes in two 5 minute bursts with a 5 
minute break between. The slides were cooled in the sodium citrate buffer prior to 
incubation with the antibodies. 
 
Slides were then placed in a humidity chamber and normal rabbit serum (Dako, High 
Wycombe, UK) was added to prevent non-specific staining (diluted 1:10 and left on 
the sections for 10 minutes at room temperature). This serum was then removed by 
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tapping off the excess and the primary antibody was layered on top at a 1:25 dilution 
in 1% BSA diluted in PBS.   
 
Before doing the experiments the antibody dilution optimised by starting with the 
recommended manufacturer's dilution and then using a range either side. The 
sections from the control tissue were then assessed for intensity of staining and 
absence of non-specific staining. Incubation time was also optimised, along with 
incubation temperature, allowing specific staining with the lowest concentration of 
antibody but still providing intense specific staining. The incubation time for the 
primary antibody was 90 minutes at room temperature. 
 
Following incubation, the primary antibody was washed off in two 3 minute washes 
with PBS. The secondary antibody was then applied in phosphate buffered saline-
bovine serum albumin (PBS-BSA; Appendix I) containing a 10% dilution of normal 
human serum. The secondary antibody uses the primary antibody as its antigen; 
hence the mouse monoclonal primary (anti Ki67, Dako, High Wycombe, UK) would 
have a secondary antibody raised against the mouse (rabbit anti-mouse biotinylated 
antibody, Dako, High Wycombe, UK). This secondary had been biotinylated; i.e. 
biotin had been added chemically. It was added at a dilution of 1:200 and was left at 
room temperature for 45 minutes. The secondary antibody was then removed by two 
3 minute washes in PBS. The streptavidin-biotin-horseradish peroxidase complex 
(Dako, High Wycombe, UK) was then made up in a dilution of 1:200 and layered 
onto the tissue and left at room temperature for 45 minutes. This was washed off and 
the slides then immersed in the chromogen 3, 3‟-diaminobenzidine 
tetrahydrochloride (Sigma-Aldrich, Gillingham, UK; Appendix I). The slides were 
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left for 8 to 12 minutes until a colour had developed, and the reaction terminated by 
placing the slides in tap water. The slides were then counterstained in Mayer‟s 
haemalum (BDH, Poole, UK) and re-hydrated with grades of ethanol. They were 
cleared with xylene to allow the refractive index to come to 1 and then mounted in 
Depex (BDH, Poole, UK) and a cover slip added.  
 
A positive control was included in each staining batch to ensure that the staining was 
successful. A negative control and was also included in each staining run. In the 
negative controls the primary antibody was omitted and replaced by PBS in one 
reaction, and the secondary antibody replaced by PBS in another, to check for non-
specific staining.  
 
To ensure staining consistency and reproducibility all sections from different blocks 
were stained as a batch on the same day and the process was repeated four times. 
Results were analysed independently by 3 observers.  
 
2.4 STATISTICAL ANALYSIS 
All statistical analysis was performed using Sigmastat for Windows, Version 2.0 
(Jandel Scientific Corporation, San Rafael, USA). Data was analysed using Student's 
t-test, the unpaired t-test, the Mann-Whitney U test, or 2-way repeated measures 
ANOVA with the Tukey post-test or Dunnett‟s post-test as appropriate, with p<0.05 
being judged as statistically significant.  
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3.1 INTRODUCTION 
Biomaterials based on proteins, such as fibronectin (Fn), have the potential to guide 
cell and tissue behaviour during healing as a function of their unique mechanical and 
bioactive properties. Fn has been reported as a scaffold for the attachment of 
fibroblasts and the subsequent deposition of collagen. During production of shear 
aggregated Fn based biomaterials with adhesive properties, withdrawal of a washing 
step resulted in a derivative of the fibronectin biomaterial (DFn) with inhibitory 
properties (Djerkovic, Phillips et al. 2005). The properties of DFn have been 
investigated both in vitro (Branford, Brown et al. 2010; this Chapter) and in vivo 
(Branford, Mudera et al. 2008; Chapter 4).  
 
The in vitro investigation tested DFn and its effects on aggressive adhesion forming 
cells, using rabbit flexor tendon synovial sheath fibroblasts. These cells were used as 
they are recognised as being active contributors to adhesion formation (Brigman, Hu 
et al. 1994; Khan, Occleston et al. 1997; Khan, Occleston et al. 1998; Ragoowansi, 
Khan et al. 2003). The stability of the biomaterial in solution was tested as a measure 
of its degradation. An ideal biomaterial would have the ability to undergo 
degradation, reducing its likelihood to stimulate further inflammation and adhesion 
formation. Attachment and infiltration of fibroblasts cultured with the DFn was 
examined, representing the biomaterial’s anti-adhesive properties and ability to act 
as a physical barrier, respectively. Toxicity of the biomaterial on fibroblasts and 
stress fibre formation by fibroblasts seeded on the biomaterial were examined. 
Finally, the interaction between fibroblasts and the biomaterial was visualised using 
time lapse photography. 
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3.1.1 Aim 
To conduct an investigation into the properties of a DFn and its effects on aggressive 
adhesion forming cells in vitro, using synovial sheath fibroblasts. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Protein Analysis of Derivative Fibronectin Biomaterial 
and Fibronectin Control 
The protein content of the solutions from the various stages of production of the DFn 
and Fn control were analysed qualitatively using an immunoelectrophoresis kit 
(section 2.2.3.1) and quantitatively using immunodiffusion techniques (section 
2.2.3.2).  
 
3.2.2 Biodegradability of Derivative Fibronectin Biomaterial 
and Fibronectin Control 
Degradation of the DFn and Fn control materials in normal growth media with 10% 
fetal calf serum (FCS; referred to as 10% NGM in the text), phosphate buffered 
saline (PBS), or PBS containing the protease inhibitor Aprotinin was tested. This 
was achieved by evaluating protein loss in solution in samples taken over 21 days, 
which were tested using a Bicinchoninic Acid Protein Assay Reagent Kit, as 
measured as described in section 2.2.3.3. 
  
3.2.3 Synovial Sheath Fibroblast Culture 
The synovial sheaths of the digital flexor tendons from 5 New Zealand white rabbit 
forepaws were dissected out using a dissecting microscope, thoroughly washed, then 
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divided into 2-5 mm
3 
pieces and explant cultured to obtain their fibroblasts, as 
described in section 2.2.1.1. 
 
3.2.4 Assessment of Fibroblast Attachment 
The attachment of synovial sheath fibroblasts to glass coated with the DFn 
biomaterial, relative to fibroblast attachment to uncoated and Fn control coated glass 
was assessed using a propidium iodide stain as a measure of cell counts, as detailed 
in section 2.2.4.1. The number of myofibroblasts was assessed using an 
immunofluorescent α-smooth muscle actin (-SMA) stain, as detailed in section 
2.2.4.1. 
 
3.2.5 Assessment of Migration 
The infiltration of the biomaterials by fibroblasts was assessed by seeding synovial 
sheath cells onto DFn and Fn control, washing, formalin fixation and Haematoxylin 
and Eosin (H and E) staining as described in section 2.2.5. This was examined using 
light microscopy for fibroblasts attached to, or having migrated beneath, the surface 
of the biomaterials. 
 
3.2.6 Fibroblast Viability Assessment 
Details of the assessment of the cytotoxicity of the DFn to fibroblasts exposed to it 
using Trypan Blue staining are outlined in section 2.2.6. 
 
3.2.7 Time Lapse Assessment 
The interaction between synovial sheath fibroblasts and DFn over 24 hours was 
visualised using time lapse photography, as described in section 2.2.7. 
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3.2.8 Statistical Analysis 
Statistical analysis was used, using a p value of <0.05 as to be statistical significant. 
The different treatment groups were compared using the unpaired t-test as the data 
was normally distributed.  
 
3.3 RESULTS 
3.3.1 Protein Analysis of the Derivative Fibronectin Biomaterial 
and Fibronectin Control 
3.3.1.1 Immunoelectrophoresis 
The immunoelectrophoretic assessment demonstrated semiquantitatively that there 
were high levels of Fn or Fn protein fragments in both the cold precipitate raw 
material and the fibrinogen depleted solution (the solution from which both of the 
DFn and Fn control biomaterials are made, just prior to their shear aggregation). 
There was no detectable fibrinogen present in the biomaterial preparation following 
fibrinogen heat depletion. The assessment also demonstrated that both the dissolved 
DFn and Fn control biomaterials were Fn or Fn protein fragments, with no detectable 
fibrinogen. This was confirmed by the presence or absence of precipitation arcs to 
these antigens on the immunodiffusion test plate (Figure 3.1).  
 
3.3.1.2 Immunodiffusion 
A radial immunodiffusion assay was used to test the concentration of Fn proteins in 
the DFn and Fn control biomaterials following precipitation and washing. Data are 
presented as mean (± SD). By calculating the Fn concentrations from the diameter of 
known protein standards, the assay demonstrated a high concentration (1162 ± 89 
mg L
-1
) of Fn or Fn protein fragments in the cold precipitate raw material Tris 1:2 
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solution, a high concentration (1467 ± 123 mg L
-1
) of these proteins in the 
fibrinogen-depleted solution prior to the precipitation of Fn, and only 18 ± 3 mg L
-1
 
of these proteins in the supernatant following precipitation of the biomaterial. This 
suggests that any fragments of Fn were largely incorporated into the DFn 
biomaterial. 
 
 
 
 
 
 
 
 
 
 
 
 153 
 
Figure 3.1  Immunoelectrophoresis plate showing precipitin arcs for Fn and 
Fibrinogen (G). The raw material Cryoprecipitate (Cryo), the biomaterial in solution 
prior to precipitation (BM), the discarded supernatant after biomaterial precipitation 
(Sup) and a control Whole Human Serum (WHS) were tested against antisera to 
Whole Human Serum (Anti WHS), Fn (Anti Fibronectin), and Fibrinogen (Anti 
Fibrinogen).  
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Figure 3.2 Calculation of Fn concentration in solution from protein standards. 
The line of best fit enables the Fn concentration of the test solutions to be calculated 
from the diameter of their precipitin rings. The 1:10 cold precipitate raw material 
Tris 1:2 solution, the 1:10 fibrinogen depleted solution and the discarded supernatant 
had mean precipitin ring diameters of 6.65 mm, 7.16 mm and 4.61 mm respectively. 
From the line of best fit (y = 0.234x + 17) for the Fn protein standards this gives 
mean Fn concentrations of 1162, 1467 and 18 mg L
-1
 respectively. 
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3.3.2 Biodegradability of the Derivative Fibronectin Biomaterial 
and Fibronectin Control 
In the next step DFn and Fn control biomaterials were assessed for stability, 
comparing their dissolution rates in PBS, PBS with Aprotinin (300 iu mL
-1
; a 
protease inhibitor, to test for proteases present in the DFn material), and 10% NGM. 
This last solution was used as it was the culture medium used in the cell attachment, 
cell migration, and cytotoxicity assays. Experiments were performed in triplicate for 
both DFn and Fn control biomaterials, which were maintained in the solutions at 
37°C for 21 days. Protein loss from the biomaterials into solution was evaluated by 
taking samples at regular intervals over 21 days, tested using a Bicinchoninic Acid 
Protein Assay Reagent Kit (Pierce Biotechnology, Illinois, USA). Samples 
containing DMEM were corrected for the protein present in FCS. 
 
As can be seen in Figure 3.3 both DFn and Fn control biomaterials were fully 
degradable, having dissolved 100% by 72 hours in PBS. There was no significant 
difference between the dissolution rates of DFn and Fn control materials in PBS. The 
resistance of DFn and Fn control biomaterials to protease dissolution was also tested 
by using Aprotinin. Data is presented as the mean percentage dissolution (± SD). 
Percentages only are presented for clarity of results. As can be seen in Figure 3.3 at 
this time point in Aprotinin (mats dissolved by 51% ± 17% and 63% ± 14% of their 
initial weight respectively, p=0.48 unpaired t-test) or in DMEM (55% ± 24% and 
71% ± 25% respectively, p≤0.92 unpaired t-test). By 3 weeks there was no 
significant difference in dissolution between DFn and Fn control biomaterial in 
DMEM (88% ± 21% and 89 ± 20% respectively, p≤0.97 unpaired t-test) or in PBS 
containing Aprotinin (64% ± 21% and 77% ± 10% respectively p≤0.46 unpaired t-
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test). Adding Aprotinin to the PBS solution resulted in significantly less degradation 
for the DFn mats (36% less, p≤0.038 unpaired t-test). However, this decrease was 
not significant for the Fn control mats (23% less, p≤0.079 unpaired t-test).  The rapid 
dissolution of the biomaterials when tested in PBS is likely to be due to proteases not 
eliminated from them during their production. Adding Aprotinin to the PBS solution 
resulted in significantly less degradation for the DFn biomaterial at 3 weeks. 
However this was not the case for the Fn control biomaterial. These results suggest 
that DFn, where soluble fragments are not eliminated during the final stages of 
production, contains higher levels of proteases than the Fn control where the soluble 
fragments are eliminated during washing. It follows that the release of proteolytic Fn 
fragments by DFn may partly be the result of the presence of these proteases. The 
reduced protein dissolution seen for both DFn and Fn control mats in DMEM 
relative to PBS may be due to anti-proteases present in the FCS (Paczek, Michalska 
et al. 2008). 
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Figure 3.3 Protein dissolution curves (n=3) for DFn and Fn control biomaterials 
in 10% NGM, PBS and PBS with Aprotinin (300 iu mL
-1
; PBS + Apr) solutions. The 
dissolution curves for DFn and Fn control in PBS were very similar. Data is 
presented as the mean percentage dissolution. 
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3.3.3 Assessment of Fibroblast Attachment 
The attachment of fibroblasts to DFn and Fn control was tested by seeding (1 x 10
5
) 
fibroblasts in 1mL 10% NGM on these materials. At 6 hours the unattached cells 
were washed off, and the remaining attached cells were fixed and stained. The 
fluorescent nuclear stain propidium iodide was used to facilitate cell counts. 
Fluorescein isothiocyanate (FITC)-labelled α-SMA immunostaining was used to test 
for any alteration of synovial sheath fibroblasts to a more myofibroblastic lineage. 
The data are presented as mean cell counts per microscopy field (± SD). The results 
showed that there almost no fibroblasts attached to cover slips coated with DFn (0.1 
± 0.0) compared to cover slips coated with Fn control or to untreated glass ((23.6 ± 
10.0) and (20.8 ± 10.0), p≤0.001 and p≤0.002 respectively), as shown in Figure 3.4. 
This showed that while fibroblasts attached to glass or the Fn control, DFn 
effectively eliminated cell attachment.  There was no microscopic evidence of 
substantial cell death, indicating that toxicity did not contribute to this effect. As 
detected by α-SMA staining there were 2.0 ± 0.7 myofibroblasts per microscopy 
field on plain cover slips. No myofibroblasts were seen on the DFn or Fn control 
mats which were clearly less stiff than the glass cover slips (Figure 3.5).  
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Figure 3.4 Immunofluorescent micrographs of biomaterials cultured with 
fibroblasts after washing and α-SMA and propidium iodide staining. (Above) DFn 
biomaterial. Note the absence of attached cells. (Centre) Fn control biomaterial. 
Cells were attached to the coated cover slips, but no myofibroblasts were seen. 
(Below) Plain glass cover slips. Attached cells were seen and some expressed α-
SMA (myofibroblast). Magnification x40. 
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Figure 3.5 Average attached fibroblast and myofibroblast cell counts per 
microscopy field to DFn, Fn control and plain glass (with myofibroblasts staining 
positively for α-SMA). The DFn biomaterial coated cover slips (n=5) showed 
significantly fewer attached cells than Fn control biomaterial coated cover slips 
(n=5) or plain glass cover slips (n=5). The data are presented as mean cell counts per 
microscopy field (± SD). 
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3.3.4 Assessment of Migration 
The ability of fibroblasts seeded on the surface of the biomaterials (DFn and Fn 
control) to migrate into a three-dimensional structure was tested by incubating 
surface seeded materials for 24 hours. Experiments were performed in triplicate and 
repeated for 3 separate synovial sheath fibroblast cell strains (n=3). Fibroblasts were 
found deep within the Fn control biomaterial with the deepest cell seen at a depth of 
70 μm, but no fibroblasts were located either at the surface of, or within, the DFn 
biomaterial (Figure 3.6).  
 
3.3.5 Fibroblast Viability Assessment 
Fibroblasts that had been plated into each of the wells of a 6-well culture plate and 
allowed to attach for 24 hours were placed in direct apposition with DFn for a further 
24 hours. Experiments were performed in duplicate and repeated for 3 separate 
synovial sheath fibroblast cell strains (n=3). Cells were then stained with Trypan 
Blue to test cell viability. No Trypan Blue uptake was detected in DFn treated cells 
(Figure 3.7), indicating no loss of cell viability resulting from exposure to the DFn. 
In contrast to the cells in the attachment assay where no attachment was seen, a large 
number of cells that had already been plated did not appear to detach after exposure 
to the DFn. This is seen in Figure 3.7 where elongated and rounded cells are seen 
attached to the base of the culture well. 
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Figure 3.6  Micrographs of biomaterials 24 hours after seeding with fibroblasts 
after washing and H and E staining. (Above) Fn control biomaterial. Cells (C) are 
evident at the material surface (S) with limited invasion by cells into the biomaterial 
substance. (Below) DFn biomaterial. No cells were seen at or below the biomaterial 
surface (S). Magnification x20. 
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Figure 3.7  Micrograph demonstrating fibroblasts that have been exposed to a 
DFn biomaterial mat for 24 hours and stained with trypan blue. No dead cells were 
seen. Some of the cells assumed a rounded morphology (R), although many cells 
remained attached to the base of the culture well. Magnification x100. 
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3.3.6 Time Lapse Assessment 
Dynamic interaction between fibroblasts and the biomaterial was monitored directly 
using time lapse microscopy for 1 randomly selected synovial sheath cell strain. 
Following fibroblast (1 x 10
5
) seeding and culture with the DFn biomaterial the 
majority of cells maintained rounded morphology with no cells attaching to the 
biomaterial (Figure 3.8). A minority of cells attached to the base of the culture well 
some distance from the DFn biomaterial. However, even these continuously shifted 
between bipolar and rounded morphologies, suggesting repeated attachment and 
detachment cycles in individual cells (Figure 3.9).  
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Figure 3.8  Micrograph from the time lapse assessment of the interaction 
between cells and the DFn biomaterial at 6 hours. This demonstrates that no cells are 
attached to the DFn biomaterial (BM; seen in the top 1/3 of the image) and that those 
adjacent to the material generally assumed a more rounded morphology (R). 
Magnification x20.  
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Figure 3.9  Detail micrographs from the time lapse assessment of the interaction 
between cells and the DFn biomaterial. Cells did not attach to the biomaterial 
surface. Some of the cells that did attach appeared to continuously shift between 
bipolar (B) and rounded (R) morphologies as seen in the images above. (Far left) At 
6 hours. (Centre left) At 12 hours. (Centre right) At 18 hours. (Far right) At 24 
hours. These cells were not dead as they were seen to alternate between detaching 
and reattaching to the culture plates. In general, cells appeared to move away from 
the biomaterial surface over time. Scale as shown.  
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 3.4 DISCUSSION 
3.4.1 Preventing Cell Attachment to Fibronectin: A Therapeutic 
Strategy 
Fn is a key cell adhesion glycoprotein secreted by wound fibroblasts, and is involved 
in organising cellular interactions with the extracellular matrix (ECM) in the healing 
surgical wound. An important component of the early healing process, Fn acts as 
biological adhesive. It promotes attachment and migration of fibroblasts on the 
ECM. It forms an intermediary scaffold for deposition of collagen by fibroblasts, 
eventually leading to the formation of adhesions (Grinnell 1984; Gelberman, 
Steinberg et al. 1991). It follows that preventing attachment of fibroblasts to the 
ECM in the days after injury is a potential strategy to interrupt the formation of 
fibrous adhesions.  
 
3.4.2 Cell Binding and Fibronectin 
Cells bind to Fn via integrin and non-integrin receptors (Clark, An et al. 2003). 
Integrins are cell adhesion molecules that link the ECM to the cytoskeleton, enabling 
cells to respond to their external environment (Johansson, Svineng et al. 1997; van 
der Flier and Sonnenberg 2001). Blocking these receptors may influence aspects of 
cell behaviour such as attachment and migration. The answer to how this may be 
achieved may lie within the Fn molecule itself.  
 
Fn has a central cell-binding domain, its predominant cell adhesive domain, 
recognised by most adherent cells via several integrin receptors. The activity of the 
central domain is attributed to the Arg-Gly-Asp (RGD) motif in the tenth type III 
module (Pierschbacher and Ruoslahti 1984; Ruoslahti 1996) and the synergistic 
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motif in the ninth type III module (Skorstengaard, Jensen et al. 1986). These cell 
adhesive sites are recognized by a cell adhesion receptor, the integrin α5β1 (Hofer, 
Syfrig et al. 1990; Watanabe, Takahashi et al. 2000). The RGD sequence has a 
central role in cell adhesion biology as the prototype adhesion signal (Ruoslahti 
1996; Meredith and Schwartz 1997). It has the capacity to support maximal 
fibroblast attachment (Clark, An et al. 2003) and is therefore a suitable target in 
modifying adhesion formation. 
 
The carboxy-terminal domain (Hep 2) contains at least 6 major cell adhesive sites, 
which support heparin-dependent, RGD-independent cell adhesion (McCarthy, 
Skubitz et al. 1990). In addition, there are cell adhesive sites in the domain adjacent 
to the Hep 2 domain in the type III connecting segment, recognized by the integrin 
α4β1 (Mould and Humphries 1991).  
 
3.4.3 An Anti-Adhesive Biomaterial 
Plasma Fn aggregates from solution, under shear force, to form fibrous materials that 
have been previously reported for use in tissue engineering applications 
(Underwood, Afoke et al. 2001; Phillips, King et al. 2004). During development of 
these aggregates (the Fn control biomaterial in this study), the elimination of a single 
processing step resulted in a material which, in complete contrast, did not support 
cell attachment (i.e. the DFn biomaterial assessed here). The soluble fraction of the 
DFn biomaterial assessed in this study has been previously shown to contain a 
heterogeneous group of Fn fragments with inhibitory effects (Djerkovic, Phillips et 
al. 2005). After separation by affinity and molecular weight a heparin binding 
fraction less than 30 kDa significantly inhibited neurite growth without increasing 
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cell death in vitro. Results from immunoassays in the present study have confirmed 
that a soluble Fn protein was present in the DFn biomaterial.  
 
The current in vitro investigation was designed to investigate the mechanism of 
action of the biomaterial, and indicates that the DFn biomaterial releases soluble Fn 
fragments that inhibit fibroblast attachment to any intact Fn. Although adhesive 
peptides can promote cell attachment when attached to a surface, when present in 
solution, they prevent attachment that would otherwise occur (Ruoslahti 1996). 
Alternatively, fragments of Fn may be acting as inhibitors to cell adhesion. 
 
3.4.4 Inhibitory Fragments Within the Fibronectin Molecule 
Proteolytic fragments of the Fn molecule, which may result from its digestion by 
wound proteases, and similar synthetic peptides have been shown to inhibit integrin 
mediated cellular processes, such as attachment, growth, differentiation of cells and 
contraction of the ECM (Fukai, Hasebe et al. 1997; Fukai, Mashimo et al. 1998; 
Fukai, Kamiya et al. 2000; Watanabe, Takahashi et al. 2000; Sethi, Mudera et al. 
2002). Fn fragment competitive self inhibition through cell receptor blocking has 
been suggested previously (Brown 1983).  
 
A number of adhesion inhibiting sequences, which may be contained within 
fragments of the Fn molecule, have been described. These include the RGD 
sequence within the central cell binding domain (Hautanen, Gailit et al. 1989; 
Ruoslahti 1996; Sethi, Mudera et al. 2002), the Y-T-I-V-I-A-L sequence (Fukai, 
Hasebe et al. 1997) and other sequences within the heparin-binding (Hep 2) domain 
(McCarthy, Skubitz et al. 1990; Mould and Humphries 1991; Wilke, Skubitz et al. 
 170 
1991; Mooradian, McCarthy et al. 1992). The prevention of cell attachment has been 
investigated using synthetic peptides (Pierschbacher and Ruoslahti 1984; Yamada 
and Kennedy 1984; Hautanen, Gailit et al. 1989; McCarthy, Skubitz et al. 1990; 
Mould and Humphries 1991; Wilke, Skubitz et al. 1991; Mooradian, McCarthy et al. 
1992; Ruoslahti 1996; Fukai, Hasebe et al. 1997; Sethi, Mudera et al. 2002) and by 
modifications in key sequences (Obara, Kang et al. 1988; Sakata, Sasatomi et al. 
2000). Yamada and Kennedy found that for inhibition of fibroblast to Fn binding 
using synthetic peptides, Gly-Arg-Gly-Asp-Ser was found to be considerably more 
active than Arg-Gly-Asp-Ser. For both proteins, the inverted peptide sequence Ser-
Asp-Gly-Arg was also moderately active, However, closely related peptides 
containing a transposition, a deletion, or a single conserved amino acid substitution 
were much less active at preventing fibroblast adhesion to Fn (Yamada and Kennedy 
1987).  
 
3.4.5 Cryptic Anti-Adhesive Site and Exposure to Urea 
Fukai and colleagues demonstrated that a 30 kDa Hep 2 fragment, which showed no 
significant effect on kidney cell attachment to Fn, suppressed cell adhesion after 
exposure to urea in a non-competitive fashion (Fukai, Takahashi et al. 1996). It 
suppressed cell adhesion when coated on a culture dish and when added as a soluble 
supplement. RGD-dependent cell adhesion was preferentially inhibited, with no 
significant binding of the Hep 2 fragment to Fn. The cryptic anti-adhesive activity of 
Fn was expressed upon conformational change and following proteolytic cleavage of 
the Hep 2 hydrophobic domain (Fukai, Takahashi et al. 1996; Watanabe, Takahashi 
et al. 2000). Interestingly, Fukai and colleagues showed that human plasma derived 
Fn, as used in the present study, which was purified without exposure to a 
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denaturant, such as urea, exhibited no central cell binding domain, amino-terminal 
fibrin-binding domain or carboxyl-terminal fibrin-binding (Hep 2) domain activity. 
By exposure to urea or surface adsorption, Fn showed central cell binding but not 
those of the other domains (Fukai, Ohtaki et al. 1995). Therefore competitive 
inhibition by Fn and its fragments may require conformational changes as occurs 
following exposure to urea.  
 
3.4.6 The Anti-Adhesive Nature of the Derivative Fibronectin 
Biomaterial  
Either one or both of two possible processes that expose the anti-adhesive site of Fn 
or its fragments (Fukai, Hasebe et al. 1997) may therefore be occurring in the present 
study: a conformational change, resulting from preparation of the mats using urea, 
and proteolytic cleavage of the Fn molecule resulting from proteases present in the 
source material. The urea used during preparation of the DFn mats may have 
promoted their antiadhesive activity by inducing a conformational change in Fn or its 
fragments to reveal a cryptic antiadhesive site as previously described (Rocco, 
Carson et al. 1983; Fukai, Takahashi et al. 1996; Watanabe, Takahashi et al. 2000). 
The extreme sensitivity of interdomain sequences of Fn to proteolysis, by a broad 
range of proteases (Brown 1983), suggests that it would be rapidly split into partly 
active fragments by the presence of these, either by plasma proteases present in the 
material or by tissue proteinases that are known to be present in the inflammatory 
wound environment in vivo (Yamada 1983; Grinnell, Ho et al. 1992; Grinnell and 
Zhu 1994). Fn degradation products may lead to increased proteinase gene 
expression and release, which may lead to further protease-mediated matrix 
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fragmentation in vivo (Werb, Tremble et al. 1989; Homandberg, Meyers et al. 1992; 
Stack and Pizzo 1993).  
 
In this investigation, time lapse studies confirmed that synovial sheath fibroblasts did 
not adhere to the material, and that cells in the area immediately adjacent to the 
dissolving DFn biomaterial maintained a rounded unattached morphology consistent 
with the idea that a released component was responsible. 
 
3.4.7 Cryoprecipitate Contains Fibronectin Fragments 
Plasma cryoprecipitate is known to be rich in Fn (Scovill, Saba et al. 1978; Harding, 
Underwood et al. 2000; Underwood, Afoke et al. 2001; Phillips, King et al. 2004). In 
addition, Fn present in cryoprecipitate is known to be heavily degraded into Fn 
fragments (Ruoslahti, Hayman et al. 1981; Brown 1983). Cryoprecipitate is also 
known to be low in the protease inhibitor antithrombin III (Cosgriff, Hodgson et al. 
1983), which may contribute to the activity of proteases contained within the DFn 
material. Qualitative and quantitative assessment of the DFn biomaterial in the 
present study confirmed that it is rich in such Fn fragments. The protein dissolution 
assessments in this study also suggest the DFn materials contain higher levels of 
proteases than the Fn control biomaterials, which may further increase their Fn 
fragment content, and result in exposure of cryptic antiadhesive sites by proteolytic 
cleavage.  
 
The results in this investigation suggest that Fn fragments are the likely candidate 
component of the source cryoprecipitate that appear to give the DFn its ability to 
reduce fibroblast attachment. The decrease in cell adhesion found in the previous 
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studies was only due to competitive binding of cleaved Fn fragments onto cell 
receptors (Brown 1983; Yamada and Kennedy 1984). It is not clear from the present 
study whether the protein fragments were causing inhibition by acting in a 
competitive or non-competitive way. If the effect is only due to competitive binding 
by dissolved Fn fragments the anti-adhesive effect will only exert its effect while the 
DFn biomaterial is still dissolving. 
    
3.4.8 Inhibition of Myofibroblastic Conversion by the 
Derivative Fibronectin Biomaterial  
In this study no myofibroblasts were seen following fibroblast culture on either DFn 
or Fn control biomaterials. It would normally be expected in a population of in vitro 
fibroblasts that a proportion of cells would be myofibroblasts. Fn-derived 
antiadhesive peptides have previously been shown to suppress myofibroblastic 
conversion of rat hepatic stellate cells (Kato, Kamiya et al. 2001). Alternatively, this 
finding may be related to the biomaterial surfaces as such materials are far less stiff 
than plain glass, generating a low tension cell-environment, removing one of the 
factors thought to stimulate myofibroblast formation (Tomasek et al., 2002). 
However, longer time frames need to be examined to determine if there is an 
increase in myofibroblast conversion over time in culture on DFn and Fn control. 
When myofibroblasts persist in fibrotic lesions they are believed to be responsible 
for excessive collagen production
 
that leads to alteration of tissue architecture and 
ultimately
 
to organ dysfunction. Myofibroblasts may promote clinically important 
adhesion formation. Preventing myofibroblast differentiation may therefore be a 
target mechanism for reducing fibrosis and adhesion formation.  
 
 174 
3.4.9 Biomaterial Degradation 
Strategies that target fibroblast to Fn adhesion are likely to have their maximal 
effects on preventing adhesion formation during the inflammatory and fibroblastic 
phases of wound healing. It is during this time that fibroblast migration and 
provisional ECM deposition (the inflammatory phase), and consequent fibroblast 
proliferation and collagen deposition (the fibroblastic phase) predominate (Mutsaers, 
Bishop et al. 1997; Liakakos, Thomakos et al. 2001; Beredjiklian 2003). These 
overlapping events last from days to weeks post injury. The biomaterial may only be 
required to be present during these early stages of wound healing. Presence of the 
biomaterial at later stages may contribute to further inflammation and adhesion 
formation. In this study, by 21 days the DFn material dissolved by 64% in PBS with 
Aprotinin and 88% in 10% NGM.  
 
3.4.10 Barrier Effects of the Derivative Fibronectin Biomaterial  
The results of this investigation have shown that fibroblast cells were clearly able to 
attach and migrate into the Fn control biomaterial as has been previously reported 
(Ejim, Blunn et al. 1993; Phillips, King et al. 2004). This in vitro study has shown 
that fibroblasts did not migrate into the DFn biomaterial substance, confirming its 
suitability as a protein barrier. The absence of migration into the DFn biomaterial by 
fibroblasts may be due the material not supporting their attachment.  
 
3.4.11 Summary 
The results of this investigation have shown that the DFn biomaterial has barrier 
properties and biodegrades to provide prolonged delivery of anti-adhesive factors, 
preventing the attachment of adhesion forming fibroblasts. This supports the idea 
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that the DFn biomaterial may be used to prevent adhesion formation at tissue 
interfaces. Importantly, the DFn biomaterial was not toxic to fibroblasts indicating 
that it is unlikely to cause a generalised loss of fibroblasts which might impair 
healing of adjacent tissues. 
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4.1 INTRODUCTION 
Fibronectin (Fn) glycoprotein binds cell surfaces and numerous substances including 
collagen and fibrin (Ruoslahti, Hayman et al. 1982) and is a promoter of cell 
proliferation (Sottile, Hocking et al. 2000). During the development of Fn-based 
biomaterials to promote healing, a modification in the fabrication process resulted in 
scaffolds not supporting fibroblast attachment. Washing the materials abolished this 
anti-adhesive effect, suggesting that soluble Fn fragments were responsible 
(Branford, Brown et al. 2010). Short fragments may act as competitive inhibitors of 
cell-surface adhesion (Brown 1983) and the Fn molecule harbours anti-adhesive sites 
(Yamada and Kennedy 1984; Fukai, Takahashi et al. 1996; Fukai, Hasebe et al. 
1997; Watanabe, Takahashi et al. 2000). Following injury to gliding tissue surfaces 
collagen is deposited by migrating cells to form stiff bridges. Cell attachment is a 
pre-requisite for migration (van der Flier and Sonnenberg 2001) and if cell 
attachment and migration is reduced this may prevent collagen deposition and 
fibrotic adhesion formation. 
 
A rabbit model has been developed using the digital tendon-synovial complex in 
which the mechanical restriction is in a single axis. It was hypothesised that if 
interposed as barriers between the tissue interfaces then these constructs would block 
extracellular matrix (ECM) bridge deposition. These constructs would encourage 
tendon surface cellularity whilst preventing the attachment of migrating fibroblasts 
by acting as delivery vehicles for anti-adhesive fragments.  
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4.1.1 Aim 
To test the novel biomimetic material in vivo to determine its efficacy in reducing 
restrictive adhesion in a flexor tendon-synovial complex injury model. 
 
4.2 MATERIALS AND METHODS 
4.2.1 Tendon Injury Model 
The deep flexor tendons of digits 2 and 4 in the right forepaw of 15 New Zealand 
White (NZW) rabbits were subjected to 5 mm long partial tenotomies as described 
in section 2.3.1. Animals were randomised to receive biomaterial tubes enveloping 
the tendon injuries or left untreated as set out in section 2.3.2. 
 
4.2.2 Mechanical Evaluation 
Mechanical pullout studies were used to determine the gross mechanical parameters 
for DFn treated and untreated digits at 2 weeks post injury. Mean peak force and 
structural stiffness for the adhesions were calculated as described in section 2.3.2.1. 
 
4.2.3 Histology and Immunohistochemical Scoring 
Tendon and adhesion surface cellularity and cell proliferation were assessed to 
clarify the material’s mechanism of action.  This was achieved using Haematoxylin 
and Eosin (H and E) staining (section 2.3.4.1) and immunohistochemical staining for 
Ki67 (section 2.3.4.2.), with cell counts being made over a 200 x 200 μm grid by 3 
independent observers. Details of the analysis are set out in section 2.3.4.1.  
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4.2.4 Statistical Analysis 
The mechanical and cellular data were assessed using the Mann-Whitney Rank Sum 
test as the data was non-parametrically distributed. Statistical analysis was used, 
using a p value of <0.05 as to be statistically significant. 
 
4.3 RESULTS 
15 treated and 14 untreated injured digits were randomised to mechanical or 
histological assessment. Of the 7 treated injured tendons that were evaluated by 
pullout testing there was macroscopic evidence of the material in only 2 cases at 14 
days, confirming reports that Fn biomaterials resorb in vivo.   
 
4.3.1 Mechanical Evaluation 
All 3 sets of pullout data are shown in Figure 4.1. Values are given below as the 
mean (± SD). Normal pullouts (uninjured, negative controls) had a mean peak 
pullout force of 0.04 ± 0.04 Newtons (N; range 0.01 to 0.13 N; n=11; Figure 4.2).  
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Figure 4.1 This force displacement graph shows a reduced mean pullout force in 
the treated injured group (n=7) relative to the untreated injured control group (n=6) 
and uninjured digits (n=11). Pale shading indicates mean (± SEM). 
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Figure 4.2 A comparison of mean peak force required to overcome adhesions in 
untreated injured digits (n=6), DFn treated injured digits (n=7) and uninjured digits 
(n=11). The mean peak force required to overcome treated adhesions (treated injury) 
was not significantly different to that for normal pullouts (uninjured digits; p=0.174) 
and was lower than for positive controls (p=0.001). Error bars = SEM. 
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For the untreated injury group (positive control), the mean peak force required to 
overcome adhesions was 7.70 ± 4.14 N (range 1.20 to 12.00 N; n=6; Figure 4.2). 
Their mean structural stiffness was 628.02 ± 139.84 N m
-1
. 
 
The mean peak force required to overcome treated adhesions (treated injury group) 
was 0.31 ± 0.41 N (range 0.01 to 1.13 N; n=7; Figure 4.2). This was not significantly 
different to that for normal pullouts (uninjured digits; p=0.174) and was lower than 
for positive controls (untreated injured digits; p=0.001). The highest peak pullout 
force for the treated adhesions was lower than the lowest peak pullout force for 
positive controls. This indicates that the highest peak pullout force with the 
biomaterial was below the nominal threshold used to functionally define adhesion. 
Treating adhesions resulted in a significantly lower mean structural stiffness (39.60 ± 
38.60 N m
-1
) than for positive controls (p=0.001). No tendons ruptured during 
testing. 
 
4.3.2 Histology and Immunohistochemical Scoring 
As described in section 2.3.4, slides were scored independently by 3 observers and a 
consensus achieved.  
 
4.3.2.1 Histological Scoring 
Adhesions were present in all injured digits on histological examination. Uninjured 
tendons (n=8) showed a rapid decrease in cellularity from 0 to 30 µm from their 
surface. Deeper than 30 µm the cell counts levelled out (Figure 4.3).  
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Figure 4.3  A comparison of cell counts measured from the tendon surface in 
microns at 2 weeks post injury in treated injured digits (n=8), untreated injured digits 
(n=8) and negative control digits (n=8). Untreated injured tendons more cellular at 
their surface than uninjured control tendons (p=0.028). Treated tendons were more 
cellular at their surface (first 10 µm) than uninjured controls (p=0.130) and untreated 
injured digits (p=0.645). Treated tendons were consistently significantly more 
cellular than their untreated counterparts deeper than 110 μm (p≤0.05). Error bars = 
SEM. 
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Untreated injured tendons (n=8) were 28% more cellular at their surface (0 to 10 μm) 
than uninjured tendons (p=0.028). There was a more gradual decrease in cellularity 
than with uninjured digits (Figure 4.3). 
 
Values are given as the mean (± SD). Treated injured tendons were 38% more 
cellular (22.3 ± 7.3 cells; n=8) at their surface (first 10 µm) than uninjured controls 
(16.2 ± 2.2 cells; n=8; p=0.130), remaining hypercellular up to 200 μm into their 
substance (Figure 4.3). There was an 8% increase in cellularity in the first 10 µm as 
a result of treatment from 20.6 ± 6.1 cells (n=8) to 22.3 +/-7.3 cells (n=8; p=0.645; 
Figure 4.3). Treated injured tendons were consistently significantly more cellular 
than their untreated injured counterparts deeper than 110 μm where the curves 
levelled out (p≤0.05). Examples of all 3 groups are shown in Figure 4.4. 
 
The mean cell count following biomaterial testing in the most superficial 10 microns 
of the adhesion surface was reduced by 55% from 18.7 ± 4.7 cells in the positive 
control adhesions (n=8) to 8.4 ± 4.7 cells in treated samples (n=8; p=0.003; Figure 
4.5). Deeper than 50 µm the cellularity of both groups reached a plateau, with treated 
adhesions being significantly more cellular (p<0.001). The untreated and treated 
injury groups are shown in Figure 4.6. 
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Figure 4.4 H and E stain of tendon injury groups. (Left) Untreated injured 
tendon. (Centre) Treated injured tendon. (Right) Uninjured tendon. Treatment with 
the biomaterial did not reduce surface cellularity, and increased cellularity within the 
substance of the tendon following injury. Magnification x20. 
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Figure 4.5 A comparison of cell counts measured from the adhesion surface in 
microns in treated injured digits (n=8) and untreated injured digits (n=8). The mean 
cell count in the most superficial 10 μm of the adhesion surface in treated injured 
digits was significantly reduced relative to untreated injured digits (p=0.003). Deeper 
than 50 µm, treated adhesions were significantly more cellular (p<0.001). Error bars 
= SEM.  
  
 188 
 
Figure 4.6 H and E stain of adhesion groups. (Left) Untreated injured adhesion. 
(Right) Treated injured adhesion. Treatment with the biomaterial reduced the surface 
cellularity of adhesions. Treated adhesions were more cellular within their substance. 
Magnification x20. 
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4.3.2.2 Immunohistochemical Scoring 
There was a significant reduction in the number of proliferating cells in the most 
superficial 10 μm of the adhesions in the treated injured digits (n=8) relative to 
untreated injured controls (n=8; p<0.001; Figure 4.7). Deeper than 50 µm the 
situation was reversed with the number of proliferating cells in the treated adhesions 
being significantly increased (p≤0.007). The hypercellularity and high number of 
Ki67 positive staining cells is evident within the bulk of the treated adhesions 
(Figure 4.8). 
 
As would be expected, the number of proliferating cells in the untreated injured 
tendons (n=8; Figure 4.9) and treated injured tendons (n=8; Figure 4.10) was greater 
than that in the uninjured tendons. There was no significant difference in the number 
of Ki67 positive cells at the tendon surface or within the tendon substance comparing 
untreated injured tendons (n=8) and treated injured tendons (n=8; Figure 4.11). The 
differences in the different treatment groups and uninjured control tendons are 
shown in Figure 4.12. 
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Figure 4.7 A comparison of Ki67 positive cell counts measured from the 
adhesion surface in microns in treated injured digits (n=8) and untreated injured 
digits (n=8). There was a significant reduction in the number of proliferating cells in 
the most superficial 10 µm of the adhesions in the treated injured digits relative to 
untreated injured controls (p<0.001). Deeper than 50 μm the situation was reversed 
with the number of proliferating cells in the treated adhesions being significantly 
increased (p≤0.007). Error bars = SEM. 
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Figure 4.8    Ki67 stained sections through adhesion surface. (Left) Untreated 
adhesion. (Right) Treated adhesion. These micrographs show increased staining and 
so cell division within the treated adhesions. There is reduced cell division in the 
treated adhesion surface, and increased cell division within the adhesion substance. 
Magnification x40. 
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Figure 4.9 A comparison of Ki67 positive cell counts measured from the tendon 
surface in microns in uninjured tendons (n=8) and untreated injured tendons (n=8). 
Error bars = SEM. 
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Figure 4.10 Ki67 positive cell counts measured from the tendon surface in 
microns in uninjured tendons (n=8) and treated injured tendons (n=8). Error bars = 
SEM. 
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Figure 4.11 Ki67 positive cell counts measured from the tendon surface in 
microns in untreated injured tendons (n=8) and treated injured tendons (n=8). Error 
bars = SEM. 
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Figure 4.12 Ki67 stained sections through tendon surface. (Left) Untreated injured 
tendon. (Centre) Treated injured tendon. (Right) Uninjured tendon. These 
micrographs show increased staining and so cell division within the injured tendons. 
There is no reduction in cell division at the treated injured tendon surface or within 
the tendon substance. Magnification x40. 
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4.4 DISCUSSION 
4.4.1 A Combined Mechanical and Histological Approach  
Much of the literature investigating adhesions is based on histological assessment, 
some using quantifiable methods (Akali, Khan et al. 1999). Few studies incorporate 
biomechanical and histopathological assessments (Strick, Filan et al. 2004). This 
study utilised a reproducible injury for quantification of the effects of the biomaterial 
in the zone of healing. The cellular response at the tendon surface has previously 
been described as ‘capping’ (Manske and Lesker 1984) or ‘thickening’ (Gelberman, 
Manske et al. 1984; Manske, Gelberman et al. 1984). In the present investigation the 
cellular responses at the tendon surface and adhesion surface were examined 
histologically to investigate the processes underlying adhesion formation. This has 
shown that the biomaterial produces a major reduction in the mechanical tethering of 
gliding interfaces by adhesions in vivo, although there was no difference in the 
incidence of adhesions between treated and untreated injury sites on histological 
examination.  
 
4.4.2 Cellular Effects of the Biomaterial  
Cellular proliferation in response to injury is greater within the synovial sheath and 
tendon surface than within the tendon core (Kakar, Khan et al. 1998). The present 
study has demonstrated that the DFn biomaterial resulted in ‘adhesions’ that were 
significantly less cellular at their surface but were far more cellular over their bulk. 
This was reflected in the pattern of cell proliferation. The cellularity of the tendon 
surface was not reduced as a result of treatment. Treated injured tendons were 
consistently significantly more cellular than their untreated injured counterparts 
deeper within their substance. It is concluded that the biomaterial reduces the 
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strength of adhesions by diminishing the formation of bridging tissue connections by 
inducing adhesion surface cellular paucity. It achieves this without compromising 
tendon surface cellularity and while increasing the cellularity of the tendon core. 
 
4.4.3 A Mechanism for Differential Cellular Effects on Injured 
Tendon and the Synovial Surface 
Following injury provisional ECM is largely composed of Fn and collagen type-III 
collagen and supports cellular migration from tissue margins (Lorenz 2003). 
Fibroblasts predominate and a causative relation has been reported between Fn 
secretion and cell chemotaxis and adherence (Gelberman, Steinberg et al. 1991). As 
fibroblasts proliferate and migrate (Yamada 1996; Greiling and Clark 1997), they 
deposit an increasingly mature, mechanically functional collagen matrix 
(Stadelmann, Digenis et al. 1998).  
 
Synovial sheath cells produce higher levels of Fn than tendon derived cells 
(Brigman, Hu et al. 1994), whereas tendon cells produce three times as much 
collagen in vitro than synovial sheath cells (Riederer-Henderson, Gauger et al. 
1983). Tendon cells are therefore the foremost contributors of collagen (and tensile 
strength) to the repair (Gelberman, Amiel et al. 1992). It seems likely then that there 
is a spatial - from the synovial sheath to the tendon and a temporal ECM gradient 
progressing from Fn-rich to collagen-rich tissue. If the anti-adhesive Fn biomaterial 
releases Fn fragments at the collagenous gliding surface then cell adhesion and 
migration within tendon would be preserved but reduced at the synovial surface. 
This would reduce the ability of fibroblasts to lay down collagen across the interface. 
Hence adhesion would be reduced but tendon repair sustained.  
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A key study provides support for this, suggesting that human fibroblasts have 
differential properties when attaching to ECM proteins (Shimo-Oka, Hasegawa et al. 
1988). The production of a Fn fragment following trypsinisation inhibited fibroblasts 
from attaching and spreading onto Fn, without inhibiting attachment to collagen. 
This is the result of competitive binding site inhibition and of fibroblasts having 
different protein binding sites (Brown 1983; Shimo-Oka, Hasegawa et al. 1988). 
RGD peptides inhibit cell attachment and migration on Fn without concomitant 
effect on collagen binding and migration (Oharazawa, Ibaraki et al. 2005). The 
collagen binding domain of Fn is spatially distinct from its cell binding (RGD) 
domains (Ruoslahti, Hayman et al. 1980), suggesting a further mechanism for a 
differential effect on tissue cellularity. 
 
The biomaterial has been shown to dissolve in vitro producing a heterogeneous 
group of fragments (Djerkovic, Phillips et al. 2005; Branford, Brown et al. 2010). 
Certain Fn fragments prevent cell adhesion and auto-inhibit Fn function (Yamada 
and Kennedy 1984; Fukai, Takahashi et al. 1996; Fukai, Hasebe et al. 1997; 
Watanabe, Takahashi et al. 2000; Yamada 2000). Both Fn (Sottile, Hocking et al. 
2000) and Fn fragments (Zlatopol'skii, Chubukina et al. 1989; Zlatopol'skii, 
Chubukina et al. 1992) promote cell proliferation. The hypercellularity within the 
tissue substance may be explained by the dual proproliferative and anti-adhesive 
action of Fn fragments. That is, encouraging proliferation of deeper, attached cells 
and causing detachment of cells with poorer attachments at the adhesion surface. 
This suggests that in the location of the biomaterial, fibroblasts experience 
competitive inhibition for occupancy of their integrins reducing their overall ability 
to bind to the ECM and to migrate. It may be suggested that this reduction in motility 
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contributes to the difference in surface cellularity and in fewer ECM attachments 
with less mechanical integration at the gliding interface.  
 
4.4.4  Suitability for Surgical Use 
Zone 2 repairs are within a tight profibrotic tunnel and therefore anti-adhesive 
materials should not be bulky. The biomaterial rapidly assumes a gelatinous 
consistency in solution, facilitating its placement, which would be simplest as a 
spray on product.  
 
It is likely that the material will be effective in sutured transected tendon injuries as 
the resultant increased inflammatory cascade may be targeted by the material’s 
cellular effects on dampening the adhesion surface response as shown in this study. 
The biomaterial may be of particular use in non compliant patients as its effects were 
so significant in the immobilised setting.  
 
4.4.5 Summary 
The goal of adhesion tissue engineering is to reduce connective tissue formation 
across gliding interfaces whilst promoting anastomosis between injured surfaces. 
This in vivo study has shown that the anti-adhesive biomaterial significantly reduces 
restrictive adhesion formation and modifies cellular reactions in the wound milieu. 
The in vitro (Chapter 3) and in vivo investigations suggest that this would be due to 
the biomaterial’s engineering properties providing a physical barrier that delivers 
both anti-adhesive and pro-proliferative fragments around the injured tendon 
synovial complex. The material was not cytotoxic as demonstrated by an absence of 
non viable cells after exposure to the material (Branford, Brown et al. 2010; Chapter 
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3). These findings may pave the way for a clinical study to use a biomaterial mat to 
reduce adhesion formation after tendon repair. In addition, this simple tendon model 
would be applicable to a much wider context for the testing of anti-adhesion 
treatments. 
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5.1  INTRODUCTION 
The composition of living tissues is less important in determining their mechanical 
behaviour under stress than the organisation of their component parts, with 
component subtype and topology being critical (Tanaka, Al-Jamal et al. 2001). In 
addition, tissues that have a hierarchical structure need to be studied at micro- and 
macrostructural levels in order to understand their intrinsic behaviour (Katz, Misra et 
al. 2007). At a microstructural level, the local strains seen in tissues are strongly 
dependent on the associations between  the cells and the surrounding extracellular 
matrix (ECM) (Screen 2004). The degree of structural heterogeneity within tissues 
may also alter their response to load and lead to mechanical failure (Zioupos, Gresle 
et al. 2008), which may be particularly relevant to tendon adhesions. Structural 
organisation is a dynamic entity and is revealed by the application of stress. The 
difficulty lies in how to visualise dynamic structural organisation and heterogeneity 
at a local level and how to quantify local tissue stress-strain responses to applied 
loads.  
 
Examinations of flexor tendon adhesions, previously described as either ‘loose’ or 
‘dense’ (Masuda, Ishii et al. 2002), have generally followed assessment of the 
integrity of the healing tendon itself. Relatively few studies, however, have 
investigated the dynamic nature of these adhesions. This has been due, in part, to the 
lack of suitable techniques that were sensitive to dynamic micromechanics. 
 
This study tests the hypothesis that adhesions are non-uniform and that their 
behaviour is a function of their organisation and their local strain responses to 
applied stress. As tendon mobilisation is a well recognised modulator of the quality 
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of adhesion formation, both immobilised and mobilised tendon adhesions were 
investigated. Adhesions were analysed using a hierarchical approach, with 
randomisation to either gross tensile testing, or to micromechanical assessment using 
defined strain regimes applied to the adhesions where the movement of fluorescently 
labelled cell nuclei, acting as dynamic markers, was visualised using real time 
confocal microscopy. Cellular organisation and local strain responses were assigned 
values using image analysis software.  
 
5.1.1 Aims 
 To describe how immobilised and mobilised tendon adhesion tissues are 
organised. 
 To examine the relationship between the local strains produced in adhesions 
and the applied strain. 
 To relate the micromechanical findings to gross restrictive parameters. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Gross Adhesion Mechanics 
11 mobilised and 10 immobilised adhesion samples were assessed using tensile 
testing to obtain structural stiffness and peak load values as described in section 
2.3.3.3. 
 
5.2.2 Micromechanical Assessment 
A custom designed tensile straining rig was used to apply a defined strain regime to 
14 mobilised and 15 immobilised adhesion samples as detailed in section 2.3.3.4.1. 
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The movement of adhesion cell nuclei was visualised using real-time confocal 
microscopy as described in section 2.3.3.4.3. 
 
5.2.3 Image Analysis 
The image analysis software Imaris® 6.1 was used to determine the exact x and y 
axis positions of each of the adhesion cell nuclei in each of the images throughout 
the entire strain range, relative to the position of a central reference nucleus. The 
tracking module of the software was then used to track the displacement of all the 
cell nuclei up to 10% applied strain. Details of this are set out in section 2.3.3.4.4. 
 
5.2.4 Data Analysis 
Local strains were determined for each sample, using the nuclei as local strain 
markers. This was achieved by plotting the displacement of each peripheral nucleus 
(over the entire strain range) against its original distance from the reference nucleus 
prior to the application of strain.  The slope of the graph represents the local strain 
for each adhesion sample. Details of this process are described in section 2.3.3.4.5. 
 
5.2.5 Statistical Analysis 
Statistical analysis was used, with p<0.05 being judged as statistically significant. 
Both the structural stiffness and load at failure of the mobilised and immobilised 
groups were compared using the Mann-Whitney U test, as the data were non-
parametrically distributed. The micromechanical data were assessed using the 
unpaired t-test (the data were normally distributed).  
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5.3 RESULTS 
Of the original 52 digits, 2 were discarded due to the poor quality of the dissected 
specimens. Prior to harvest, digits were randomised to either immobilisation (n=25) 
or mobilisation (n=25). These digits were further randomised to either tensile testing 
(n=21) or to confocal assessment (n=29). Macroscopically, the immobilised 
peritendinous adhesions were pale, fibrotic and surrounded the injured tendon, 
whereas the mobilised adhesions were more translucent, pliable and less extensive 
(Figure 5.1). 
 
5.3.1 Gross Adhesion Mechanics  
The combined load displacement data for both mobilised (n=11) and immobilised 
(n=10) specimens are shown in Figure 5.2 (Table 5.1). The structural stiffness of 
immobilised adhesions was 140% of that of mobilised adhesions (p=0.010). The 
corresponding value for the load at failure was 160% (p=0.049). Although the 
adhesions failed during testing, the tendons themselves were not observed to fail. 
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Figure 5.1  Dissection of tendon-adhesion-synovial complexes at 14 days. 
(Above) In situ specimen prior to isolation. (Below left) Immobilised specimen 
demonstrating whiter, fibrous peritendinous tissue completely encasing the tendon. 
(Below right) Mobilised specimen showing translucent, pliable adhesions with 
visible tendon. 
 208 
 
 
Figure 5.2 Load displacement graph for mobilised adhesions (n=11) and 
immobilised (n=10) adhesions. The immobilised adhesions’ structural stiffness was 
140% of that for the mobilised adhesions (p=0.010). The load at failure of the 
immobilised adhesions was 160% of that of the mobilised adhesions (p=0.049). Pale 
shading indicates mean (± SEM).  
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Integrity of Adhesion Mobilised (n=11) Immobilised (n=10) 
Structural Stiffness 
(N mm
-1
) 
840  (640 – 990) 1200 (910 – 1700) 
Load at Failure (N) 2.7 (1.7 – 3.7) 4.2 (3.6 – 6.9) 
 
Table 5.1 Mobilised versus immobilised adhesions: Comparison of structural 
stiffness and load at failure. Results are expressed as median (interquartile range). 
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5.3.2 Micromechanical Assessment 
5.3.2.1 Confocal Assessment 
The rig successfully strained the specimens with no slippage. Adhesions could be 
readily identified from other component tissues by their densely packed arrangement 
of cell nuclei as seen in Figure 5.3. The confocal images were reconstructed as 
movies of the cellular displacement over the entire strain regimen. The images in the 
movies detailed below are centred on the adhesion, and represent the entire imaged 
region of the specimen, at x10 magnification. When interpreting the movies the 
applied strain is in the vertical axis. This may be conceptualised in terms of a digit 
being extended in this direction, with visualisation of the deformation of the 
adhesion under applied strain. A variety of dynamic adhesion patterns were noted in 
both adhesion groups, with the imaged region of each specimen exhibiting a single 
pattern of local strain. These may be designated as:  
 Stretch (See Additional Illustrative Digital Material, Video 5.1, which 
demonstrates the stretching dynamic pattern for a mobilised adhesion tissue 
sample, where adhesion cell nuclei become increasingly separated in the axis 
of the applied strain; See Additional Illustrative Digital Material, Video 
5.2, which demonstrates the stretching dynamic pattern for an immobilised 
adhesion tissue sample, where adhesion cell nuclei become increasingly 
separated, although less than for the mobilised adhesion sample, reflecting 
lower local strain); 
 Compress (See Additional Illustrative Digital Material, Video 5.3, which 
demonstrates the compressing dynamic adhesion pattern, where adhesion cell 
nuclei become increasingly approximated to each other);  
 211 
 Shear (See Additional Illustrative Digital Material, Video 5.4, which 
demonstrates the shearing dynamic adhesion pattern, where groups of 
adhesion cell nuclei move perpendicularly to each other);  
 Random (See Additional Illustrative Digital Material, Video 5.5, which 
demonstrates the random dynamic adhesion pattern, where adhesion cell 
nuclei appear to move at random);  
 Tear (See Additional Illustrative Digital Material, Video 5.6, which 
demonstrates the tearing dynamic adhesion pattern).  
 
5.3.2.2 Image Analysis 
Typical graphs of local strain for both mobilised and immobilised adhesion samples 
are shown in Figure 5.4. The corresponding mean local strain data at 10% applied 
strain for both groups are presented in Figure 5.5 (Table 5.2), revealing considerable 
differences. The mean local strain for mobilised adhesions was 325% of that of the 
immobilised adhesions (3.83% (n=14) and 1.18% (n=15) respectively). However, 
due to the variability, these differences were not statistically significant (p=0.310). 
The spread of mean local strain values for mobilised adhesions, represented by the 
standard deviation (SD), was twice that of the immobilised adhesions (8.86% and 
4.28% respectively). 
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Figure 5.3 Confocal images showing characteristic appearance of component 
tissues in specimens.  (Above) Tendon core cell nuclei appear as long, narrow, non-
overlapping lines. (Centre) Tendon surface cell arrangement, with evenly distributed 
cells. (Below)  Adhesions could be readily identified from other component tissues 
by their densely packed arrangement of cell nuclei. Magnification x10.  
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Figure 5.4 Example graphs of the local strain for adhesion samples at 10% 
applied strain. The displacement of each peripheral nucleus, (y2 - y1), was plotted 
against y1, where y1 is the distance between the position of the central reference 
nucleus and the peripheral nucleus in the y axis at 0% applied strain and y2 is this 
distance at 10% applied strain. The gradient of the line of best fit was equal to the 
local strain for the adhesion sample. (Above) Mobilised adhesion with 3.7% local 
strain. (Below) Immobilised adhesion with 1.9% local strain.   
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Figure 5.5 Graphical comparison of mean local strain values at 10% applied 
strain for mobilised (n=14) and immobilised (n=15) adhesion samples. Error bars = 
SEM. 
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The local strain data were further analysed into five regional patterns (Table 5.3). 
Although the numbers associated with each pattern were relatively small, certain 
trends could be noted. For example, the local strains for mobilised adhesions were 
considerably higher than their immobilised counterparts, in both stretched and 
compressed regions, with fold increases of two and five, respectively. The random 
type of adhesion pattern had relatively low mean local strain values for both 
adhesion groups.  
 
The SD for each sample, calculated from the movement of each of the peripheral 
nuclei, represented the spread of local strains and, hence, the heterogeneity of the 
micromechanical response at an intercellular level. The data for all movement 
patterns suggest a similar magnitude of distribution, between 7 and 8%.  
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 Mobilised (n=14) Immobilised (n=15) 
Local Strain (%) 3.83 ± 8.86 1.18 ± 4.28 
 
Table 5.2  Comparison of mean local strain values at 10% applied strain for 
mobilised (n=14) and immobilised (n=15) adhesion samples. Results are presented 
as mean local strain (%; ± SD). 
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Table 5.3 Frequency and mean local strain of regional patterns seen in 
mobilised and immobilised adhesions. 
 
 
 
 
 
 
 
 
Regional 
Pattern 
Mobilised 
(n=14) or 
Immobilised 
(n=15) 
Number 
(n) 
Mean 
Local 
Strain (%) 
Mean 
Spread (SD) 
(%) 
Stretch Mobilised 9 6.42 7.74 
Stretch Immobilised 7 2.90 7.45 
Compress Mobilised 1 -10.08 7.59 
Compress Immobilised 2 -2.06 7.27 
Shear Mobilised 2 2.06 8.65 
Shear Immobilised 4 2.44 7.04 
Random Mobilised 1 0.68 8.05 
Random Immobilised 2 -1.17 7.26 
Tear Mobilised 1 -5.37 8.58 
Tear Immobilised 0   
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5.4 DISCUSSION 
5.4.1 A Hierarchical Approach to Adhesion Assessment 
This investigation adopted a hierarchical multiscale approach to examine the 
mechanical behaviour of digital flexor tendon adhesions. Both immobilised and 
mobilised tendon adhesions were assessed, employing an established flexor tendon 
injury model (Jones, Burnett et al. 2002; Branford, Mudera et al. 2008).    
Macroscopically, the immobilised adhesions were more fibrous in nature compared 
with their mobilised counterparts. Macromechanical testing demonstrated that 
immobilised adhesions had significantly higher values for structural stiffness and 
load at failure than mobilised adhesions (Table 5.1). The micromechanical 
assessment of adhesions employed a confocal laser microscope to visualise the 
movement of cell nuclei to examine local tissue organisation and local strain 
responses to applied stress. Different dynamic adhesion patterns (stretch, compress, 
shear, random and tear) were observed in both adhesion groups. Mobilised adhesions 
exhibited over a three-fold higher local strain than their immobilised counterparts 
(Table 5.2).  Although the difference in mean local strain was not statistically 
significant due to the high variability of the data, the considerable change in the 
observed magnitude of the local strain suggests that the mobilised adhesions were 
more easily deformed by an applied force. This would be useful in the clinical 
setting as the adhesion would be more likely to deform and then fail.  
 
5.4.2 Local Strains in Adhesions Cannot be Inferred from 
Applied Strain 
Confocal microscopy enables very accurate dynamic assessments to be made of the 
local strain fields between cells and within tissues, in viable and unprocessed 
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samples (Arnoczky, Lavagnino et al. 2002; Screen, Lee et al. 2003; Bruehlmann, 
Hulme et al. 2004; Screen, Lee et al. 2004; Screen 2004; Cheng 2007). Screen and 
colleagues previously examined the local strain in tendons using confocal 
microscopy, and found that local strains within a tendon fascicle were consistently 
smaller than the applied strain, never exceeding 1.2%, for a maximum applied strain 
of 8% (Screen, Lee et al. 2004; Screen 2004). By comparing these results with the 
data obtained in the present Chapter, this suggests that when strain is applied to 
immobilised adhesions, which exhibit low local strain, there may be greater 
deformation of the tendon itself, increasing the risk of tendon rupture. By contrast, 
when strain is applied to mobilised adhesions, which exhibit higher local strain 
values, the adhesions are more likely to deform and fail. However, although the 
increase in local strain following mobilisation may be partly responsible for the 
lower macromechanical structural stiffness of mobilised adhesions, the relation 
between local strain and gross adhesion mechanics is likely to be more complex. 
Indeed previous studies estimating bulk strain and local tissue strain using confocal 
techniques have found low levels of correlation between them (Schinagl, Gurskis et 
al. 1997; Arnoczky, Lavagnino et al. 2002). In the present investigation, the finding 
that different dynamic adhesion patterns occur, each with differences in their local 
strain values suggest that local strains within the tendon-adhesion-synovial complex 
cannot be inferred from the applied strain during gross mechanical testing.  
 
5.4.3 Mobilisation Favours Dynamic Patterns with Higher Local 
Strain  
Interrelated biochemical and biomechanical changes are seen in tendons as a result 
of increased or decreased applied loads (Gelberman, Amiel et al. 1981; Woo, 
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Gelberman et al. 1981; Amiel, Woo et al. 1982; Gelberman, Woo et al. 1982; Woo, 
Gomez et al. 1982; Gelberman, Vande Berg et al. 1983; Gelberman, Manske et al. 
1986; Hitchcock, Light et al. 1987; Hannafin, Arnoczky et al. 1995; Kubota, Manske 
et al. 1996; Lin, Cardenas et al. 2004). However, much of the work on tendon 
adhesions has been secondary to that of the investigation of tendons themselves. For 
example, it is not clear why the tensile strength of mobilised adhesions is not 
increased following mobilisation in a similar manner to that of the tendon. From the 
results of this investigation it appears that injured adhesions appear to respond to 
mobilisation by local ECM remodelling to form dynamic patterns which exhibit 
higher local strains. This is a useful adaptation as the adhesion becomes less 
restrictive to glide and is more likely to fail. The lower local strain values for the 
immobilised adhesions seen in this investigation may reflect increases in neo-tissue 
deposition and/or collagen cross-linking (Masuda, Ishii et al. 2002). 
 
5.4.4 Mobilisation Favours Tissue Heterogeneity  
The spread of mean local strain values for mobilised adhesions was twice that of the 
immobilised adhesions, reflecting their greater heterogeneity, which may be 
associated with the presence of tissue subunits with differing mechanical properties. 
It seems likely that the micromechanical environment within each of the subunits is 
relatively uniform, as demonstrated by the similar range of local strain values. Thus 
heterogeneity within the mobilised adhesions may be due to a greater variety of 
different subunit types forming following mobilisation. It may be hypothesised that, 
due to their increased heterogeneity, mobilised adhesions contain points of weakness 
which are prone to failure.  
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5.4.5 Summary 
This investigation has demonstrated that immobilised and mobilised adhesions differ 
at both micro- and macromechanical levels, supporting the need for a hierarchical 
approach to their evaluation. The confocal microscopy assessments described, using 
fibroblast nuclei as dynamic markers, have provided an accurate measure of local 
adhesion organisation and local strain responses to applied stress. This is the first 
investigation to describe the micromechanical changes in mobilised and immobilised 
tendon adhesions following injury, providing insight into the specific influence of in 
vivo loading on adhesion ECM remodelling. The increased local strain values and 
heterogeneity seen in the mobilised adhesions may explain why they are less 
restrictive in vivo than immobilised adhesion: adhesions may fail in localised areas 
corresponding to more readily deformed subunit patterns. It may be hypothesised 
that anti-adhesion treatments should favour the formation of sites either expressing 
increased local strain responses or those predisposed to heterogeneity and localised 
mechanical failure. These findings are fundamental to providing a better 
understanding of the micromechanical building blocks that are responsible for the 
overall dynamic response of flexor tendon adhesions, which is so critical to tendon 
function.  
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6.1  INTRODUCTION 
Strickland has stated that it is impossible to isolate intrinsic and extrinsic 
contributions to flexor tendon healing in the clinical setting (Strickland 2000). With 
regard to anti-adhesion strategies it is unlikely that any barrier entirely prevents all 
cellular migration. In addition, current biochemical treatments are non-specific to 
cells of different origins. Treatments may reduce the adhesion response at the 
expense of impairing healing in the tendon, thereby favouring tendon rupture 
(Golash, Kay et al. 2003). A new strategic approach to modifying tendon healing is 
required. The results from Chapters 3 and 4 have demonstrated that, by using a 
biomaterial that reduces cell attachment, it may be possible to selectively target 
postsurgical adhesions without compromising tendon cellularity (Branford, Mudera 
et al. 2008; Branford, Brown et al. 2010).   
    
The attachment profile of cells of the flexor tendon-synovial complex to the 
components of the extracellular matrix (ECM) and the effects of mobilisation on the 
attachment of peritendinous adhesion cells has not previously been reported. As 
tendon mobilisation is known to improve tensile strength in tendons and fewer 
adhesions (Gelberman, Woo et al. 1982; Gelberman and Manske 1985; Gelberman, 
Botte et al. 1986), cells from both immobilised and mobilised tendon adhesions were 
investigated.  
 
Cell shape is a function of cell behaviour and reflects the distribution of focal 
adhesion complexes and therefore cell attachment (Singhvi, Kumar et al. 1994; 
Wang, Jia et al. 2003; McBeath, Pirone et al. 2004; Yang, Crawford et al. 2004; Lee, 
Jones et al. 2006; Li, Li et al. 2008). A morphological investigation was therefore 
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also conducted. The attachment of tendon core, tendon surface, synovial sheath, 
mobilised adhesion and immobilised adhesion cells to collagen and fibronectin (Fn) 
was investigated using both attachment assays and morphometric analysis. 
  
6.1.1 Aims 
 To determine if there is a difference in cell attachment between the cells of 
different origins from within the digital tendon-synovial complex to collagen 
and Fn in vitro.  
 To determine if mobilisation has an effect on the attachment of cells 
contributing to tendon adhesion formation. 
  
6.2 MATERIALS AND METHODS 
6.2.1 Preparation of Explant Cultures 
5 New Zealand White (NZW) rabbit right forepaws were dissected to isolate the 
components of the deep digital flexor tendon-synovial complex (tendon core, tendon 
surface, and synovial sheath), which were explanted separately in 10% NGM, as 
described in section 2.2.1.1. A further 10 animals were subjected to deep flexor 
tendon injuries as set out in section 2.3.1. Animals were then randomised to either 
mobilisation or immobilisation as detailed in section 2.3.3.1. The resultant adhesions 
were harvested at 2 weeks and explant cultured as described in section 2.2.1.1.  
 
6.2.2 Cell Adhesion Assay 
Collagen type-I or Fn were adsorbed at 0, 1, 2, 6, 12, 25 and 50 μg mL-1 onto Nunc 
MaxiSorp 96-well ELISA plates as described in section 2.2.8.1. The different cell 
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groups were seeded onto the coated plates and adherent cells fixed and stained using 
crystal violet solution as detailed in section 2.2.8.3. 
 
6.2.3 Cell Adhesion Assessment  
Bound crystal violet was dissolved in acetic acid. Absorbance, representing cell 
attachment, was measured in a microplate reader as detailed in section 2.2.8.3. 
 
6.2.4 Morphological Assessment  
Digital images taken at random of the cells attached to either collagen type-I or Fn at 
25 μg mL-1 were captured using a Zeiss Axioskop Inverted Optical Microscope. Cell 
area, perimeter and circularity were quantified using ImageJ software as set out in 
section 2.2.8.4. The proportion of elongated or circular cells was quantified using 
particle counting as described in section 2.2.8.4. 
 
6.2.5 Statistical Analysis 
Statistical analysis was used, using a p value of <0.05 as to be statistically 
significant. The cell attachment data was compared using the 2-way analysis of 
variance (ANOVA) with the Tukey post-test. The quantitative morphological data 
was compared using Student's t-test for the adhesion cell groups (the Mann Whitney 
U Test was used when the data was not normally distributed). A 2-way analysis of 
variance (ANOVA) with Dunnett’s post-test for the tendon-synovial complex cell 
groups.  
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6.3 RESULTS 
A total of 30 digits were explanted and included in the investigation (digits 2 and 4 
from 15 NZW rabbit forepaws). This represents 5 cell strains (n=5) for each of 
tendon core, tendon surface, synovial sheath, mobilised adhesion and immobilised 
adhesion cell groups. These cell strains were tested for both cell attachment to 
collagen type-I and Fn using a crystal violet assay. Cell morphology when attached 
to these proteins was assessed using ImageJ, an image analysis and processing 
program. Results are shown separately for the tendon-synovial complex cell groups 
and for the adhesion cell groups. Representative micrographs and their processed 
images are shown in Figures 6.1, 6.2, 6.3, and 6.4. 
   
6.3.1 Cell Adhesion Assessment 
Absorbance of crystal violet, representing cell attachment, was measured in 
quadruplicate in a microplate reader at 595 nm. Corrected values were expressed for 
each matrix protein for the tendon-synovial complex cell groups and for the adhesion 
cell groups.  
 
6.3.1.1 Tendon-Synovial Complex Cell Groups 
Cell attachment for each of the tendon core, tendon surface, and synovial sheath cell 
groups (all n=5) to protein-coated culture wells at 0 to 50 μg mL-1 is shown for 
collagen type-I in Figure 6.5 (Table 6.1) and for Fn in Figure 6.6 (Table 6.2). Results 
indicate that cell attachment was greatest for tendon core cells and lowest for 
synovial sheath cells for both collagen type-I and Fn for all concentrations tested. 
The attachment of tendon surface cells was consistently between that of tendon core 
and synovial sheath cell groups. The difference in the mean absorbance values, 
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representing cell attachment, to both collagen type-I and Fn among the different cell 
groups was statistically significant (p<0.001), after allowing for effects of 
differences in concentration.  
 
6.3.1.2 Adhesion Cell Groups 
Cell attachment for mobilised (n=5) and immobilised adhesion cell groups (n=5) to 
protein-coated culture wells at 0 to 50 μg mL-1 is shown for collagen type-I in Figure 
6.7 (Table 6.3) and for Fn in Figure 6.8 (Table 6.4). Results indicate that cell 
attachment was greater for mobilised adhesion cells than for immobilised adhesion 
cells both on collagen type-I and Fn at all concentrations tested. The difference in the 
mean absorbance values, representing cell attachment, to both collagen type-I and Fn 
between mobilised and immobilised groups was statistically significant (p<0.001), 
after allowing for effects of differences in concentration.  
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Figure 6.1  Representative micrographs of tendon-synovial cell groups attached to 
collagen type-I. Processed images using ImageJ are shown on the right. The cell 
outlines are delineated for quantitative analysis. (Above) Tendon sheath cells. 
(Centre) Tendon surface cells. (Below) Tendon core cells. Attachment is greatest for 
cells from the tendon core, and least for cells derived from the synovial sheath. 
Magnification x20. 
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Figure 6.2  Representative micrographs of tendon-synovial cell groups attached to 
Fn. Their processed images using ImageJ are shown on the right. (Above) Tendon 
sheath cells. (Centre) Tendon surface cells. (Below) Tendon core cells. Attachment is 
greatest for cells from the tendon core, and least for cells derived from the synovial 
sheath. Magnification x20. 
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Figure 6.3 Representative micrographs of adhesion cell groups attached to 
collagen type-I. Their processed images using ImageJ are shown on the right. 
(Above) Immobilised adhesion cells. (Below) Mobilised adhesion cells. Mobilisation 
increases cell attachment and increases the proportion of elongated cells. 
Magnification x20. 
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Figure 6.4  Representative micrographs of adhesion cell groups attached to Fn. 
Their processed images using ImageJ are shown on the right. (Above) Immobilised 
adhesion cells. (Below) Mobilised adhesion cells. Mobilisation increases cell 
attachment and increases the proportion of elongated cells. Magnification x20. 
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Figure 6.5 Graph of attachment of tendon-synovial complex cell groups (all n=5) 
to collagen type-I. There was a statistically significant difference in cell attachment 
to collagen type-I among the different cell groups (p<0.001). Error bars = SEM.  
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   Conc. μg ml-1 
 
Cell Group  
0 1 2 6 12 25 50 
Core (n=5) 
0.111 
± 
0.017 
0.537 
± 
0.328 
0.632 
± 
0.428 
0.958 
± 
0.418 
1.077 
± 
0.353 
1.113 
± 
0.404 
1.121 
± 
0.361 
Surface (n=5) 
0.067 
± 
0.033 
0.194 
± 
0.084 
0.358 
± 
0.134 
0.603 
± 
0.186 
0.654 
± 
0.177 
0.740 
± 
0.232 
0.829 
± 
0.260 
Sheath (n=5) 
0.065 
± 
0.027 
0.174 
± 
0.081 
0.296 
± 
0.125 
0.379 
± 
0.108 
0.424 
± 
0.125 
0.419 
± 
0.137 
0.463 
± 
0.140 
 
Table 6.1 Cell attachment for tendon-synovial complex cell groups to collagen 
type-I. Data are presented as mean absorbance (± SEM). 
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Figure 6.6 Graph of attachment of tendon-synovial complex cell groups (all n=5) 
to Fn. There was a statistically significant difference in cell attachment to Fn among 
the different cell groups (p<0.001). Error bars = SEM.  
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   Conc. μg ml-1 
 
Cell Group  
0 1 2 6 12 25 50 
Core (n=5) 
0.117 
± 
0.017 
0.406 
± 
0.111 
0.796 
± 
0.281 
1.167 
± 
0.351 
1.295 
± 
0.346 
1.488 
± 
0.411 
1.514 
± 
0.438 
Surface (n=5) 
0.066 
± 
0.034 
0.144 
± 
0.087 
0.294 
± 
0.103 
0.604 
± 
0.151 
0.850 
± 
0.295 
0.937 
± 
0.305 
1.050 
± 
0.312 
Sheath (n=5) 
0.064 
± 
0.027 
0.143 
± 
0.066 
0.293 
± 
0.076 
0.528 
± 
0.159 
0.571 
± 
0.165 
0.621 
± 
0.179 
0.649 
± 
0.164 
 
Table 6.2 Cell attachment for tendon-synovial complex cell groups to Fn. Data 
are presented as mean absorbance (± SEM). 
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6.3.2 Morphological Assessment 
The morphology of the crystal violet cells was assessed after the cells had attached to 
collagen type I and Fn coated plates. 
 
6.3.2.1 Tendon-Synovial Complex Cell Groups 
Cell area (Table 6.5), cell perimeter (Table 6.6), cell circularity (Table 6.7) and 
percentage elongated morphology (Table 6.8) for each of the tendon core, tendon 
surface, and synovial sheath cell groups (all n=5) attached to collagen type-I and Fn 
are shown in Figure 6.9 and Figure 6.10, respectively. Comparing morphology data 
for the different cell groups attached to collagen type-I and Fn there were no 
statistically significant differences in cell area, cell perimeter, cell circularity or 
percentage of cells with an elongated morphology. 
 
6.3.2.2 Adhesion Cell Groups 
Cell area (Table 6.9), cell perimeter (Table 6.10), cell circularity (Table 6.11) and 
percentage elongated morphology (Table 6.12) for each of the mobilised and 
immobilised adhesion cell groups (all n=5) attached to collagen type-I and Fn are 
shown in Figure 6.11 and Figure 6.12, respectively.  
 
For cells attached to collagen type-I, when compared to mobilised adhesion cells, 
immobilised adhesion cells had a 26% greater area (p=0.069), a 6% greater perimeter 
(p=0.733) and were 8% more circular (p=0.300). Mobilised adhesions expressed 
300% more cells with an elongated morphology relative to immobilised adhesions 
(p=0.004), which was highly significant. 
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For cells attached to Fn, when compared to mobilised adhesion cells, immobilised 
adhesion cells had a 9% greater area (p=0.717), a 1% greater perimeter (p=0.974) 
and were 6% ‘more circular’ (p=0.440). Mobilised adhesions had 68% more cells 
with elongated morphology relative to immobilised adhesions (p=0.046) when 
attached to Fn. 
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Figure 6.7 Graph of attachment of mobilised and immobilised adhesion cell 
groups (all n=5) to collagen type-I. There was a statistically significant difference in 
cell attachment to collagen type-I between the 2 cell groups (p<0.001). Error bars = 
SEM. 
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Conc. μg ml-1 
 
Cell Group  
0 1 2 6 12 25 50 
Mobilised  
(n=5) 
0.068 
± 
0.026 
0.858 
± 
0.105 
1.017 
± 
0.064 
1.092 
± 
0.049 
1.024 
± 
0.050 
1.018 
± 
0.067 
0.916 
± 
0.028 
Immobilised 
(n=5) 
0.096 
± 
0.044 
0.561 
± 
0.101 
0.666 
± 
0.132 
0.704 
± 
0.135 
0.661 
± 
0.121 
0.618 
± 
0.094 
0.588 
± 
0.094 
 
Table 6.3 Cell attachment for mobilised and immobilised adhesion cell groups 
to collagen type-I. Data are presented as mean absorbance (± SEM). 
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Figure 6.8 Graph of attachment of mobilised and immobilised adhesion cell 
groups (all n=5) to Fn. There was a statistically significant difference in cell 
attachment to Fn between the 2 cell groups (p<0.001).  Error bars = SEM. 
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   Conc. μg ml-1 
 
Cell Group  
0 1 2 6 12 25 50 
Mobilised  
(n=5) 
0.068 
± 
0.026 
0.378 
± 
0.103 
0.754 
± 
0.064 
1.013 
± 
0.049 
1.137 
± 
0.050 
1.192 
± 
0.067 
1.111 
± 
0.028 
Immobilised 
(n=5) 
0.096 
± 
0.026 
0.316 
± 
0.103 
0.605 
± 
0.108 
0.699 
± 
0.065 
0.751 
± 
0.063 
0.777 
± 
0.074 
0.765 
± 
0.066 
 
Table 6.4 Cell attachment for mobilised and immobilised adhesion cell groups 
to Fn. Data are presented as mean absorbance (± SEM). 
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Cell Area (µm
2
) Core (n=5) Surface (n=5) Sheath (n=5) 
Collagen type-I 513.7 ± 54.3 433.1 ± 68.2 408.7 ± 94.5 
Fibronectin  825.5 ± 222.7 1017.4 ± 347.7 629.8 ± 113.7 
 
Table 6.5 Cell area for tendon-synovial complex cell groups attached to 
collagen type-I and Fn. Values are expressed as mean cell area (± SEM). 
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Cell Perimeter (µm) Core (n=5) Surface (n=5) Sheath (n=5) 
Collagen type-I 101.5  ± 7.8 92.2 ± 9.4 91.7 ± 13.4 
Fibronectin 135.5 ± 23.7 135.6 ± 21.0 116.3 ± 14.9 
 
Table 6.6 Cell perimeter for tendon-synovial complex cell groups attached to 
collagen type-I and Fn. Values are expressed as mean cell perimeter (± SEM).
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Cell Circularity Core (n=5) Surface (n=5) Sheath (n=5) 
Collagen type-I 0.569  ± 0.034 0.618 ± 0.029 0.614 ± 0.044 
Fibronectin  0.527 ± 0.034 0.577 ± 0.037 0.578 ± 0.044 
 
Table 6.7 Cell circularity for tendon-synovial complex cell groups attached to 
collagen type-I and Fn. Values are expressed as mean cell circularity (± SEM). 
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Percentage Elongated 
Morphology (%) 
Core (n=5) Surface (n=5) Sheath (n=5) 
Collagen type-I 14.7 ± 4.9 15.6 ± 4.5 22.2 ± 5.4 
Fibronectin  24.1 ± 5.2 12.3 ± 2.3 37.6 ± 7.4 
 
Table 6.8 Percentage elongated morphology for tendon-synovial complex cell 
groups attached to collagen type-I and Fn. Values are expressed as mean percentage 
elongated morphology (± SEM). 
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Figure 6.9 Graphs of morphology of cells attached to collagen type-I. Results are 
shown for tendon core, tendon surface, and synovial sheath cell groups (all n=5). 
(Above left) Cell area. (Above right) Cell perimeter. (Below left) Cell circularity. 
(Below right) Percentage elongated morphology. Error bars = SEM. 
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Figure 6.10 Graphs of morphology of cells attached to Fn. Results are shown for 
tendon core, tendon surface, and synovial sheath cell groups (all n=5). (Above left) 
Cell area. (Above right) Cell perimeter. (Below left) Cell circularity. (Below right) 
Percentage elongated morphology. Error bars = SEM. 
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Cell Area (µm
2
) 
Immobilised 
Adhesion  
(n=5) 
Mobilised 
Adhesion  
(n=5) 
Collagen type-I 286.0 ± 54.3 226.1 ± 40.4 
Fibronectin  362.5 ± 58.3 334.1 ± 48.2 
 
Table 6.9 Cell area for mobilised and immobilised adhesion cell groups attached 
to collagen type-I and Fn. Values are expressed as mean cell area (± SEM). 
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Cell Perimeter (µm) 
Immobilised 
Adhesion  
(n=5) 
Mobilised 
Adhesion  
(n=5) 
Collagen type-I 71.3 ± 7.8 67.5 ± 7.0 
Fibronectin  83.4 ± 8.7 82.4 ± 6.4 
 
Table 6.10 Cell perimeter for mobilised and immobilised adhesion cell groups 
attached to collagen type-I and Fn. Values are expressed as mean cell perimeter (± 
SEM). 
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Cell Circularity 
Immobilised 
Adhesion  
(n=5) 
Mobilised 
Adhesion  
(n=5) 
Collagen type-I 0.665  ± 0.034 0.615 ± 0.029 
Fibronectin  0.627 ± 0.031 0.593 ± 0.028 
 
Table 6.11 Cell circularity for mobilised and immobilised adhesion cell groups 
attached to collagen type-I and Fn. Values are expressed as mean cell circularity (± 
SEM). 
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Percentage Elongated 
Morphology (%) 
Immobilised 
Adhesion  
(n=5) 
Mobilised 
Adhesion  
(n=5) 
Collagen type-I 10.4 ± 2.6 41.6 ± 7.3 
Fibronectin  24.8 ± 5.5 41.6 ± 1.5 
 
Table 6.12 Percentage elongated morphology for mobilised and immobilised 
adhesion cell groups attached to collagen type-I and Fn. Values are expressed as 
mean percentage elongated morphology (± SEM). 
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Figure 6.11 Graphs of morphology of cells attached to collagen type-I. Results are 
shown for mobilised and immobilised adhesion cell groups (all n=5). (Above left) 
Cell area. (Above right) Cell perimeter. (Below left) Cell circularity. (Below right) 
Percentage elongated morphology. Mobilised adhesions expressed significantly more 
cells with an elongated morphology relative to immobilised adhesions (p=0.004). 
Error bars = SEM. 
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Figure 6.12 Graphs of morphology of cells attached to Fn. (Above left) Cell area. 
(Above right) Cell perimeter. (Below left) Cell circularity. (Below right) Percentage 
elongated morphology for mobilised and immobilised adhesion cell groups (all n=5). 
Mobilised adhesions expressed significantly more cells with an elongated 
morphology relative to immobilised adhesions (p=0.046). Error bars = SEM. 
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6.4 DISCUSSION  
6.4.1 Selectivity in Tendon Healing 
Various strategies to modify flexor tendon adhesion formation have previously been 
investigated. These may be categorised as either biochemical agents (for example 
non steroidal anti-inflammatory agents, 5-fluorouracil, and mannose-6-phosphate) 
(Bates, Morrow et al. 2006; Zhao, Zobitz et al. 2009; Tan, Nourbakhsh et al. 2010) 
or physical barriers (such as polytetrafluoroethylene, ADCON®, and phospholipid 
polymer hydrogel) (Hanff and Hagberg 1998; Golash, Kay et al. 2003; Ishiyama, 
Moro et al. 2010). However, no ideal treatment exists at present and none are used 
routinely following tendon repair. The difficulty with this clinical problem lies in 
how to selectively favour intrinsic tendon healing, in order to reduce the risk of 
tendon rupture, while reducing the formation of restrictive adhesions (Lin, Cardenas 
et al. 2004). The treatment strategies previously described are not specific in 
selecting for cells of a particular origin. The results of Chapters 2 and 3 have 
demonstrated, that using a novel biomaterial that appears to reduce cell attachment, it 
may be possible to target postsurgical adhesions without compromising tendon 
cellularity (Branford, Mudera et al. 2008; Branford, Brown et al. 2010).   
 
This investigation adopted a quantitative scientific approach to examine the 
attachment of the different cellular components of the tendon-synovial complex and 
adhesions to collagen type-I and Fn. There were two aims to this investigation. 
Firstly, to determine if there is a difference in cell attachment between the cells of 
different origins from within the digital tendon-synovial complex to collagen and Fn. 
Secondly, to determine if mobilisation has an effect on the attachment of cells 
contributing to tendon adhesion formation. Crystal violet based attachment assays 
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and quantitative morphometric analyses of cell size and shape using image analysis 
software were employed. 
 
6.4.2 Intrinsic Cells Show Greater Attachment to Collagen and 
Fibronectin 
The attachment of intrinsic tendon cells (tendon core cells and tendon surface cells) 
was statistically significantly higher than that of extrinsic tendon cells (synovial 
sheath cells). This was the case for attachment to both collagen type-I and Fn, at all 
concentrations tested. This difference in attachment was not reflected in changes in 
cell morphology with regard to cell area, perimeter or percentage of cells with an 
elongated or circular morphology on either collagen type-I or Fn.  
 
Wong and colleagues have also shown that the greatest activity following tendon 
injury occurs in the tissues surrounding the tendons (Wong, Lui et al. 2009). The 
flexor tendon synovial sheath demonstrates a vigorous inflammatory response post-
injury to the flexor tendon (Khan, Edwards et al. 1996). Cell proliferation in 
response to injury is greater within the synovial sheath than within the tendon itself 
(Kakar, Khan et al. 1998). Previous studies suggest that synovial sheath fibroblasts 
contribute actively to adhesion formation (Brigman, Hu et al. 1994; Khan, Edwards 
et al. 1996; Khan, Occleston et al. 1997; Kakar, Khan et al. 1998; Klein, Pham et al. 
2001; Ragoowansi, Khan et al. 2003). This is the result of their high proliferative 
level, their capacity to degrade the ECM (facilitating the process of cell migration), 
and their ability to contract a collagen lattice. In the present study, the cells that have 
previously been recognised as being the most aggressively adhesion forming cells, 
(that is the synovial sheath fibroblasts), expressed lowest attachment to both collagen 
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type-I and Fn. Khan and colleagues demonstrated that synovial sheath fibroblasts are 
more active migrators than tendon fibroblasts (Khan, Occleston et al. 1998). Cell 
migration is regulated through cell-substratum adhesive interactions. Although cell 
attachment is a prerequisite for migration (van der Flier and Sonnenberg 2001), at 
high adhesiveness forces are insufficient to break cell-substratum attachments, 
leaving cells incapable of locomotion (Huttenlocher, Sandborg et al. 1995). At lower 
adhesiveness cytoskeletal forces are roughly in balance with adhesion so that traction 
can be maintained at the cell front while it can be disrupted at the cell rear (DiMilla, 
Stone et al. 1993). This permits net cell body movement. The synovial sheath cells, 
being more active migrators, therefore show lower attachment than tendon cells. The 
implication of the results of this Chapter are that as the synovial sheath cells are the 
least avidly attached, then the prevention of the attachment of these cells may 
therefore be a suitable selective biological therapeutic target. 
 
The results of this investigation confirm the results of a previous study where tendon 
synovial sheath fibroblasts had a lower attachment efficiency than did tendon cells 
(Riederer-Henderson, Gauger et al. 1983). However, the authors examined 
attachment to tissue culture plastic and not to ECM proteins. The study did not 
examine all the components of the tendon-synovial complex and did not assess 
adhesion cells or the effect of mobilisation on cell phenotype. However, such studies 
augment existing data that not all fibroblasts have identical phenotypes. The 
variation in phenotypic expression of tendon-synovial complex fibroblasts has not 
been extensively investigated, and this information may prove useful for optimising 
repair strategies (Sharma and Maffulli 2005).  
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6.4.3 Mobilisation Increases Cell Attachment and Favours 
Elongated Cellular Morphology  
The effect of mobilisation on tendon healing is well documented: adhesions are 
reduced and tendon tensile properties are enhanced (Gelberman, Woo et al. 1982; 
Gelberman, Manske et al. 1986; Kubota, Manske et al. 1996). Mobilisation may 
result in increased cellular activity, collagen and glycosaminoglycan content in 
tendons, whereas immobilisation may cause increased collagen degradation and a 
reduction in proline and sulphate incorporation (Gelberman, Amiel et al. 1981; 
Amiel, Woo et al. 1982; Gelberman, Woo et al. 1982; Woo, Gomez et al. 1982; 
Vailas, Pedrini et al. 1985; Gelberman, Manske et al. 1986; Hannafin, Arnoczky et 
al. 1995; Kubota, Manske et al. 1996; Yasuda and Hayashi 1999). However, the 
effect of mobilisation on cell attachment has not been previously investigated.  
 
The results of this investigation have shown that the attachment of cells derived from 
mobilised adhesions was statistically significantly higher than that of cells derived 
from immobilised adhesions. This was seen for attachment to both collagen type-I 
and Fn, at all concentrations tested. Mobilised adhesion cells expressed a statistically 
significantly greater percentage of elongated cells to both collagen type-I and Fn 
than did immobilised adhesion cells. When compared with cells derived from 
mobilised adhesions, immobilised adhesion cells had a 26% and 9% greater area 
when attached to collagen type-I and Fn respectively. Although these differences 
were not statistically significant, they approached significance for collagen type-I. 
Synovial sheath fibroblasts have previously been shown to be larger than tendon 
cells (Ragoowansi, Khan et al. 2003). The results from the present investigation 
appear to confirm that synovial sheath cells contribute disproportionately to 
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adhesions, and therefore tendon healing, when digits are immobilised, as 
demonstrated by the larger size and poorer attachment of the adhesion cells. 
Conversely, intrinsic cells appear to be favoured in mobilised adhesions, where cells 
were smaller, more elongated and showed higher attachment.  
 
Previous studies have shown that cell attachment and morphology is related to cell 
fate, gene expression and protein production, implying cell shape-based regulation of 
cellular function (Singhvi, Kumar et al. 1994; McBeath, Pirone et al. 2004; Lee, 
Jones et al. 2006). Li and colleagues have shown that elongated human tendon cells 
expressed 65% higher collagen type-I than circular cells with the same cell area (Li, 
Li et al. 2008). The authors proposed that this indicated that tendon cells in vivo, 
which assume an elongated shape in normal tendons, have an ‘‘optimal shape’’ to 
perform their major function, that is, to synthesise collagen type-I. By producing 
collagen type-I, tendon cells in vivo function to maintain, repair and remodel the 
tendon matrix (Yang, Crawford et al. 2004). Li and colleagues demonstrated that 
elongated cells have focal adhesions that were concentrated at their two ends. They 
also showed that in circular cells focal adhesions were uniformly distributed along 
the circumference of the cell (Li, Li et al. 2008). The observation that cell shape 
determines the distribution of focal adhesion complex formation may explain why 
these elongated tendon cells produce aligned collagen matrix in vitro and in vivo 
(Wang, Jia et al. 2003; Li, Li et al. 2008). The results from this Chapter have shown 
that mobilisation favours the formation of elongated cells, which may explain why 
mobilised tendons demonstrate improved tensile properties. 
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6.4.4 A New Therapeutic Strategy: Selectively Preventing 
Extrinsic Cell Attachment to Fibronectin 
Previous studies suggest that tendon synovial sheath cells secrete Fn, in contrast to 
tendon fibroblasts (Banes, Link et al. 1988; Brigman, Hu et al. 1994). Conversely, 
synovial sheath cells produce less collagen than do tendon cells (Riederer-
Henderson, Gauger et al. 1983). Therefore, there appears to be a gradient from a Fn 
rich to a collagen rich environment from the synovial sheath to the tendon itself. 
Berglund and colleagues have identified spatial and temporal-specific aspects to the 
healing process in a rabbit flexor tendon injury model (Berglund, Reno et al. 2006), 
supporting this concept. It may be proposed that preventing attachment of poorly 
adherent extrinsic cells to Fn may be a suitable target for selective inhibition within 
the tendon healing complex. This may explain the results of Chapter 4 that 
demonstrated significant reduction in the restrictive nature of postsurgical adhesions 
following treatment without compromising tendon cellularity (Branford, Mudera et 
al. 2008). As demonstrated in Chapter 3, this was achieved using a biomaterial that 
appears to prevent the attachment of fibroblasts to Fn (Branford, Brown et al. 2010).  
 
6.4.5 Summary  
Flexor tendon adhesion formation continues to be a significant and unsolved 
problem. Other than by using rehabilitative regimes, the selection of intrinsic tendon 
healing over extrinsic tendon healing has escaped previous therapeutic strategies. 
This is the first study to demonstrate that attachment of intrinsic tendon cells and 
mobilised adhesion cells is significantly higher to both collagen type-I and Fn than 
their respective extrinsic tendon cell and immobilised adhesion counterparts. 
Mobilised adhesion cells expressed a statistically significantly greater percentage of 
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elongated type cells attached to both collagen type-I and Fn than did mobilised 
adhesion cells. This study suggests that the differential avidity of cell attachment 
within the healing tendon-synovial complex is a potential therapeutic target when 
developing novel anti-adhesive strategies. It may be proposed that this approach may 
favour intrinsic cell contributions to tendon healing while minimising extrinsic 
tendon cell contributions. This may ultimately reduce formation of restrictive 
adhesions without compromising tendon healing. The model developed allows for a 
robust basis with which to assess the efficacy of potential anti-adhesion strategies in 
differentially affecting cell attachment. Novel treatments may be introduced into this 
system by topical application over the protein coated plates before the cells are 
seeded. 
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7.1 INTRODUCTION  
Despite adhesion formation being a significant problem in reconstructive hand 
surgery, there were currently no anti-adhesive treatments in widespread clinical use 
at the time of commencing this thesis (Strickland 2005). Mobilisation of injured 
flexor tendons remains the only clinically useful method to produce improved tendon 
healing and reduced adhesion formation (Woo, Gelberman et al. 1981; Gelberman, 
Vande Berg et al. 1983; Gelberman, Manske et al. 1986; Hitchcock, Light et al. 
1987; Feehan and Beauchene 1990; Khanna, Gougoulias et al. 2009). Although 
cyclical strain applied to cultured tendon cells can enhance cell proliferation and 
extracellular matrix (ECM) production (Riboh, Chong et al. 2008), the precise 
mechanism for how adhesions are modified by mobilisation is unknown. Treatments 
are required that mimic, complement and augment the beneficial effects of 
mobilisation. Protein based biomaterials demonstrate ability to guide cell and tissue 
behaviour during healing as a function of the complex interplay that exists between 
their mechanical and bioactive properties (Maskarinec and Tirrell 2005; Brown and 
Phillips 2007). Precisely through the selectivity in their effects, protein biomaterials 
may provide a solution to the almost ubiquitous drawback of many anti-adhesive 
strategies: that dampening the adhesion response results in reduced healing at the 
tendon injury site.  
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7.2 MAJOR FINDINGS AND CRITIQUE OF 
METHODOLOGIES 
A novel micromechanical assessment technique was developed in this thesis to 
examine the effect of mobilisation on tendon adhesions. Tissue organisation and 
local strain responses produced to applied strain were examined. These findings were 
related to gross restrictive parameters. The effect of mobilisation on the attachment 
of adhesion cells to the ECM has not previously been investigated and is assessed in 
this thesis. The attachment of intrinsic and extrinsic tendon cells to components of 
the ECM was also assessed. A novel derivative fibronectin biomaterial (DFn) with 
anti-adhesive effects was tested for its effects on cell attachment in vitro and in 
reducing restrictive adhesion, while preserving tendon surface cellularity, in vivo.  
 
A rabbit flexor tendon-synovial complex injury model was used in this thesis. The 
use of human tendons was precluded from study due to their limited availability and 
the poor quality of surgically removed specimens. In humans, fresh specimens are 
often traumatised or degenerative. The rabbit model is comparable to man both in 
terms of cellular behaviour during healing and structural anatomy. The deep flexors 
of the forepaw were chosen over the hindpaw due to their accessibility and to their 
being functionally closer to human hand tendons (Jones, Ladhani et al. 2000; Ngo, 
Pham et al. 2001; Harrison, Jones et al. 2003; Henn, Kuo et al. 2010; Tan, 
Nourbakhsh et al. 2010). A partial tenotomy window was used as it avoids the need 
for suture repair, thereby minimising the number of injury variables (Kubota, 
Manske et al. 1996; Chan, Fu et al. 1998; Jones, Mudera et al. 2003). This injury 
also conveniently allows for immediate postoperative mobilisation. Where required, 
immobilisation was achieved using a proximal division of the flexor digitorum 
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profundus (FDP) tendon as in a previous flexor tendon adhesion model (Jones, 
Burnett et al. 2002).  
 
7.2.1 Shear-Aggregated Fibronectin with Anti-Adhesive 
Properties  
The investigation of the novel DFn biomaterial in vitro has shown that it biodegrades 
to provide a prolonged delivery of anti-adhesive factors, preventing the attachment 
of adhesion forming synovial sheath fibroblasts (Branford, Brown et al. 2010). The 
qualitative and quantitative assessments of the biomaterial indicate that anti-adhesive 
fibronectin (Fn) fragments are responsible for this effect. This may be the result of a 
conformational change in the protein during production, resulting from preparation 
of the mats using urea, or proteolytic cleavage of the Fn molecule resulting from 
proteases present in the cryoprecipitate source material. It is not clear from the 
results of this investigation whether the protein fragments were causing inhibition by 
acting in a competitive or non-competitive way. However, if the effect is due to 
competitive binding by dissolved Fn fragments the anti-adhesive effect will only 
exert its effect while the DFn biomaterial is still dissolving. Time lapse studies 
confirmed that synovial sheath fibroblasts did not adhere to the material. The DFn 
biomaterial did not cause cell death indicating that it is unlikely to impair healing in 
the adjacent tendon in vivo. These findings support the idea that DFn biomaterial 
may be used to prevent adhesion formation at tissue interfaces as a bioactive 
mechanical barrier.  
 
Myofibroblasts were not seen following culture on either DFn or Fn control 
biomaterials. This may be due to suppression of myofibroblastic conversion by Fn-
266 
 
derived peptides (Kato, Kamiya et al. 2001). Alternatively, this finding may be 
because the biomaterial surfaces are less stiff than plain glass, with an associated 
lower tension cell-environment, removing one of the stimulating factors in 
myofibroblast differentiation (Tomasek et al., 2002). However, longer time frames 
need to be examined to determine if there is an increase in myofibroblastic 
conversion over time in culture on DFn. 
 
7.2.2  A Novel Biomimetic Material for Engineering Postsurgical 
Adhesion in the Injured Digital Flexor Tendon  
The in vivo investigation into the effects of the DFn biomaterial showed a significant 
reduction in adhesion strength following treatment (Figure 4.1). The mean peak 
force required to overcome adhesions was reduced from 7.7 Newtons (N) to 0.3 N 
(Figure 4.2). The mean structural stiffness was reduced from 628 N m
-1
 to 40 N m
-1
. 
There was a 55% fall in the cellularity at the surface of the adhesions (Figure 4.5), 
which was also reflected in the pattern of cell proliferation. Importantly, the 
cellularity of the tendon surface was not reduced as a result of treatment. Treated 
tendons were significantly more cellular than their untreated counterparts deeper 
within their substance. The tensile strength of the tendons themselves was not 
examined directly as this would have required a doubling of the number of animals 
used in the study. Further, this study was primarily assessing adhesion strength. 
However, none of the treated tendons ruptured during testing. 
 
The DFn material had suitable mechanical properties allowing it to be handled and 
inserted into a wound in vivo for surgical application (Underwood, Afoke et al. 2001; 
Branford, Mudera et al. 2008). However, only 2 out of 7 DFn treated tendons had 
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any macroscopic evidence of the material at 14 days. The biodegradability of the 
material is likely to be an advantage, reducing the risk of stimulating further 
inflammation and adhesion formation. 
 
Although the biomaterial was only tested in a partial tenotomy model where tendons 
did not require suture, it is likely that the material will be effective in sutured 
transected tendon injuries. The increased inflammatory cascade as a result of 
suturing may be targeted by the material’s cellular effects, with dampening of the 
adhesion surface cellular response.  
 
7.2.3 Relating Structure to Hierarchical Mechanics of 
Immobilised and Mobilised Flexor Tendon Adhesions 
This thesis adopted a hierarchical approach to examine the mechanical behaviour of 
immobilised and mobilised digital flexor tendon adhesions. Macroscopically, the 
immobilised adhesions were more fibrous compared with the mobilised adhesions. 
Macromechanical testing demonstrated that immobilised adhesions had significantly 
higher values for structural stiffness and load at failure, than mobilised adhesions 
(Table 5.1). The structural stiffness of immobilised adhesions was 140% of that of 
mobilised adhesions. The corresponding value for the load at failure was 160%. The 
micromechanical assessment of adhesions employed a confocal laser microscope to 
visualise the movement of cell nuclei to examine local tissue organisation and local 
strain responses to applied stress. Cellular organisation and local strain responses 
were assigned values using image analysis software. The mean local strain for 
mobilised adhesions was 325% of that of the immobilised adhesions. This suggests 
that mobilised adhesions were more easily deformed by an applied force. However, 
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due to the variability, the differences in local strain values were not statistically 
significant. An unexpectedly high range of dynamic local adhesion patterns (stretch, 
compress, shear, random and tear) were observed in both adhesion groups. This may 
account for the high variability in local strain values. With more time available it 
would have been interesting to perform more local strain assessments to delineate 
local adhesion organisation more completely.  
 
7.2.4 The Attachment of Intrinsic and Extrinsic Tendon Cells 
and Adhesion Cells to Collagen and Fibronectin 
The investigation of cell attachment adopted a quantitative scientific approach to 
examine the attachment of the different cellular components of the tendon-synovial 
complex and adhesions to collagen type-I and Fn. The attachment of intrinsic tendon 
cells (tendon core and tendon surface cells) was statistically significantly higher than 
that of extrinsic tendon cells (synovial sheath cells) to both collagen type-I and Fn. 
The attachment of cells derived from mobilised adhesions was statistically 
significantly higher than that of cells derived from immobilised adhesions to both 
collagen type-I and Fn. 
 
The results from this thesis have also shown that mobilisation favours the formation 
of elongated cells, which may in part explain why mobilised tendons demonstrate 
improved tensile properties. Li and colleagues have shown that elongated human 
tendon cells expressed 65% higher collagen type I than circular cells with the same 
cell area (Li, Li et al. 2008).  
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7.3 NOVEL APPROACHES TO THE ASSESSMENT AND 
STRATEGIC MODIFICATION OF FLEXOR TENDON 
ADHESION FORMATION 
7.3.1 Assessment of Adhesions 
7.3.1.1 Mechanical Assessment 
Few studies investigating flexor tendon adhesions incorporate both biomechanical 
and histopathological assessments (Isik, Ozturk et al. 1999; Strick, Filan et al. 2004; 
Thomopoulos, Kim et al. 2010). The investigation of the effects of the biomaterial in 
vivo utilised a reproducible injury for quantification of the effects of the biomaterial 
in the zone of healing using both tensiometer pullout and histopathological 
assessments. This enabled the mechanical effects of biomaterial treatment to be 
correlated to tissue cellularity and cell proliferation. 
 
This investigation has demonstrated that immobilised and mobilised adhesions differ 
at both micro- and macromechanical levels, supporting the need for a hierarchical 
approach to understand their behaviour (Katz, Misra et al. 2007). The confocal 
microscopy assessments described, using fibroblast nuclei as dynamic markers, have 
provided an accurate measure of local adhesion organisation and local strain 
responses to applied stress. Structural organisation is a dynamic entity and is only 
revealed by the application of stress. The local strains seen in tissues are strongly 
dependent on the associations between  the cells and the ECM (Screen 2004). This is 
the first investigation to describe the micromechanical changes in mobilised and 
immobilised tendon adhesions following injury, providing insight into the specific 
influence of in vivo loading on adhesion ECM remodelling. Increased local strain 
values and heterogeneity seen in the mobilised adhesions may explain why they are 
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less restrictive in vivo than immobilised adhesion. From the results of this thesis it 
appears that adhesions may fail in localised areas corresponding to more readily 
deformed subunit patterns. It is known that structural heterogeneity within tissues 
may alter their response to load and lead to mechanical failure (Zioupos, Gresle et al. 
2008). These findings are fundamental to providing a better understanding of the 
micromechanical building blocks that are responsible for the overall dynamic 
response of flexor tendon adhesions, which is critical to tendon glide and function.  
 
7.3.1.2 Assessment of Cell Attachment 
The results of this thesis have shown that the attachment of tendon core and tendon 
surface cells were statistically significantly higher than that of synovial sheath cells 
to both collagen type-I and Fn. The results of this investigation confirm the results of 
a previous study where synovial sheath fibroblasts had a lower attachment efficiency 
than did tendon cells (Riederer-Henderson, Gauger et al. 1983). However, the 
authors examined attachment to tissue culture plastic and not to ECM proteins. The 
study did not examine tendon cell attachment and did not assess adhesion cells or the 
effect of mobilisation on cell phenotype. It is clear that subpopulations of fibroblasts 
have differing phenotypes (Khan, Occleston et al. 1998; Ragoowansi, Khan et al. 
2003). Targeting such differences in the phenotypic expression of tendon and 
synovial sheath fibroblasts may prove useful for optimising future repair strategies 
that have a selective effect on wound healing (Sharma and Maffulli 2005). In this 
thesis mobilisation of injured digits resulted in greater attachment of adhesion cells 
to collagen type-I and Fn.  
271 
 
These findings suggest that one possible pathway for the beneficial effects of 
mobilisation in adhesions is in favouring the attachment and therefore contribution 
of intrinsic cells, which demonstrate greater attachment than extrinsic cells. 
 
The results from this thesis suggest that the differential avidity of cell attachment 
within the healing tendon-synovial complex is a potential therapeutic target when 
developing novel anti-adhesive strategies. It may be proposed that it may be possible 
to favour intrinsic cell contributions to tendon healing while minimising extrinsic 
tendon cell contributions. This may ultimately reduce the formation of restrictive 
adhesions without compromising tendon healing. 
 
7.3.2 Modification of Adhesions 
The effect of mobilisation on cell attachment has not been previously determined. 
Cell attachment is a prerequisite for migration (van der Flier and Sonnenberg 2001) 
and if cell attachment and migration is reduced this may prevent collagen deposition 
and fibrotic adhesion formation. The present work confirms that it is possible to 
reduce the restrictive nature of fibrous adhesion using a cell attachment based 
approach, without compromising tendon cellularity. In this way, the effect of 
mobilisation on differential healing in the tendon synovial-complex may be 
replicated. In the location of the DFn biomaterial it may be proposed that fibroblasts 
experience competitive inhibition for occupancy of their integrins, reducing their 
overall ability to bind to the ECM and to migrate. Inducing adhesion surface cellular 
paucity reduces strength of adhesions by diminishing ECM attachments, preventing 
the formation of bridging tissue connections.  
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The selectivity of the protein based treatment may be understood using a matrix 
based approach. Previous studies suggest that synovial sheath cells secrete greater 
quantities of Fn than tendon fibroblasts (Banes, Link et al. 1988; Brigman, Hu et al. 
1994). Conversely, synovial sheath cells produce less collagen than do tendon cells 
(Riederer-Henderson, Gauger et al. 1983). Previous authors have identified spatial 
and temporal-specific aspects to the healing process in a rabbit flexor tendon injury 
model (Berglund, Reno et al. 2006). The authors demonstrated using the reverse 
transcription polymerase chain reaction that there was a shift in collagen expression 
with a marked increase in type-III mRNA levels in both the tendon and tendon 
synovial sheath, with the greatest increase being seen in the tendon itself. Berglund 
and colleagues have also shown using similar techniques that collagen type-I is 
higher in the flexor tendon than in its synovial sheath (Berglund, Wiig et al. 2004). 
There appears to be a gradient from a Fn rich to a collagen rich environment from 
the synovial sheath to the tendon itself. Wong and colleagues investigated collagen 
type-I production in a mouse tendon injury model and found that the peak in 
production was later for tendon than in peritendinous tissues (Wong, Lui et al. 2009). 
This confirms that collagen synthesis in tendon and subcutaneous tissues is 
temporally different. It seems likely then that there is a spatial ECM gradient - from 
the synovial sheath to the tendon, and a temporal ECM gradient progressing from 
Fn-rich to collagen-rich tissue. In an in vivo canine study comparing Fn levels in 
injured tendons subjected to passive motion and immobilised controls there were 
higher levels of Fn in the mobilised tendon synovial-complex tissues (Amiel, 
Gelberman et al. 1991). Mobilisation may result in augmentation of the ECM 
gradients seen in the healing tendon. Ragoowansi and colleagues have demonstrated 
that synovial sheath cells produce greater amounts of matrix metalloproteinase 
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(MMP)-2 and MMP-9  when compared to tendon core cells (Ragoowansi, Khan et 
al. 2003). It has been proposed that there is flooding of the healing wound milieu 
with Fn following mobilisation (Amiel, Gelberman et al. 1991). This may result in 
competitive self inhibition (Brown 1983) and reduced synovial sheath cell 
attachment to the ECM as the synovial sheath is already exposed to a higher level of 
Fn than the tendon itself (Banes, Link et al. 1988; Brigman, Hu et al. 1994). 
Alternatively, increased Fn levels, combined with the increased MMP activity that 
has been observed in the synovial sheath cells in vitro (Ragoowansi, Khan et al. 
2003) may result in proteolytic Fn fragments being produced which have been 
shown to inhibit cell-ECM binding (Yamada and Kennedy 1984; Fukai, Takahashi et 
al. 1996; Fukai, Hasebe et al. 1997; Watanabe, Takahashi et al. 2000; Yamada 
2000). Watanabe and colleagues have shown that MMP-2 may play a particularly 
important role in generating biologically active ECM fragments (Watanabe, 
Takahashi et al. 2000). Certain Fn peptides can inhibit cell attachment and migration 
on Fn without concomitant effect on collagen binding (Oharazawa, Ibaraki et al. 
2005). If this observation is combined with the presence of the spatial Fn gradient it 
would follow that extrinsic cell attachment may be selectively inhibited in the 
peritendinous tissues following mobilisation. In this way mobilisation may share a 
common pathway with the action of the DFn biomaterial in the in vivo study 
(Branford, Mudera et al. 2008; Chapter 4). If the DFn biomaterial releases Fn 
fragments at the collagenous tendon surface then cell adhesion would be maintained, 
but reduced at the predominantly Fn-based adhesion surface. This would reduce the 
ability of fibroblasts to attach, migrate and lay down collagen across the interface. 
Hence adhesion would be reduced but tendon repair sustained.  
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Shimo-Oka and colleagues demonstrated that human fibroblasts have differential 
properties when attaching to ECM proteins (Shimo-Oka, Hasegawa et al. 1988). The 
authors showed that the production of a Fn fragment following trypsinisation 
inhibited fibroblasts from attaching and spreading on to Fn, without inhibiting 
attachment to collagen. In a more recent study, the authors demonstrated that RGD 
peptides inhibit cell attachment and migration on Fn without concomitant effect on 
collagen binding and migration (Oharazawa, Ibaraki et al. 2005). This is likely to be 
due to the collagen binding domain of Fn being spatially distinct from its cell 
binding (RGD) domains (Ruoslahti, Hayman et al. 1980), suggesting a further 
mechanism for a differential effect on tissue cellularity.  
 
It may be proposed that preventing the attachment of the poorly adherent extrinsic 
cells to Fn may be a suitable target for selective inhibition within the tendon healing 
complex. This may explain the results of Chapter 4 that demonstrated a significant 
reduction in the restrictive nature of postsurgical adhesions following treatment, 
associated with a significant decrease in adhesion surface cellularity, without 
compromising tendon cellularity (Branford, Mudera et al. 2008).  
 
Increased cellularity was seen within both the adhesion and tendon tissue during in 
vivo DFn testing. This may be the result of the pro-proliferative action of Fn 
fragments (Zlatopol'skii, Chubukina et al. 1989; Zlatopol'skii, Chubukina et al. 
1992). Cells deeper within the tendon may be protected by having more of their 
ECM binding sites occupied. Alternatively, cells deep within the tissues may not be 
exposed to such high levels of anti-adhesive fragments, partly due to the dissolved 
anti-adhesive fragments going into the systemic circulation. The effects of the anti-
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adhesive fragments may also be diminished by the presence of other proteins from 
the surgical wound.  
 
Tendon fibroblasts are highly sensitive to their mechanical environment, detecting 
strain during tissue loading (Asundi and Rempel 2008). Fibroblasts respond through 
mechanotransduction pathways, transducing mechanical into chemical information 
(Gillard, Reilly et al. 1979; Slack, Flint et al. 1984; Abrahamsson 1991; Khan, 
Edwards et al. 1996; McNeilly, Banes et al. 1996; Screen, Lee et al. 2003; Chiquet, 
Gelman et al. 2009). These signals are integrated with growth factor derived stimuli 
to achieve specific changes in gene expression to remodel the ECM. Strain-induced 
changes in biomechanical properties are likely to be the result of changes in ECM 
production and MMP activity, secondary to strain-induced changes in growth factor 
and cytokine production (Zeichen, van Griensven et al. 2000; Archambault, Tsuzaki 
et al. 2002; Webb, Hitchcock et al. 2006). Mechanical strengthening most likely 
results from increased collagen type-I production through transforming growth factor 
beta-1 (TGFβ-1) and connective tissue growth factor (CTGF). ECM adhesion 
contacts are now recognised as the major sites of crosstalk between mechanical and 
chemical stimuli (Chiquet, Gelman et al. 2009). For fibroblasts, production of the 
ECM is a prominent response to changes in mechanical load. Integrin-containing 
cell-ECM adhesion contacts are essential for force transmission from the ECM to the 
cytoskeleton. For these reasons using a cell-ECM attachment based approach to the 
problem of adhesion formation is useful if progress in developing anti-adhesive 
treatments is to be made. 
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7.4 FUTURE WORK 
These findings may pave the way for a clinical study to use the DFn biomaterial to 
reduce adhesion formation after tendon repair. However, further studies need to be 
carried out assessing DFn treated sutured transected tendons that are mobilised to 
relate the treatment to the clinical situation. Longer time points need to be assessed 
to determine whether abolishing the initial adhesion response dampens the entire 
response or whether it is merely delayed. However, therapeutic benefit is likely in 
either case. 
 
In future work it would be interesting to stain the in vivo specimens for -smooth 
muscle actin (-SMA) to determine the presence of myofibroblasts, which contribute 
to excessive fibrosis in healing tissues (Desmouliere, Chaponnier et al. 2005). 
Ragoowansi and colleagues demonstrated that synovial sheath fibroblasts 
demonstrated greater amounts of intra-cellular -SMA than tendon core cells, 
implying that synovial sheath fibroblasts play an active role in adhesion formation 
and should be specifically targeted to inhibit or treat tendon adhesions (Ragoowansi, 
Khan et al. 2003).     
 
In future work, the anti-adhesive DFn biomaterial could be separated into fractions 
according to heparin or gelatin binding affinity, and by ultrafiltration according to 
molecular weight. Each of these fractions could be tested for their effects in vitro and 
in vivo. However, it is likely that the DFn biomaterial is a heterogeneous mix of 
fragments which may act synergistically or in combination. Alternatively the 
material may only have its effects while the solid material is dissolving and may not 
possess anti-adhesive properties in soluble form. 
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The attachment model developed in this thesis allows for testing the efficacy of 
potential anti-adhesion strategies in differentially affecting cell attachment to various 
ECM proteins. Novel treatments may be introduced into this system by topical 
application over the protein coated plates before the cells are seeded onto the 
proteins. Other substances with a similar effect to the DFn biomaterial, without the 
stigma of being derived from a blood product could be tested. For example, 
epigallocatechin-3-gallate (EGCG), a constituent of green tea, has been shown to 
have an effect on TGFβ-1-stimulated wound contraction (Klass, Branford et al. 
2010). Hung and colleagues have shown that EGCG inhibits fibroblast to Fn binding 
(Hung, Huang et al. 2005). It appears to bind to Fn but not to collagen and therefore 
possesses selective properties in inhibiting cell adhesion to ECM components. 
Similarly the quantitative hierarchical mechanical and histopathological models used 
in this thesis could be used to test anti-adhesive treatments, introduced at the time of 
injury, for their effects on adhesion formation. 
 
Peptides of Fn also have effects on cells other than fibroblasts that are found in the 
surgical site, for example promotion of chemotaxis and adhesion of monocytes 
(Clark, Wikner et al. 1988; Chung and Kao 2009), and promotion of phagocyte 
activity (Czop and Austen 1982). It would be interesting to determine if these had 
beneficial effects on reducing post-surgical wound infection, which is a potential 
cause of worsening adhesions. 
 
In future studies selective matrix based approaches may be combined with cytokine-
based strategies to provide further selectivity in tendon healing. Fu and colleagues 
found that in the presence of TGF-ß1, the gene expression of procollagen type-I was 
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promoted in tendon fibroblasts anchored to a collagen type-I matrix, but not in those 
with Fn anchorage (Fu, Wong et al. 2005). Klass and colleagues demonstrated a 
differential response in rabbit endotenon, epitenon and synovial sheath in cells in 
collagen type-I gene expression in response to TGF-β1 in vitro (Klass, Rolfe et al. 
2009). 
 
In future work, bilayered scaffolds, with an inner adherent mesenchymal stem cell 
seeded layer and an outer anti-adhesive layer, could be tissue engineered in 
bioreactors with cyclic strain regimes. These could have cytokines incorporated then 
implanted and tested in vivo. 
 
There are several plastic reconstructive surgical applications where the lines of 
investigation used in the present study may be useful. Tissue engineering is likely to 
play an ever increasing role in future plastic surgery research and is pervaded by 
principles of mechanotransduction. The techniques described in the present study 
have broad application to healing tissues subject to distortion under strain. The 
dynamic assessment of the organisation of healing tissues, especially where they are 
under applied load, would be suitably applied to investigating cutaneous scarring, 
and also in ligament and muscle healing. Such approaches would be readily 
transferrable to other areas of hand surgery, for example, in assessing novel 
therapeutic strategies in Dupuytren’s disease. Outside the field of plastic surgery 
such approaches are relevant to assessing dynamic healing tissues as occur following 
cardiac injury, or post surgical intra-abdominal adhesions, where the mechanical 
properties of these tissues under shear stress are critical to function. The tendon 
models described in this thesis would be applicable to a much wider context for the 
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testing of anti-adhesion treatments, due to the commonality of the process of 
adhesion formation at different anatomical sites. 
 
Proposed future studies: 
 Various topical anti-adhesive treatments could be tested for their differential 
effects on matrix attachment using the models described in this thesis 
 Further micromechanical assessments could be made, at slightly lower 
magnification, to try to understand how the individual dynamic adhesions 
patterns fit together to form higher order adhesions 
 A bilayered tissue-engineered biomaterial could be developed with an 
adhesive inner (tendon surface) layer seeded with mesenchymal stem cells 
and an outer anti-adhesive (synovial) layer: Cytokines could be incorporated 
into these materials to further enhance selectivity in tendon healing, with the 
materials being conditioned in bioreactors prior to implantation in vivo 
 
7.5 GENERAL SUMMARY 
This thesis presents a series of studies, used to develop a quantitative assessment of 
adhesion formation using biomechanical, histopathological, biological and dynamic 
cellular approaches in a rabbit flexor tendon-synovial complex injury model. The 
hypotheses challenged within this thesis were: 
 Mobilisation results in increased intrinsic cell attachment and reduced 
extrinsic cell attachment in adhesions 
 Mobilisation has a favourable effect on the local strain responses of 
adhesions to applied stress, which reduces the restrictive nature of the 
adhesions 
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 Selectively blocking cell-ECM attachment mimics the effects of mobilisation 
by selectively inducing adhesion surface cellular paucity. This reduces ECM 
deposition and fibrotic adhesion formation without compromising tendon 
cellularity 
 
A model system was developed, enabling the microanalysis of local strain fields 
within rabbit tendon adhesions, using the cell nuclei as dynamic strain markers. The 
system was used in conjunction with macromechanical analysis, in order to examine 
the mechanisms by which tendon adhesions are modified by mobilisation. The 
attachment of tendon-synovial complex cells and mobilised and immobilised 
adhesion cells to collagen and Fn was examined in vitro. A novel protein based anti-
adhesive biomaterial was investigated in vitro and in vivo to determine its effects on 
adhesion formation. 
 
These studies led to the following conclusions: 
 Mobilisation favours intrinsic cell attachment to the ECM relative to that of 
extrinsic cells and therefore intrinsic contributions to healing 
 Mobilisation results in three-fold higher local strain values and increased 
heterogeneity in adhesions. The increased heterogeneity may provide a 
mechanism for localised mechanical failure due to altered local strain 
patterns and therefore points of weakness in mobilised adhesions 
 Immobilised and mobilised adhesions differ at both micro- and 
macromechanical levels, supporting the need for a hierarchical approach to 
understand their behaviour 
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 A matrix based approach preventing cell-Fn attachment may mimic the 
effects of mobilisation by selectively reducing adhesion cellularity while 
maintaining tendon cellularity 
 
The hypotheses stated above are therefore accepted. Accordingly, it would appear 
that the local strain and ECM environment of fibroblasts in tendon adhesions is 
complex. Improving the understanding of how these local phenomena are linked 
together will enable the selective manipulation of healing in a way that further 
favours recovery of tensile strength in tendons while reducing restrictive adhesion 
formation. 
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APPENDIX 
APPENDIX I: SOLUTIONS AND PROTOCOLS 
DIAMINOBENZIDINE (DAB) SOLUTION 
1. Add 180 mg of 3, 3’-diaminobenzidine tetrahydrochloride to 270 mL distilled 
water 
2. 30 mL Tris-buffered saline 
3. 1 mL imidazole solution 
4. Add 120 µL hydrogen peroxide just before use 
 
FORMAL SALINE  
For 10% formal saline: 
40% formaldehyde 100 mL 
Sodium chloride 9 g 
Water 900 mL 
 
IMIDAZOLE SOLUTION 
(Merck, Poole, UK) 
For 0.1M imidazole solution: 
Add 0.681 g imidazole to 100 mL distilled water 
Store at 4ºC 
 
NEUTRAL BUFFERED FORMALIN 
For 10% neutral buffered formalin: 
40% formaldehyde 100 mL 
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Distilled water 900 mL 
Sodium dihydrogen phosphate monohydrate 4 g 
Disodium hydrogen phosphate anhydrous 6.5 g 
 
HYDROGEN PEROXIDE SOLUTION 
For 3% hydrogen peroxide solution: 
Add 10 mL 30% hydrogen peroxide to 90 mL distilled water 
 
NORMAL HUMAN SERUM  
1. Withdraw 9 mL of blood into serum tube 
2. Allow to clot for 1 hour at room temperature 
3. Centrifuge at 3000 rpm for 15 minutes 
4. Remove supernatant 
5. Heat at 56C for 30 minutes (water bath) to denature complement 
6. Store at -20C in 500 µL aliquots in Eppendorf tubes 
 
PHOSPHATE BUFFERED SALINE (PBS) 
Dissolve 5 PBS powder sachets in 5 L distilled water 
Check pH 7.4 
 
PHOSPHATE BUFFERED SALINE-BOVINE SERUM ALBUMIN 
(PBS-BSA) 
Weigh out 100 mg bovine serum albumin (BSA) and dissolve in 100 mL PBS 
0.1% (w/v) BSA 
 329 
Store at 4C 
 
SODIUM CITRATE BUFFER 
For 0.01M sodium citrate (pH 6.0 at 25C): 
1. Weigh out 2.1 g citric acid monohydrate  
2. Add 950 mL distilled water 
3. Add 13 mL 2M NaOH. Make up to 1 L 
4. Adjust pH 6.0.  
5. Store at 4C 
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